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Abstract 
Daniel M. Gatti 
Genome-wide Analysis of Transcriptional Regulation in the Murine Liver 
(Under the direction of Ivan Rusyn, M.D. Ph.D.) 
The liver is a primary organ for toxicant metabolism in the body.  This metabolism 
in influenced by genetic polymorphisms that can alter protein structure and influence gene 
expression levels in an allele specific manner.  These polymorphisms produce significant 
differences in toxicant metabolism across human populations and an understanding of their 
influence on gene expression will improve our ability to predict toxic outcomes from 
chemical exposures.  In order to understand the influence of polymorphisms on gene 
expression across populations, we studied liver gene expression in a model system 
consisting of two panels of laboratory inbred mice.  We performed gene expression 
quantitative trait locus mapping in both panels of mice to discover polymorphisms that 
influence gene expression through both local and distant mechanisms and found several 
regions of the genome that regulate large numbers of genes in the liver.  We examined the 
effect of sex of liver gene expression in one of the mouse panels and found significant 
differences between the sexes in many genes involved in xenobiotic metabolism.  We also 
found that while gene expression level differences between sexes are important, there are 
also important differences in correlation between sets of genes in each sex.  Finally, we 
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studied the effect miRNAs on gene expression levels in the mouse liver and found, 
surprisingly, that their effect is mild.  This report adds several new discoveries to the 
literature on transcriptional regulation in the liver and improves our understanding of the 
complex factors that control constitutive gene expression. 
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Chapter 1 
 
Introduction 
 One of the goals of molecular toxicology is the discovery of the biochemical 
mechanisms underlying toxicity responses in humans.  This research leads to the discovery 
of genes and polymorphisms responsible for this toxicity and an understanding of how 
molecular pathways are altered in response to xenobiotic exposure.  Recent advances in 
high-throughput methods of gathering biological data and in computational power to 
manipulate these data sets has changed the manner in which this research can be conducted.  
While toxicology will always rely upon systematic in vitro and in vivo investigation of 
model systems, the generation of new hypotheses regarding the genetic causes of toxicity 
has benefited greatly from the sequencing of mammalian genomes and the invention of 
gene expression microarrays.  The sequencing of several mammalian genomes, including 
mouse (Waterston et al. 2002) and human (Venter et al. 2001), has opened up new methods 
for investigating the genetic basis of toxicity responses.  Gene expression microarrays have 
produced a global view of transcriptional changes in response to xenobiotic exposure and 
allow investigators to discover clusters of genes, that may be part of the same biological 
pathway, that are related to injury.  The combination of these two developments has opened 
up new approaches to the understanding of toxicity as affected by differing genetic 
backgrounds. 
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 In vivo toxicity screens and mechanistic studies are often carried out in a single 
strain of mouse (Rao et al. 1998; Morgan et al. 1999; Constan et al. 2002).  This is done in 
order to fix as many variables as possible and has the benefit of standardizing the genotype 
across multiple chemicals.  While this approach provides mechanistic information about 
toxicant activity in a single genetic background, the reality of human toxicity is more 
complex, including both diverse genetic backgrounds and uncontrolled environmental 
effects.  Environmental interactions such as synergistic or additive effect of multiple 
toxicants, nutritional and disease status are important aspects of human toxicology.  Genetic 
background is also an important component of toxicity responses (Chorley et al. 2008; 
Lowes and Buttrick 2008).  A successful in vivo approach to modeling the effects of genetic 
diversity on toxicity will both improve the prediction of toxicity in humans as well as 
improve the identification sensitive sub-populations. 
 While human diseases such as diabetes, high cholesterol and obesity can be studied 
directly in humans, many toxicity phenotypes cannot be studied directly because it is 
unethical to dose humans with most toxicants.  This has led to a focus on in vitro methods 
in human derived cell lines as well as the use of animal models.  Rodent models in 
particular have been extensively used for in vivo toxicity testing.  The laboratory mouse in 
particular has proven useful in dissecting the complex relationships between genetics and 
toxicity due to the large number of existing inbred strains and the high degree of synteny 
between the mouse and human genomes.  Panels of inbred mice have also been shown to 
have phenotypic (Svenson et al. 2007) and genetic diversity (Roberts et al. 2007b) similar to 
that observed in human populations, which is critical for the application of mouse models to 
understand the genetic basis of toxicity responses. 
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 When research into the genetic basis of toxicity is initiated, the responsible genes 
could lie anywhere in the genome.  A forward genetics approach, in which the genetic basis 
of this toxicity investigated, is a reasonable approach to this problem.  The first step is to 
search for evidence that the responsible genes lie in certain chromosomal regions by 
searching for correlation between the toxicity phenotype and genotype at loci throughout 
the genome.  This is often carried out using quantitative trait locus (QTL) mapping (Lander 
and Botstein 1989; Haley and Knott 1992).  This involves selecting or breeding a 
genetically segregating population, such as a backcross or intercross of two inbred parental 
strains, which demonstrates quantitative variation in the toxicity phenotype of interest.  This 
quantitative phenotype, such as liver histology score or serum alkaline aminotransferase 
levels, is measured in each individual, who is then genotyped at a number of markers across 
the genome.  A statistic of association, such as a likelihood ratio statistic or a linear model, 
is then calculated between the phenotypic values and each marker.  QTL mapping of 
clinical phenotypes has been used to study ethanol related behavior (Crabbe 2002), ethanol 
metabolism (Grisel et al. 2002), iron transport (Wang et al. 2007) and other diseases and 
phenotypes. 
 QTL mapping can be performed on any quantitative phenotype.  With the 
maturation of gene expression microarrays (Allison et al. 2006), a proposal was made to 
study the genetics of transcriptional regulation by performing QTL mapping on the 
expression traits (Jansen and Nap 2001) (eQTL mapping).  In this approach, the intensity of 
each transcript in a panel of individuals is used a phenotype in QTL mapping.  Since 
microarrays measure the expression of transcripts on the order of 105, this leads to tens of 
thousands of QTL plots.  eQTL mapping can be combined with clinical trait QTL mapping 
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by searching for eQTL that are co-located with clinical trait QTL, thus implicating the 
gene(s) with eQTL at the same locus as influencing the clinical trait (Schadt et al. 2003).  
This type of analysis pre-supposes that some traits are influenced by expression variation 
alone as opposed to non-synonymous coding SNPs, but data from natural populations 
suggests that this is not an unreasonable assumption (Oleksiak et al. 2002). 
 Early eQTL studies surveyed natural variation in crosses of model organisms such 
as budding yeast (Brem et al. 2002; Yvert et al. 2003) and mouse (Schadt et al. 2003).  In 
the mouse, two inbred parental stains are selected and bred in either a backcross or 
intercross design.  All progeny mice are genotyped at a density sufficient to distinguish all 
recombination blocks and microarrays are used to measure transcript expression.  Both 
investigators reported significant numbers of eQTL (~9% of the transcripts surveyed) and 
demonstrated that there are genomic loci that contain more eQTL than expected by chance.  
These eQTL “hotspots” (Schadt et al. 2003) are thought to regulate the expression levels of 
dozens of transcripts and have been observed in several tissues in the mouse (Schadt et al. 
2003; Chesler et al. 2005; Bystrykh et al. 2005).  By examining the genes that lie beneath 
the eQTL hotspot, investigators can propose regulatory candidates for the transcripts with 
eQTL at the hotspot. eQTL studies also commonly identify both cis-acting eQTL (Doss et 
al. 2005), for which a transcript’s  eQTL is located near the transcript itself, and trans-acting 
eQTL, for which a transcript’s eQTL is located far from the transcript.  It has been 
hypothesized that cis-eQTL are caused by polymorphisms in regulatory regions close to the 
transcript itself whereas trans-eQTL are caused by polymorphisms in distant genes that 
affect transcript expression, either directly or indirectly, in an allele specific manner. 
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 The accuracy of cis-eQTL detection has been called into question due to the 
possibility of SNPs residing within the sequence queried by microarray probes (Doss et al. 
2005; Alberts et al. 2007; Ciobanu et al. 2010).  Microarray probes are designed based on 
the reference sequence of C57BL/6J.  Transcripts in other strains with polymorphisms in 
the probe sequence will bind with lower affinity than the C57BL/6J transcript, giving the 
false appearance of allele specific expression levels associated with the transcript location, 
which is the defining characteristic of a cis-eQTL.  Studies in which shorter 25 nucleotide 
microarray probes are used (Alberts et al. 2007) appear to be more significantly affected 
than studies that use longer 50 to 60 nucleotide long probes (Doss et al. 2005; Ciobanu et al. 
2010).  This is consistent with the hypothesis that a SNP within a probe sequence will affect 
short probe more strongly than longer probes.  
 The validity of eQTL hotspots has also been questioned (de Koning and Haley 2005; 
Breitling et al. 2008) due to the possibility that sets of highly correlated genes will naturally 
cluster over the same genomic marker.  Further, sets of highly correlated genes are likely to 
be part of the same Gene Ontology (GO) category and so when GO category enrichment is 
conducted on eQTL hotspots, they are likely to (falsely) appear biologically coherent.  A 
permutation strategy, in which the sample labels are permuted and the expression labels are 
held fixed, has been suggested to address this problem (Churchill and Doerge 2008; 
Breitling et al. 2008).  False eQTL hotspots may also arise due to intersample correlation 
and a mixed-model approach has been shown to eliminate spurious eQTL hotspots in mouse 
data (Kang et al. 2008a). 
 Another matter of concern in eQTL mapping studies is how to control for the 
massive multiple testing involved.  There are two levels of multiple testing carried out in an 
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eQTL study; multiple testing across correlated SNPs and across multiple correlated 
transcripts.  Multiple testing across SNPs may be addressed by permuting the sample labels 
in the genotype data while holding the expression data fixed (Churchill and Doerge 2008).  
Multiple testing across genes may be addressed using approaches based on the false 
discovery rate (Storey and Tibshirani 2003). 
 While the study of individual genes is informative and can improve our 
understanding of the causes of differential toxicity in populations, a broader approach that 
focuses on gene networks and biological pathways may produce more interpretable results.  
eQTL mapping can be used to generate hypotheses regarding transcriptional regulation and 
can be integrated with gene co-expression data to discover gene networks or pathways that 
are associated with a clinical trait.  For example, transcript expression data in the livers of a 
panel of C57BL/6J x DBA/2J F2 mice was combined with obesity data and eQTL mapping 
to produce causal gene expression networks (Zhu et al. 2004; Drake et al. 2005).  eQTL 
data may also be combined with estimates of transcription factor activity to infer causal 
relationships between transcription factors and clusters of eQTL genes (Sun et al. 2007).   
Other methods to infer causality between regulatory candidate genes under eQTL hotspots 
and the trans-regulated genes that map to the eQTL locus have also been proposed to assist 
in narrowing the list of candidate genes for further biological investigation (Doss et al. 
2005; Peng et al. 2007). 
 Network based approaches have been used in research into Type I diabetes and heart 
disease and have shown the power of integrating human data with data derived from mouse 
models.  A genome wide association study in a large human population proposed the 
receptor typrosine kinase ERBB3 as the best candidate gene near a QTL for Type I diabetes 
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(Wellcome Trust Case Control Consortium 2007).  Separate work that examined liver gene 
expression in a smaller cohort of human samples with and without Type I diabetes found 
that ERBB3 did not have a cis-eQTL but that a flanking gene, RPS26, did.  Since the disease 
phenotype and RPS26 both had QTLs in the same location, this suggested the RPS26 was a 
stronger candidate than ERBB3.  The authors then used mouse liver and adipose expression 
data from several mouse crosses to construct causal expression networks for the ERBB3 and 
RPS26 orthologs in the mouse.  They then showed that ERBB3 is not associated with any 
known Type I diabetes genes whereas RPS26 is associated a network of several genes that 
are part of the KEGG Type I diabetes pathway (Schadt et al. 2008).  This type of analysis 
demonstrates the power of combining human and mouse data with a network based 
approach that has been proposed for use in drug discovery (Schadt et al. 2009) and may 
prove useful in toxicology. 
 Specific Aim 1, Fast eQTL Mapping in Homozygous Populations, consists of a 
hypothesis driven approach to software development in which we surmised that the 
conventional gene expression quantitative trait locus (QTL) mapping algorithms suffered 
from a lack of computational efficiency and could be greatly improved through the use of 
algebraic and algorithmic improvements.  By carefully analyzing the structure of the data 
and the calculations, we were able to provide a 10-fold improvement in computational 
efficiency.  We packaged this algorithm into a user-friendly software packge called 
FastMap, which is freely and publicly available. 
 Specific Aim 2, Genome-level analysis of genetic regulation of liver gene 
expression networks, was motivated by the hypothesis that novel liver transcriptional 
networks can be discovered by measuring gene expression in a panel of recombinant inbred 
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mice.  Previous work in the brain and hematopoetic stem cells demonstrated that panels of 
recombinant inbred mice can increase our understanding of which genes form co-expressed 
clusters, can produce putative regulatory candidates for these clusters of genes and can 
produce candidate genes that regulate liver phenotypes.  The data was deposited in 
WebQTL, a publicly available database of gene expression and phenotypic data to allow 
future investigators to correlate their phenotype data with our liver expression data to 
candidate discover genes meriting further biological follow-up. 
 Specific Aim 3, Sex-specific Gene Expression in the BXD Mouse Liver, is a 
reanalysis of the same liver gene expression data collected in Aim 2, but with a focus on sex 
differences in gene expression.  Our hypothesis was that there are liver gene expression 
differences between the sexes that are relevant to liver toxicology.  We studied differences 
in expression levels, in transcriptional regulation and in network connectivity between male 
and female mice and discovered significant differences in Cytochrome P450s, Flavin-
containing Mono-oxygenases and Glutathione-S-Transferases.  We also compared the 
direction and degree of differential expression of gene in the mouse liver with a human liver 
gene expression data set. 
 In Specific Aim 4, Replication and Narrowing of Gene Expression Quantitative 
Trait Loci in Inbred Mice , we hypothesized that gene expression quantitative trait loci from 
a panel of recombinant inbred mice are reproducible in a separate panel of related inbred 
mice.  To test this hypothesis, we analyzed liver gene expression data in a panel of 
commonly available laboratory inbred mice and examined the overlap between QTL from 
this panel and from the QTL discovered in Aim 2.  We found a remarkable overlap in gene 
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expression QTL and concluded that the replication of gene expression QTL in inbred mice 
should prove highly useful to future investigators. 
 Finally, in Specific Aim 5, MicroRNA Expression Profiling of the Mouse Liver, we 
hypothesized that constitutive liver transcript levels are influenced by microRNA 
expression levels in the mouse liver.  We measured liver miRNA expression in the two 
panels of inbred mice used in Aims 2 and 4, and searched for correlations between miRNA 
and gene expression.  Surprisingly, we found that liver miRNA levels do not correlate well 
with the expression of predicted target transcripts and hence, that miRNAs are not critical 
regulators of constitutive transcript abundance.  
 
 
 
 
 
Chapter 2 
 
FastMap: Fast eQTL Mapping in Homozygous Populations 
 
Introduction 
 
Quantitative Trait Locus (QTL) mapping is a set of techniques that locates genomic 
loci associated with phenotypic variation in a genetically segregating population. QTL 
mapping has been highly successful in determining causative loci underlying several 
disease phenotypes (Wang et al. 2004; Cervino et al. 2005; Abboud and Kaplowitz 2007) 
and can broadly be subdivided into two classes: linkage mapping and association mapping. 
For standard linkage mapping in experimental crosses, likelihood or regression approaches 
are used to map QTL, with flanking markers used to infer genotypes in the intervals 
between widely spaced markers (i.e. > 1cM) (Lander and Botstein 1989; Haley and Knott 
1992). As marker density increases, linkage statistics may be computed at individual marker 
loci, with minimal loss in precision or power (Kong and Wright 1994). In contrast, simple 
association mapping does not attempt to explicitly consider the linkage disequilibrium 
structure between marker loci, and thus typically considers association statistics computed 
only at the marker loci. In either case, the statistics computed at the markers in experimental 
cross linkage designs, and in association studies, are often identical, e.g. t-statistics to detect 
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differences in phenotype means as a function of genotype. Here, we consider the case of 
markers collected at sufficient density so that association statistics may be calculated only at 
the observed markers. 
Recent advances in gene expression and single nucleotide polymorphism (SNP) 
microarray technology have lowered the cost of collecting gene expression and high density 
genotype data on the same population. These technologies have been used to produce high 
density SNP data sets with thousands of transcripts and millions of allele calls in both mice 
(El Serag and Rudolph 2007; Szatkiewicz et al. 2008) and humans (Frazer et al. 2007). 
eQTL mapping has been successfully carried out in several inbred mouse populations 
(Schadt et al. 2003; Pletcher et al. 2004; Chesler et al. 2005; Bystrykh et al. 2005; Gatti et 
al. 2007; McClurg et al. 2007). These studies have provided a revealing genome-wide view 
of the genetic basis of transcriptional regulation in multiple tissues, and form a necessary 
foundation for systems genetics (Mehrabian et al. 2005; Kadarmideen et al. 2006). 
The calculation of associations between tens of thousands of transcripts and 
thousands to millions of SNPs creates a computational challenge that can stretch or 
overwhelm existing tools. These challenges are further compounded by multiple 
comparison issues arising from the large number of available SNPs and transcripts. Various 
methods have been used to address these issues. A resampling approach (Churchill and 
Doerge 1994; Carlborg et al. 2005; Peirce et al. 2006) is one common way of addressing 
multiple comparisons among markers, and it is used by several available QTL mapping 
tools (Manly et al. 2001; Wang et al. 2003; Broman et al. 2003). Multiple comparisons 
among transcripts has been previously addressed by thresholding transcripts using q-values 
(Storey and Tibshirani 2003) obtained from transcript specific testing of association with 
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SNPs using likelihood ratio statistic (Chesler et al. 2005) or the mixture over markers 
method (Kendziorski et al. 2006). 
While parallel computation has been suggested as a potential solution to the 
computational challenges associated with eQTL analysis, (Carlborg et al. 2005), many 
researchers have neither the expertise nor the resources required to administer and maintain 
a computing cluster. To address the growing need for eQTL mapping in high density SNP 
data sets, and the poor scalability of the existing computational tools, we developed the 
FastMap algorithm and implemented it as a Java-based, desktop software package that 
performs eQTL analysis using association mapping. We achieve computational efficiency 
through the use of a data structure called a Subset Summation Tree, which is described in 
the Methods section below. FastMap performs either single marker mapping (SMM) or 
haplotype association mapping (HAM) by sliding an m-SNP window across the genome 
(Pletcher et al. 2004). FastMap is currently intended for use with inbred mouse strains. 
Significance thresholds and p-values are calculated for each transcript using multiple 
permutations of transcript expression values. In order to address multiple comparisons 
across transcripts, FastMap assigns a q-value (Storey and Tibshirani 2003) assessing FDR, 
to each transcript. We apply our software tool to two publicly available data sets consisting 
of gene expression measurements in panels of inbred mice and compare our results to other 
software tools. 
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Methods 
 
This section first describes the calculations of test statistics (correlations) for SMM 
in a 1 SNP sliding window. First we introduce the concept of a subset sum Mg(s) and a 
Subset Summation Tree. Subset sums are quantities that can be efficiently calculated using 
the subset summation tree, and are used in the calculation of correlations. We then show 
how the subset sums and Subset Summation Tree can be adapted to the fast calculation of 
ANOVA test statistics for m-SNP sliding windows (m > 1). 
In association mapping for homozygous inbred strains, the input data consists of two 
matrices: the first contains real-valued transcript expression measurements and the second 
contains SNP allele calls, coded as 0 for the major allele and 1 for minor allele. Each matrix 
has the same number of samples (strains) n. Let S be the number of SNPs and let G be the 
number of transcripts. 
Homozygous SNPs: 1 SNP window. We use the Pearson correlation as an association 
statistic in the case of a 1 SNP window. For a given transcript g and SNP s the correlation 
between g and s is 
 
 
 
To simplify the formula, we assume without loss of generality that each transcript 
expression vector g is centered and standardized such that 
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In this case, the correlation expression reduces to 
 
 
 
The denominator can be calculated once for each SNP, because it depends only upon the 
Hamming weight of s. By contrast, the numerator must be calculated for every SNP-
transcript pair (S x G computations). Our goal is to speed up calculation of the numerator.  
Denote the numerator by Mg(s): 
 
 
As the SNPs are binary, Mg(s) is simply the sum of transcript expression values over a 
subset of samples defined by the minor allele of the SNP. 
To illustrate how the calculation of theMg(s) can be simplified, consider two SNPs s 
and s’ that differ only at the ith position (thus s and s’ have Hamming distance of 1): 
s = (s1, s2, …, si-1,  si = 0, si+1, …, sn) 
s’ = (s1, s2, …, si-1,  s’i = 1, si+1, …, sn) 
In this case, the quantity Mg(s’) can be calculated quickly (in one arithmetic operation) from 
Mg(s) as follows: 
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For any given transcript, the association statistic is the same for SNPs with the same 
strain distribution pattern (SDP). Hence, we calculate the association statistic once for each 
unique SDP. The McClurg mouse data used in this paper contains 156,525 SNPs, but has 
only 64,157 unique SDPs. Additional improvements are based on Formula 2. To take full 
advantage of this relationship between correlations, we construct a tree, which we call a 
Subset Summation Tree. The vertices of the tree correspond to unique subsets of samples. 
Each SDP defines a subset of samples associated with its minor allele. The tree contains all 
SDPs appearing in the SNP matrix. By construction, the edges of tree connect SDPs which 
differ in one position (i.e. Hamming distance 1). The process of tree construction is 
described later in this section. It ensures that the tree is at least as efficient (in terms of 
weight based on the Hamming distance) as the minimum spanning tree connecting all SDPs 
from the SNP matrix. An illustration of a subset summation tree is given in Figure 2.1. 
 
Figure 2.1. The Subset Summation Tree is used to calculate the covariance sums in 
Pearson’s correlation statistic. The table shows one gene expression vector and 6 
corresponding SNP vectors for 7 strains. At each node, the covariance of the gene 
expression with each SNP is calculated with one addition operation. 
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Traversing the tree we can calculate the covariance Mg(s) for all SDPs in the tree 
with 1 arithmetic operation per SDP. One additional arithmetic operation is required to 
calculate the correlation from Mg(s). 
 
Homozygous SNPs: m-SNP sliding window. The use of a consecutive 3-SNP sliding 
window has been shown to improve the associations that can be detected in mouse studies 
(Pletcher et al. 2004). FastMap is capable of employing any m-SNP window specified by 
the user. Within each m-SNP window, the strains form haplotypes that partition strains into 
ANOVA groups. A one way ANOVA test statistic is then used to assess the relationship 
between a gene g and an m-SNP window. 
Consider a 3-SNP window that contains k unique haplotype (ANOVA) groups 
across the n stains. Let Ai denote the set of samples in the ith ANOVA group, and let the 
transcript expression values in the ith ANOVA group be The associated ANOVA test 
statistic is calculated as 
 
 
where the between group sum of squares SSB, and within group sum of squares SSW are 
calculated as follows: 
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The sums of squares are related by SST = SSB + SSW. For a given transcript, the total sum 
of squares (SST) remains constant across all SNPs. As in the 1-SNP window case, the gene 
expression values are standardized to satisfy the conditions in Equation(1). For standardized 
expression measurements, the SST and SSB calculations simplify as follows: 
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where Mg(Ai) is sum of the transcript expression values for the ith ANOVA group. As 
before, Mg(Ai) can be calculated efficiently using the Subset Summation Tree. The 
difference is that the tree for these calculations connects subsets of samples defining the m-
SNP ANOVA groups, as opposed to SDPs defined by single SNPs. Once the SSB is 
calculated, the F statistic is calculated as: 
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Tree Construction. The Subset Summation Tree is used for fast calculation of Mg(Ai) - 
sums of transcript expression values over subsets of samples Ai. Tree construction is 
initiated by obtaining the family of sample subsets of interest Ai from the set of SNPs. The 
tree is grown starting from single root element (empty subset) by sequential addition of the 
nearest element from Ai to the tree. 
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All the subsets Ai are put in a hash table (HT) that stores the subsets that are not yet 
members of the tree. The tree is grown by connecting subsets that are at the minimum 
distance from the tree. Node selection and connection to the tree can be optimized by taking 
advantage of two facts. First, the Hamming distances are positive integers. Thus, once we 
find a subset in the HT within distance 1 of a particular tree vertex, we connect them, 
adding the subset to the tree and removing it from the HT. To find such an SDP in the HT 
we use the second fact: for any subset, there are only n possible subsets that are within 
hamming distance 1 from it. Thus, instead of calculating distances from a certain tree vertex 
to all subsets in the HT we can check if the HT contains any of the n possible neighbor 
subsets. This approach reduces the complexity of the search for close (within distance 1) 
neighbors of a given tree vertex from O(nS) to O(n). 
The procedure above is applicable as long as there are SDPs in the HT within 
distance 1 from the tree. Once there are no SDPs in the HT within distance 1 from tree 
vertices, the search continues for SDPs within distance 2. The same optimizations are 
applicable here - once an SDP within distance 2 is found, it should be connected to the tree 
and there are n(n - 1)/2 possible SDPs within distance 2 from a given tree vertex. The same 
technique is applied even for the search for subsets within distance 3. When the remaining 
vertices are at Hamming distance 4 or greater, an exhaustive search is performed to find a 
node in HT that is a minimum distance from the tree. This process is repeated until all SNPs 
have been inserted into the tree. 
 
Permutation Based Significance Thresholds. For a single transcript, the association statistic 
is calculated between the observed values of that transcript and all SNPs. The transcript data 
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is then permuted while the SNP data is held fixed. Association statistics are calculated 
between the permuted transcript values and all SNPs and the maximum association statistic 
is stored. The distribution of the maximum association statistics obtained from 1000 
permutations of the transcript’s values is used to define significance thresholds for 
individual (transcript, SNP) pairs, and to assign a percentile based p-value to the observed 
maximum association of the transcript across SNPs. 
 
Significance Across Multiple Transcripts. The procedure above assigns a p-value to each 
transcript that accounts for multiple comparisons across SNPs through the use of the 
maximum association statistic. In order to correct for multiple comparisons across 
transcripts, we calculate q-values (Storey and Tibshirani 2003) for each transcript, using the 
p-values obtained from the permutation based maximum association test. 
 
BXD Gene Expression Data. The BXD Liver data set is available from genome.unc.edu, 
and is described in (Gatti et al. 2007). Briefly, it consists of microarray derived expression 
measurements for 20,868 transcripts in 39 BXD recombinant inbred strains and the 
C57BL/6J & DBA/2J parentals. The data was normalized using the UNC Microarray 
database and QTL analysis was performed on all transcripts. 
 
BXD Marker Data. The BXD marker data consists of 3,795 informative markers taken from 
a larger set of 13,377 markers. Briefly, consecutive markers with the same strain 
distribution pattern were removed and only the flanking markers of such regions were 
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included. The data was downloaded from www.genenetwork.org/genotypes/BXD.geno; 
further information is available at www.genenetwork.org/dbdoc/BXDGeno.html. 
 
Hypothalamus Gene Expression Data. The mouse hypothalamus data set GSE5961 was 
downloaded from the NCBI Gene Expression Omnibus website. This data is described in 
(McClurg et al. 2007). The 58 CEL files were normalized using the gcrma package from 
Bioconductor (version 1.9.9) in R (version 2.4.1). The data was subset to include only the 
31 male samples, and removing the NZB data because the entire array appeared as an 
outlier in hierarchical clustering of the arrays. There were 36,182 probes on the array; of 
these a subset of 3,672 transcripts having an expression value >200 and at least a 3-fold 
difference in expression in one strain were selected. Transcripts containing a single outlier 
strain with expression values >4 standard deviations from the mean were removed from the 
data set. There were 402 such transcripts, leaving 3,270 transcripts for analysis in FastMap. 
 
Hypothalamus SNP Data. The SNP data was obtained from (McClurg et al. 2007) and 
originally contained 71 inbred strains. Missing genotype data were imputed using the 
algorithm of (Roberts et al. 2007a). There were 156,525 SNPs, of which 99 were 
monomorphic across the 32 strains. These SNPs were removed from the analysis, leaving 
156,426 SNPs. There were 64,790 unique SDPs in this final data set.  
In section 3.2 we compare FastMap performance with two other publicly available tools: 
SNPster (McClurg et al. 2007) and R/qtl (Broman et al. 2003). The setting used to run them 
are detailed below. 
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Snpster settings. SNPster runs were performed using the tool available at snpster.gnf.org. 
The following settings were selected and are listed in the order in which they appear on the 
website. (i) Log transform data: No. (ii) Test statistic: F-test. (iii) Method of Calculating 
Significance: parametric. (iv) Compute gFWER: No. The default settings were used for the 
remaining options on the web site. 
 
R/qtl setting. R/qtl version 1.08-56 for R 2.7 was used to perform eQTL analysis on the 
BXD Liver data set. R/qtl was configured to perform Haley-Knott regression only at the 
observed markers. eQTL significance was determined by performing 1000 permutations for 
each transcript and selecting only those eQTLs above the 95% LOD threshold. 
 
Computer for performance testing. A Pentium 4 with a clock speed of 3.4GHz and 4GB of  
RAM running Microsoft Windows XP Professional(r), SP2 was used for all timing runs. No 
other applications were open during the runs. 
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Results and Discussion 
 
FastMap Application 
 
FastMap is written in the Java programming language and is driven by a simple 
graphical user interface (GUI, Figure 2.2a). The required input files are 1) a transcript 
expression file with mean expression values for each mouse strain and 2) a SNP file 
containing allele calls for all strains, with the major and minor alleles coded as 0 and 1 
respectively. Once the SNP file has been loaded, FastMap constructs a Subset Summation 
Tree (see Methods) for the SNP data, a computational task that is performed only once for a 
given set of strains. FastMap allows the user to perform either SMM by calculating the 
Pearson correlation of each transcript expression measurement with each SNP, or HAM by 
sliding an m-SNP window across the genome and calculating the ANOVA F-statistic for the 
phenotype vs. the distinct haplotypes observed in the window (Pletcher et al. 2004). The 
Figure 2.2. FastMap application GUI. Panel (a) shows FastMap with a list of probes on the 
left and the QTL plot on the right. Panel (b) shows a zoomed in view of the significant 
QTL on Chr 1. Panel (c) shows the same region in the UCSC Genome browser, to which 
FastMap can connect.  
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association statistic at each SNP is displayed in a zoomable panel that links to the 
University of California at Santa Cruz Genome Browser (Kent et al. 2002) (Figure 2.2b & 
c). Association plots may be exported as text files or as images. 
 
QTL mapping with sparsely distributed markers has traditionally used Maximum 
Likelihood methods and has employed the Likelihood Ratio Statistic (LRS) or the related 
Log of the Odds ratio (LOD) as a measure of the association between genotype and 
phenotype (LRS = 2 ln(10) x LOD). When marker density is high, regression techniques 
applied only at the observed markers will produce results which are numerically equivalent 
to the LRS or LOD (Kong and Wright 1994). In fact, the LRS, Student t-statistic, Pearson 
correlation and the standard F-statistic, can be shown to be equivalent when they are applied 
at the marker locations. While previous literature has shown that regression methods 
produce estimates with a higher mean square error and have less power (Kao 2000), these 
results apply primarily to the case of interval mapping when the spacing between markers is 
wide (> 1cM). For these reasons, FastMap employs the Pearson correlation for SMM and 
the F-statistic for HAM when employing high density SNP data sets. 
The significance of eQTLs for a single transcript may be determined using a 
permutation-based approach (Churchill and Doerge 1994). The expression values of each 
transcript are permuted, the association statistics of each transcript with all SNPs are 
calculated and the maximum transcript specific association statistic is retained. This process 
is repeated 1,000 times, and a significance threshold is taken as the (1 – α) percentile of the 
empirical distribution of the maxima. Both the number of permutations and the significance 
thresholds may be specified by the user. Since the various association statistics are 
equivalent when applied at the markers, the significant marker locations will be the same 
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for any choice of these statistics. Once a QTL peak that exceeds a user selected threshold 
has been identified, the width of the QTL must be defined in order to identify potential 
candidate genes for further study. Given a local maximum d, a confidence region can be 
defined as all markers q in an interval around d such that 2 ln(LR(q)) ≥ maxd 2 ln(LR(d)) - x 
and this interval is referred to as an (x/2 ln 10)-LOD support interval (Dupuis and Siegmund 
1999). The choice of x = 4.6 yields a 1-LOD confidence interval, which has been widely 
used in linkage analysis. A more conservative choice of x = 6.9 (a 1.5-LOD interval) is 
more appropriate to situations with dense markers, yielding approximate 95% coverage 
under dense marker scenarios. Intervals for non-LR association statistics can be calculated 
from the relationships between association statistics. In practice, eQTL peak regions are 
limited by the effective resolution determined by breeding and recombination history. 
FastMap assigns a p-value to each transcript that indicates the significance of the 
maximum association of that transcript across all the available markers. In situations where 
it is necessary or of interest to simultaneously consider multiple transcripts, additional steps 
must be taken to account for the resulting multiple comparison problem. We address this by 
calculating the q-value (Storey and Tibshirani 2003) of every transcript. The q-value of a 
transcript is related to the false discovery rate. In particular, the q-value of a transcript is an 
estimate of the fraction of false discoveries among transcripts that are equally or more 
significant than it is. For example, if we create a list of transcripts consisting of a transcript 
with q-value equal to 10%, and all those transcripts having smaller permutation based 
values, then we expect 10% or less of the transcripts on the list to have a significant 
association with at least on SNP or haplotype. 
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Permutation based significance testing is frequently used in eQTL analysis (Doerge 
and Churchill 1996; Peirce et al. 2006), and typically forms the bulk of the computational 
burden in eQTL mapping. It is natural to ask whether a parametric approach, based on 
Gaussian p-values, would be just as effective and save a significant amount of time. We 
note that permutation based testing offers several advantages over parametric approaches. 
Permutation testing deals cleanly with the problem of multiple comparisons, and induces a 
null distribution under which there is no association between transcript expression and 
genotype, regardless of the underlying distributions from which the data are drawn, and the 
correlations between SNPs. In addition, the normality assumptions underlying parametric 
tests are often violated in practice. 
 
Performance and Speed 
 
In order to gauge the performance improvement provided by FastMap over existing 
software, we compared computation times using two microarray data sets. The first consists 
of 20,868 transcripts and 3,795 markers in 41 strains of mice (BXD data set; (Gatti et al. 
2007)). This data set was selected because, unlike the following larger data set, it can be 
loaded into the widely used R/qtl package without exhausting computer memory. The 
second is a hypothalamus data set (McClurg et al. 2007) that consists of 3,672 transcripts, 
156,525 markers in 32 strains of laboratory inbred mice. This data set was selected for its 
dense genotype information, which is on the scale of the expected high density SNP data for 
which we designed FastMap. 
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Table 2.1. FastMap eQTL Mapping Times 
Software Data Set Method Transcripts Markers Tim(min) 
R/qtl 
BXD 
LRS 100 
3,795 
2.8 
FastMap SMM 20,868 12.9 
SNPster 
McClurg 
HAM 3,672 
156,525 
16.5 
FastMap HAM 3,672 25.5 
 
The amount of time required to perform eQTL mapping in these data sets is 
summarized in Table 2.1. In the BXD data set, FastMap performs SMM for the entire set of 
20,868 transcripts in about half an hour, which is the same time required for R/qtl to 
analyze 100 transcripts. The hypothalamus data was previously analyzed with an 
association mapping tool called SNPster (McClurg et al. 2007), which is available as a web 
application hosted by the Genomic Institute of the Novartis Research Foundation (GNF). A 
single transcript typically requires less than 5 minutes to analyze, depending on the load on 
SNPster’s web server. However, obtaining results for thousands of transcripts from 
submissions to an external website is impractical in most cases. Another version of SNPster 
runs at GNF in parallel on a 200 node cluster, which is not publicly available, in batches of 
10 transcripts per node. It requires 18 minutes to process these 10 transcripts using 
1,000,000 bootstrap resamplings for each transcript, and a -log(p-value) threshold of 2.5, 
which implies ~1.8 CPU-minutes per transcript (T. Wiltshire, pers.com.). If these 3,672 
transcripts were analyzed serially rather than in parallel, this would require 110.2 hours. In 
contrast, FastMap runs on a standard desktop computer and can perform eQTL mapping for 
these same 3,672 transcripts with 156,000 SNPs in 32 strains in 12.3 hours. Large 
computing clusters, and the expertise required to administer them, are not available to all 
laboratories. FastMap offers the convenience of running on a single, local computer in a 
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reasonable amount of time (overnight, or over a weekend for more than ten thousand 
transcripts). 
We evaluated the scalability of FastMap with increasing numbers of transcripts and 
SNPs using the hypothalamus data set. Since we are aware of no stand-alone software that 
can perform eQTL mapping with hundreds of thousands of SNPs, we compared FastMap’s 
performance in these plots to a brute force approach in which all calculations are performed 
without any optimizations. In the case of both SMM and HAM, computation time for 
FastMap scales linearly with increasing numbers of transcripts (Figure 2.3a). FastMap also 
scales linearly with increasing number of SNPs (Figure 2.3b). 
In order to examine the scalability of our algorithm with increasing numbers of 
strains, we determined tree construction times for various sets of inbred strains genotyped at 
~156,525 SNPs (Table 2.2). The amount of time required to construct the tree is a function 
of both the number of strains as well as their  ancestral relationships. Strains that are closely 
related (i.e. all derived from M.m.domesticus) will produce nodes in the tree that are close 
Figure 2.3. FastMap scales linearly with increasing numbers of genes and SNPs. Panels 
(a) & (b) show the time required to compute the association of increasing numbers of 
transcripts with 156K SNPs. Panels (c) & (d) show the time required to compute the 
association of one transcript with increasing numbers of SNPs. In all 4 cases, 1000 
permutations per transcript were performed. 
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to each other. As more distantly related strains are added (i.e. M.m.domesticus derived 
strains combined with M.m.musculus derived strains), the distance between SDPs becomes 
larger and tree construction times increase. Most existing eQTL studies in panels of inbred 
strains have used less than 40 strains (Bystrykh et al., 2005; Chesler et al., 2005; McClurg 
et al., 2007). Tree construction required 5.3 minutes for the 32 strains of the hypothalamus 
data set. In contrast, for a panel of 71 inbred strains derived from both M.m.domesticus and 
non-M.m.domesticus strains, tree construction requires ~10 hours using a 1 SNP window 
and ∼24 hours using a 3 SNP window. Tree construction is carried out only once, and the 
resulting calculations still require less time than a brute force approach. Faster algorithms 
for tree construction that improve scalability with increasing numbers of strains are 
currently under investigation. 
Table 2.2. FastMap tree construction and association mapping times with increasing 
numbers of strains (in seconds) 
 1SNP Window 3 SNP Window 
# Strains Tree Constr. SMM Tree Constr. HAM 
16 1 0.05 8 2.8 
32 168 2.5 320 12.9 
54 3,791 2.8 27,138 16.5 
71 13,672 4.6 81,186 25.5 
 
Population Stratification 
 
As noted by (McClurg et al. 2007), considerable population stratification is present 
when panels of laboratory inbred strains are used. Common laboratory inbred strains are a 
mixture of M.m.domesticus, M.m.musculus, M.m.castaneus, M.m.molossinus and M. 
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spretus, which arose during the creation of the laboratory inbred strains (Beck et al. 2000; 
Yang et al. 2007). Figure 2.4 shows a SNP similarity matrix for the 32 inbred strains in the 
hypothalamus dataset, where each cell represents the proportion of SNPs that have the same 
allele between 2 strains (normalized Hamming distance) across all 156K SNPs. The non-
M.m.domesticus derived strains cluster tightly in the lower left hand corner, indicating that 
they are more genotypicly similar to each other than to the M.m.domesticus derived strains. 
Numerous transcripts and SNPs exhibit systematic differences across these two strata. 
Consequently, each such transcript will show a significant association with every such 
marker. In eQTL mapping, this produces numerous markers that show significant 
associations with the expression of a single transcript, leading to horizontal banding in the 
transcriptome map (Figure 2.5a,b). When such differences exist, most permutations of the 
transcript will yield a lower association statistic than the observed one, this leads to 
inappropriately low significance thresholds (Figure 2.5c). In order to remove this strata 
effect, we median center the values of each transcript within M.m.domesticus and non-
M.m.domesticus strata. As shown in Figure 2.5d the resulting transcriptome map becomes 
interpretable with cis-eQTLs along the diagonal. The few horizontal bands that remain are 
due to a subset of the M.m.musculus derived strains with transcript expression levels that 
differ from the other strains; this prevents the median subtraction method from removing 
the strata effect completely. We recommend removing those few transcripts that 
demonstrate this effect. 
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FastMap allows the user to select strata by genotype a priori, and subtracts strata 
means or medians from the transcript values in each stratum (Pritchard et al. 2000). While 
there are more sophisticated methods for addressing population stratification (Kang et al. 
2008b), FastMap is not primarily designed to address this problem. While laboratory inbred 
strains have been  useful in mapping Mendelian traits, eQTL mapping with FastMap will 
have greater utility in well segregated populations like the Collaborative Cross (Churchill et 
al. 2004; Roberts et al. 2007b), due to increased genetic diversity, as well as the finer 
recombination block structure. In such well mixed populations, mean/median subtraction 
Figure 2.4. SNP Similarity matrix demonstrates population stratification among laboratory 
inbred strains. In one row, each cell represents the proportion of SNPs (in the 156K data 
set) with the same allele in the other strains. The similarity matrix has been hierarchically 
clustered (distance = SNP similarity, linkage = average). 
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within strata or the non-uniform resampling technique used by SNPster should not be 
required. 
 
 
Comparison of FastMap to other QTL software 
 
We compared the eQTL results produced by FastMap to those produced by R/qtl. 
R/qtl was configured to use Haley-Knott regression (Haley and Knott 1992) and 1,000 
permutations to determine significance thresholds. While R/qtl is designed to perform 
linkage mapping, we note that when linkage mapping is performed exclusively at the 
markers, the calculations are identical to those performed in eQTL. eQTLs may be broadly 
separated into two categories; eQTLs located within 1Mb of the transcript location (cis-
eQTLs), and eQTLs located further than 1 Mb from the transcript location (trans-eQTLs). 
Both FastMap and R/qtl found similar numbers of total eQTLs, ciseQTLs and trans-eQTLs 
(Figure 2.6a). Figure 2.6b shows that the eQTL locations found by each software package 
are essentially identical; 98% of the eQTLs found by each method are within 5 Mb of each 
other, a margin of resolution consistent with the resolution of the BXD marker set. Since 
permutation based testing involves randomization, it should not be expected that 100% of 
the eQTLs would match between the two methods. Furthermore, the eQTL histograms 
produced by each method (Figure 2.6c & d) are similar, with differences being due to 
histogram binning effects (see insets). 
 
QTL mapping in the hypothalamus data set was performed to evaluate 
computational performance, rather than to compare the results with SNPster. However, it is 
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natural to ask how the results of the two methods compare when we employ median 
centering in FastMap to correct for population stratification. We correct for population 
stratification by median centering transcript values within M.m.domesticus and non-
M.m.domesticus derived strains. 
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Figure 2.5. Strata median correction dramatically improves transcriptome map.  Panel (a) 
shows the transcriptome map for 3,270 transcripts without correcting for the population 
structure for all eQTL above a transcript-specific significance threshold of 0.05.  The 
horizontal bands dominate the plot and are due to gene expression profiles like the one in 
panel (b), which is marked by the red arrow in (a).   The grey colored strains are the M. m. 
domesticus derived strains and the red ones are the non-domesticus derived strains.  By 
subtracting out the strata median from each strata, the transcriptome map (d) is greatly 
improved.  Gene expression values are no longer split by genotypic strata (e) and the 
permutation derived thresholds are appropriate (f). 
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Since SNPster does not provide a fixed threshold for significance, we selected 2,413 
transcripts which had SNPster p-values less than 10-4. Of these, 105 were cis-eQTLs and 
2,308 were trans-eQTLs. FastMap produced eQTLs for 382 transcripts at or above a 0.05 
significance threshold, of which 29 were cis-eQTLs and 353 were trans-eQTLs. The 
locations of 55 eQTLS were common between the two methods and all of these were cis-
Figure 2.6. FastMap eQTL mapping results almost equivalent to those obtained with R/qtl. 
Panel (a) describes the BXD data set and shows the number of matching eQTLs between 
FastMap and R/qtl at varying distances. Panel (b) shows the high degree of concordance 
between FastMap and R/qtl. Panels (c) & (d) present eQTL histograms produced by 
FastMap and R/qtl. They are substantially equivalent with differences on Chr 1 and 12 
being due to histogram binning effects (insets). Data is shown at 5% significance threshold. 
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eQTLs, which have been reported to be more reproducible than trans-eQTLs (Peirce et al. 
2006). 
It should be noted that FastMap and SNPster differ in several important respects. 
SNPster uses a heuristic weighted F-statistic who’s null distribution is not known, it 
employs a resampling approach that selects strains in a random manner with a nonuniform 
distribution. FastMap uses the standard F-statistic and conventional permutation-based 
significance thresholds. For these reasons, it is unclear whether the results of the two 
methods should be concordant, and biological validation of both eQTL mapping approaches 
may be necessary to address the differences. 
 
Conclusion 
 
We have introduced new software for fast association mapping that uses a new 
method to speed the time required to calculate summations involved in QTL mapping. 
These improvements are particularly advantageous in the context of eQTL mapping when 
thousands of transcripts are analyzed, and permutation based significance thresholds are 
calculated for each transcript. The utility of the Subset Summation Tree extends beyond 
eQTL mapping: the idea can be applied to any situation where sums must be calculated over 
groups whose membership can be specified with a binary string. FastMap does not require 
the use of computer clusters and can be run on a standard desktop computer. FastMap 
performs both SMM and HAM overm-SNP windows, and calculates permutation based p- 
and q-values. These performance enhancements make FastMap suitable for eQTL mapping 
in high-density SNP data sets. 
 
 
 
 
Chapter 3 
 
Genome-level analysis of genetic regulation of liver gene expression networks  
  
Introduction 
 With the recent sequencing of entire mammalian genomes (Venter et al. 2001; 
Waterston et al. 2002), the possibility exists that the genetic basis of liver injury can be 
unraveled.   Several high density genotyping projects are underway to sequence panels of 
inbred strains at densities of ~150,000 and ~8.3 loci (Lindblad-Toh et al. 2000; Sherry et al. 
2001), providing an unprecedented density of genomic information.  This detailed sequence 
data can be combined with high throughput gene expression microarrays to examine the 
effect of genetics on constitutive levels of gene expression (Schadt et al. 2003; Chesler et al. 
2005; Bystrykh et al. 2005).  The combination of such high dimension data sets can offer 
insight into complex mechanisms of liver disease and toxicity (Schadt 2005). 
 Liver injury is the primary reason that prospective drugs are pulled from clinical 
testing and such idiosyncratic liver responses account for up to 50% of liver failure cases 
(Holt and Ju 2006).  While the drug in testing may behave as designed in most of the 
population, some proportion experiences serious and unpredicted toxicity.  This toxicity is 
typically not observed in animal models and has a low incidence in the general population 
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(Watkins and Seeff 2006).   These properties make idiosyncratic liver injury extremely 
difficult to predict.  Further, if such reactions occur when patients are intentionally exposed 
to drugs, it is possible that environmental xenobiotics can have the same effects.  While most 
of the population does not experience an adverse response to common environmental 
exposures, a small percentage may experience an idiosyncratic response.  An increased 
understanding of the mechanisms of toxicity in the liver will allow us to better predict and 
prevent such incidents. 
 All human populations are exposed to environmental toxins and toxicants.  However, 
the response to such exposures is not uniform.  While the majority of the population may 
experience exposure and suffer no measurable injury, a minority may experience severe 
toxicity.  The reasons for such differential responses are many.  Exposure dose and duration, 
lifestyle and nutritional choices, genetic differences and other variables can all affect the 
response.  In this study, the focus is specifically on the genetic differences that influence the 
differential response to toxic insult. 
 In order to study these genetic differences, mouse models are used.  Mice have been 
used in the study of many chemicals including 1,1,2-trichloroethylene (Crebelli and Carere 
1989), cadmium (Klaassen and Liu 1998) and 1,3-butadiene (Melnick and Huff 1992).   
Mice are preferable to simpler organisms because they are easy to house and feed, breed well 
and are mammalian systems with more similarity to humans than fish or insects.  They are 
also preferable to in vitro systems because cells in culture may or may not respond 
identically to cells in the body.  Further, in vivo systems retain the complex signaling 
interactions between disparate cell types within and between organs (Harbrecht and Billiar 
1995; Clayton et al. 2006).  
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 In order to study the effect of genetic background on gene expression, mice with a 
controlled genotype are used.  Inbred strains are homozygous at all genomic loci and whose 
individuals have identical genotypes. These strains are developed through extended sibling 
mating for over 20 generations.  This process leads to increased homozygosity over at least 
99% of the genome.  The use of inbred strains in genetics is well established and some 
strains have been bred and used in laboratory experiments for almost 100 years (Wade and 
Daly 2005).   The decreased genetic diversity within a single inbred strain leads to greatly 
reduced phenotypic variance, reducing the number of mice needed to detect statistically 
significant phenotypic differences.  The stable genotype is also invaluable for reproducing 
phenoptypic measurements in different laboratories.  Environmental factors can be varied in 
a controlled manner without additional genotypic variation (Paigen and Eppig 2000).   It is 
important to note that while the phenotypic variation within an inbred strain is reduced, the 
phenotypic variation among a panel of inbred strains can remain vast (Svenson et al. 2007).  
 The progeny of inbred mice can be bred in such a way that the genomes are permuted 
in a controlled manner.  Such recombinant inbred (RI) mice are inbred mice whose 
progenitors are themselves inbred mice.   These mice are produced by mating two inbred 
parents (i.e. C57BL/6J & DBA/2J) to produce an F1 generation.   The F1 litter is sibling 
mated to produce an F2 generation.  Each F2 generation is then sibling mated for over 20 
generations to produce a unique RI line.  The naming of these lines uses an ‘X’ between a 
letter from each of the two progenitor strains.  For example, the C57BL/6J and DBA/2J 
derived RI line is called ‘BXD.’  The advantage of using RI strains is that they provide a 
known ancestry and a controlled mixing of genotypes while retaining the homozygosity and 
reduced intrastrain phenotypic variance of inbreds. 
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  Quantitative Trait Locus (QTL) mapping has been used to associate a specific 
genotype with the variation in a single measured phenotype like high density lipoproteins 
(Wang and Paigen 2005) and ethanol tolerance (Grisel et al. 2002).   At each locus in a 
segregating population, a model is fit which estimates the likelihood that this locus explains 
the variation in phenotype versus the likelihood that there is no genotypic effect on the 
phenotype.  
Interval mapping (Lander and Botstein 1989) is a variation on QTL mapping which 
uses maximum likelihood estimation.  At each marker, the likelihood that the marker is 
associated with the phenotype over the likelihood that the marker is associated with no 
genotype is calculated.  This is the Likelihood Ratio Statistic (LRS).   Between markers, the 
exact genotype is unknown.  Because of this missing data, the expectation maximization 
algorithm is used to estimate the genotype based on recombination frequencies.  The result is 
a QTL plot of the entire genome with LRS scores indicating the strength of association 
between the phenotype and each genomic location. 
While QTL mapping was initially used with a single phenotype, the arrival of 
microarray technology allows for the measurement of thousands of phenotypes 
simultaneously.  Beginning with a study in yeast (Brem et al. 2002), QTL mapping has been 
done with gene expression as the phenotype.  In such a study, the genomic loci responsible 
for variation in gene expression can be used to infer regulatory control.  While such a study 
is not conclusive, it can be used to narrow the potential regulatory candidates, generate 
hypotheses for further testing and construct regulatory networks in silico. 
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 This approach has been applied in the mouse liver (Schadt et al. 2003),brain (Chesler 
et al. 2005) and hematopoetic stem cells (Bystrykh et al. 2005).  The liver study (Schadt et 
al. 2003) used an F2 population derived from C57BL/6J and DBA/2J to study the 
relationship of liver gene expression to fat pad mass.  The others (Chesler et al. 2005; 
Bystrykh et al. 2005) looked at constitutive gene expression in a panel of BXD RI mice to 
infer the regulation of basal gene expression.  These studies were significant in increasing 
our understanding gene regulatory networks including the existence of master regulator loci, 
clusters of co-regulated genes and the association of gene expression with previously 
measured behavioral traits. 
 Missing from the current literature is a study of constitutive gene expression in the 
mouse liver using a panel of RI strains.  Such a study would lay a foundation of basic 
research for liver toxicologists and provide a resource which can be used to associate genes 
expression with phenotype measurements.  It could be used to find clusters of co-regulated 
genes that may not have been otherwise associated in previous work and to build regulatory 
networks for genes relevant to xenobiotic metabolism.  Lastly, such a data set could be used 
for intelligent strain selection when a knockout model is otherwise unavailable. 
 The maturation of gene expression technology has opened the door to the exploration 
of the genetics of gene expression (Brem et al. 2002; Schadt et al. 2003; Chesler et al. 2005).  
Microarrays allow for the concurrent measurement of thousands of transcripts with the 
resultant genomic data being increasingly used to improve biological interpretation of data 
from mechanistic research.  Phenotypic anchoring of observed phenotypes to gene 
expression changes has proven useful in uncovering the molecular mechanisms that lead to 
liver injury (Waring et al. 2001; Powell et al. 2006).  Such experiments connect the variation 
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in transcript expression to phenotypes.  However, they do not lead to detailed gene 
expression networks where the expression of one gene is found control the expression of 
another.  
Recombinant Inbred (RI) mice are created by crossing two parental strains followed 
by sib-mating for over 20 generations (Taylor 1989).  Strains created this way have the 
advantage of being homozygous at almost every location along the genome.  As such, each 
representative of an RI line will have limited phenotypic variation within that line, but the 
variation between lines is usually vast. RI panels are widely used to determine genotype-
phenotype associations using QTL mapping techniques (Lander and Botstein 1989). The 
relationships between phenotypes and genotypes are calculated using a likelihood ratio 
statistic (LRS), which is a measure of the probability that a given genetic marker explains the 
variation in the phenotype.  When mRNA levels are used as the phenotype, regions of the 
genome with a high LRS are likely to contain genes that control the expression of the gene 
transcript being profiled; this process is referred to as expression Quantitative Trait Loci 
(eQTL) mapping (Schadt et al. 2003; Farrall 2004).   
The BXD panel of RI strains was created from the C57BL/6J and DBA/2J parental 
strains (Taylor 1978; Peirce et al. 2004). These two parental inbred strains are known to 
exhibit widely different phenotypes in response to a number of exposures. Thus, BXD mice 
have been a useful tool for elucidation of the genetic control of certain diseases. For 
example, the BXD lines have been used to study alcohol preference and tolerance (Treadwell 
2006), alcohol metabolism (Gill et al. 1996), responsiveness to aromatic hydrocarbons 
(Bigelow and Nebert 1986), N,N-diethylnitrosamine induced hepatocarcinogenesis (Lee et 
al. 1995) and diabetes and atherosclerosis (Nishina et al. 1993; Davis et al. 2005).  Recently, 
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BXD mice were used for eQTL studies that elucidated the genetics of gene expression in the 
brain (Chesler et al. 2005) and hematopoietic stem cells (Bystrykh et al. 2005).   
The genetic basis and networks that control gene expression in the liver are not well 
delineated and improving our understanding of these pathways and controlling loci will 
advance knowledge of physiological and pathophysiological changes in this organ. Here, 
eQTL mapping was applied to data from genome-wide microarray profiling of liver gene 
expression in the naïve state of the parental C57BL/6J and DBA/2J strains, the F1 cross and 
37 BXD strains. Using this approach, potential key regulators of gene expression in the liver 
were identified. The comparison of the liver and brain transcriptome maps demonstrated 
tissue-specific differences in regulation of gene expression.  Finally, we demonstrate how the 
data collected in this study may be used to infer genotype-phenotype correlations, generate 
testable hypothesis, and identify strains that may differ in responsiveness to xenobiotics 
based on the genetically-determined differences in expression of the key genes.   
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Methods 
 
Animals and Tissues.  BXD1 through BXD42 mice are original RI strains available from the 
Jackson Laboratory (Bar Harbor, ME). BXD43 through BXD100 lines were generated using 
ninth or tenth generation Advanced Intercross Line (AIL) progenitors. AILs are generated by 
breeding two inbred parents (here is C57BL/6J and DBA/2J) and crossing their offspring so 
as to minimize inbreeding and maximize recombination events at each generation (Peirce et 
al. 2004).  Mice were maintained at 20-24°C on a 14/10 hr light/dark cycle in a pathogen-
free colony at the University of Tennessee-Memphis. Animals were fed a 5% fat Agway 
Prolab 3000 rat and mouse chow and given tap water in glass bottles.  Strain details are 
provided in Appendix 1. Mice were raised to between 54 and 177 days (mean 70 days) of 
age. Liver tissues were collected following sacrifice by cervical dislocation. The whole liver 
was removed immediately, and placed in five volumes of RNAlater (Ambion, Austin, TX) at 
4°C overnight, before removing from RNAlater and storing at -80°C until processing. All 
animal studies for this project were approved by Animal Care and Use Committee at the 
University of Tennessee-Memphis. 
 
RNA Isolation. Total RNA was isolated from liver samples (~30 mg) using the RNeasy mini 
kit (Qiagen, Valencia, CA) as detailed by the manufacturer. RNA quality and quantity was 
determined spectrophotometrically from the absorbance at 260 nm and 280 nm. Aliquots of 
RNA samples were frozen at −80°C until microarray analysis. For each microarray, RNA 
was pooled from 2-3 mice of the same sex and strain. 
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Microarray Analysis. One µg of total RNA from 3 individual mouse liver samples of the 
same sex and strain was pooled, amplified and labeled with a fluorescent dye (Cy5) and a 
common reference - pooled mouse tissues (equal amounts of RNA from liver, kidney, lung, 
brain and spleen) mRNA isolated from the livers of 100 male C57BL6/J mice [see (Bammler 
et al. 2005) for details] - were amplified and labeled with Cy3 using Agilent Technologies 
(Palo Alto, CA) Low RNA Input Linear Amplification labeling kit following the 
manufacturer’s protocol. The quantity of the resulting fluorescently labeled cRNA was 
measured using a Nanodrop ND-100 spectrophotometer (Nanodrop Technologies, 
Wilmington, DE) and its integrity assessed using an Agilent Bioanalyzer. Equal amounts of 
Cy3 and Cy5-labeled cRNA (750 ng) from the individual animals and from the pooled 
control, respectively, were hybridized to an Agilent Mouse Oligo Microarray (~21,000 
features, catalogue# G4121) for 17 hours at 65°C. The hybridized microarrays were then 
washed and scanned using an Agilent G2565BA scanner. Data were extracted from the 
scanned image using Agilent Feature Extraction software version 6.1. A total of 122 arrays 
were run in 8 batches. The samples were semi-randomly distributed throughout the batches 
prior to microarray analysis in order to separate sexes and strains, and to minimize between- 
and within- batch bias. Technical and biological replicates were run both within each batch 
and between batches.  The microarray data was deposited in the UNC Microarray Database 
and extracted using Log2 ratios of the mean red channel intensity over the mean green 
channel intensity. This was followed by LOWESS normalization to remove the intensity 
dependent dye bias (Yang et al. 2002).  Neither the genes nor the arrays were centered.  
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Inter-batch normalization was carried out using a nested ANOVA mixed model with samples 
within each batch crossed with sex and strain. 
 
QTL Analysis and WebQTL.  QTL linkage mapping was carried out using the QTL Reaper 
software package (qtlreaper.sourceforge.net).  One thousand permutations of the strain labels 
were performed to estimate the genome wide p-value (Churchill and Doerge 1994). Liver 
expression data was deposited in WebQTL (www.genenetwork.org) which is a web-based 
resource for exploring gene expression and phenotype interactions.  WebQTL was used to 
produce interval maps for specific genes. 
 
Transcriptome Map and Whole Genome QTL Clustering.  The transcriptome map of the liver 
was produced using the R statistical package using the output data from QTL Reaper which 
consisted of the maximum Likelihood Ratio Statistic (LRS) value for each transcript on the 
microarray as well as a permutation derived p-value (number of permutations = 1000). The 
p-value threshold was applied at a 25% False Discovery Rate (Storey 2002). The QTL data 
for all informative markers and 18,716 transcripts on the G4121A microarray was used to 
perform hierarchical clustering of the QTL data.  Transcripts were clustered using each 2,325 
marker vector of LRS values. The distance metric used for complete (maximum distance) 
hierarchical clustering was "1 – Pearson  correlation" and colored by normalized LRS value. 
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Transcription Factor Analysis. Three web-based tools were used to search for possible 
transcription factor binding sites in candidate loci: the National Cancer Institute’s Advanced 
Biomedical Computing Center promoter analysis tool (grid.abcc.ncifcrf.gov/promoters.php), 
oPossum version 1.3 (Ho Sui et al. 2005) and PAINT (Vadigepalli et al. 2003).  In the first 
two cases, transcripts were divided based on increased expression correlating with the 
C57BL/6J of DBA/2J allele. The transcripts were submitted in 4 groups: 1) high expression 
with the C57BL/6J allele and an LRS of 30 or greater, 2) high expression with the C57BL/6J 
allele and an LRS of 40 or greater, 3) high expression with the DBA/2J allele and an LRS of 
30 or greater and 4) high expression with the DBA/2J allele and an LRS of 40 or greater.  
With PAINT, all transcripts were submitted as one list, but a gene cluster file was also 
submitted that clustered the C57BL/6J high and DBA/2J high transcripts into separate 
clusters. 
 
Quantitative Real Time PCR analysis.  In order to test the hypothesis that Dicer1 might be 
the regulatory gene at the distal chromosome12 locus which controls the 111 transcripts, 
female Dicer1 wild type and heterozygote mice (Bernstein et al. 2003) were obtained.  No 
knockout is available because Dicer1 is embryonic lethal. 10 genes that are trans-regulated at 
this locus were selected (Abhd1, Dhrsx, Hnf4g, Met, Neurog3, Olfr656, Pms1, Runx3, 
Rqcd1, Sel1h).  9 genes were selected that are known to be expressed in the murine liver but 
do not have a significant or suggestive QTL on distal chromosome 12 (Abcb11, Abcc2, 
Abcd3, Cyp2e1, Cyp3a11, Cyp7a1, Cyp8b1, Ppar1, Rara). RNA isolation was carried out 
using the Qiagen (Valencia, CA) RNeasy Mini Kit 50.  RNA concentration and quality was 
checked using the Nanodrop (Wilmington, DE) ND-1000 spectrophotometer at the 260 and 
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280 nm wavelengths.  20 µg of RNA were used to produce cDNA using the Applied 
Biosystems Inc. (Foster City, CA) High Capacity cDNA Archive Kit. The Stratagene (La 
Jolla, CA) FullVelocity QYBR Green QPC Master Mix was used to perform the RTPCR and 
the plates were run on a Stratagene Mx3000P instrument.  
 
Results and Discussion 
 
Genetic control of gene expression in liver 
 
 Using web-based eQTL mapping tools and data collected in this study, regulatory 
loci controlling each liver transcript can be easily visualized in WebQTL 
(www.genenetwork.org). Figure 3.1 shows examples of the three types of expression control 
found in the liver. A transcript with a maximum locus of control near (+/- 20 Mb) the 
genomic location of the transcript itself is considered to be cis-regulated (Doss et al. 2005). 
This implies some mechanism of control near the gene itself; perhaps a polymorphism in the 
promoter region. An example of a strong cis-regulated transcript is the cytochrome P450, 
family 3, subfamily a, polypeptide 13 (Cyp3a13) gene, located on distal chromosome 5 
(Figure 3.1a). A transcript with a maximum locus of control far from the gene location is 
trans-regulated. This implies regulation by another gene like a transcription factor. ADP-
ribosyltransferase 5 (Art5) gene, located in the middle of chromosome 7, is an example of a 
trans-regulated gene whose expression levels are determined by polymorphisms on 
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chromosome 3 (Figure 3.1b). Interestingly, many liver-expressed transcripts are regulated by 
multiple loci.  The interleukin 21 receptor (Il21r) gene, located on distal chromosome 7, is a 
good example (Figure 3.1c). Il21r has two significant QTL peaks - one on chromosome 7 
proximal to the gene itself and one on chromosome 14.   
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Figure 3.1.  WebQTL interval mapping reveals genetic control of gene expression. a, 
An example of a cis-regulated gene (Cyp3a13) where the QTL is co-located with the gene.  
The horizontal axis displays the mouse genome.  The vertical axis displays the Likelihood 
Ratio Statistic (LRS), The gene location is shown by the red triangle. The red horizontal 
line indicates a significant level of association as determined by permutation analysis. The 
grey horizontal line below it represents a suggestive association. The blue line displays the 
LRS along the genome and the yellow bars are the results of a bootstrap analysis. The inset 
shows a zoomed-in view of the Cyp3a13 QTL on Chr5 (130-145Mb) and illustrates the 
features of WebQTL. The red line indicates that C57BL/6J alleles at the marker increase 
expression of the gene. The colored boxes along the top represent known genes which, 
when selected, will take the user to the NCBI EntrezGene entry for that gene. A SNP track 
is displayed along the bottom as an orange seismogram. b, An example a trans-regulated 
gene (Art5). c, An example of a gene (Il21r) that is regulated by multiple loci.  
 
50 
 
To visualize the patterns of genetic control of gene expression on a genome-wide 
level, the 18716 annotated transcripts were clustered using the LRS vector for each transcript 
(Figure 3.2a).  As expected, the majority of the transcripts in liver are independently 
regulated; however, several distinct patterns emerge. Specifically, there are a number of 
clusters of transcripts that all share a common maximal QTL as well as clusters that are co-
regulated by a complex set of common loci.  We refer to clusters regulated by only one 
strong QTL as “simple” QTL clusters and ones regulated by multiple loci as “complex” 
clusters. 
 Chromosome 8 contains a simple cluster of transcripts that all have a strong 
maximum QTL (mean LRS = 47.5, Figure 3.2b). Of the 27 transcripts in this cluster, 26 are 
located on chromosome 8 at the same location as the maximum QTL which indicates that 
this cluster contains predominantly cis-regulated genes or perhaps is due to a strain-specific 
difference in a regional transcriptional enhancer. Interestingly, the presence of one of the 
parental (C57BL/6J or DBA/2J) allele at this locus strongly affects expression of these genes 
(Figure 3.2b, yellow-red correlation plot). 
 Chromosome 12 also contains a simple cluster that consists of a set of transcripts 
with a maximal QTL (mean maximum LRS = 42.6) at the distal region of the chromosome 
(Figure 3.2c).  However, only 5 of the 111 transcripts in this cluster are cis-regulated and 
hence located under the maximal QTL. This region in the genome is a master-regulator since 
the majority of the transcripts are trans-regulated by this locus.  Again, the correlation 
between expression levels of these transcripts is strongly dependent on the type of the 
parental allele that is present at this locus implying a common regulator of all 111 transcripts.   
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 To further understand the genetic basis for the difference in the proportion of cis- and 
trans-regulated transcripts in simple clusters, 31 simple clusters comprised of at least 80% 
cis-regulated transcripts were examined.  It was hypothesized that the clustering of these cis-
regulated QTLs might be due to higher gene or SNP density as opposed to biological 
pathways. To determine why a large number of cis-regulated transcripts might be located in 
very small genetic loci gene density at each region was considered versus adjacent up- and 
down-stream regions.  For gene density, it was found that the QTL cluster regions had 79.5 ± 
70.0 (mean ± SD) genes while the immediately adjacent up- and down-stream regions 
contained 45.0 ± 48.3 and 45.0 ± 44.2 genes, respectively.  For SNP density, it was found 
that the QTL cluster regions had 4362 ± 3707 SNPs and the up- and down-stream regions 
had 2924 ± 2963 and 3318 ± 3957 SNPs, respectively. In this analysis, only those SNPs that 
differ between the C57BL/6J and DBA/2J strains in the Perlegen mouse SNP data set 
(mouse.perlegen.com/mouse/index.html) were considered. Thus, on the level of individual 
clusters, QTL clustering may be driven by a combination of gene and SNP density. 
Furthermore, the transcripts in these cis-regulated clusters do not appear to be enriched for 
any particular GO category. This indicates that the co-regulation of cis-controlled genes 
throughout the genome is not due to functional relatedness, but rather the high gene/SNP 
density in each region. 
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Figure 3.2. Genome-wide clustering of the genetic control of gene expression in liver. a, 
Hierarchical clustering diagram of all transcripts on the array by Likelihood Ratio Statistic 
(LRS) profile. Rows – transcripts on the microarray, columns – SNP markers used for the 
QTL analysis. Strength of the LRS values is depicted using a head map with black being the 
lowest LRS, and bright red – the highest. b, A zoomed-in view of the cluster of genes 
controlled by a single genetic locus on Chr8. An auto-correlation matrix of the measured 
expression values for the transcripts in the cluster and a plot of chromosomal location of 
these transcripts are shown below. c, A cluster of 111 transcripts controlled by one locus on 
Chr12. d, A cluster of 43 transcripts that are controlled by a complex set of loci on several 
chromosomes.  
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 Lastly, a cluster of 43 transcripts (Figure 3.2d) that are controlled by a complex 
pattern of loci across multiple chromosomes (mean maximum LRS = 13.3) is shown. Not 
surprisingly, these genes are scattered around the genome. The pair-wise gene expression 
correlation matrix for these transcripts shows that mRNA levels for these genes are highly 
positively correlated regardless of the allele type at each QTL.  
 The proportion of cis-eQTLs that had higher expression when the C57BL/6J allele is 
present was assessed. Following the criterion set out in Pierce et al. (Peirce et al. 2006), a 
cis-eQTL was defined as a transcript that has a maximum QTL within +/- 5Mb of the 
transcript’s location in the genome.   At a genome wide p value of 0.05, 1,255 cis-eQTLs 
with 54.3% were found as having C57BL/6J high expression. At higher levels of statistical 
stringency 1,075 cis-eQTLs (p = 0.01)  are found with 53.9% higher for the C57BL/6J allele 
and 867 cis-eQTLs (p = 0.001) with 53.3% higher for the C57BL/6J allele. The data 
presented by Doss et al (Doss et al. 2005) and the data from this study both show only a 
slight (54-56%) enrichment for C57BL/6J high cis-eQTLs when Agilent long oligo arrays, 
produced from the reference sequence of the C57BL/6J strain, are used. Consequently, much 
higher (72-75%) enrichment in the Pierce et al. (Peirce et al. 2006) data set could be 
attributed to a low fidelity binding of short oligos used on Affymetrix arrays. These results 
show that long oligo array platforms are more suitable for eQTL analysis. 
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Mouse brain and liver transcriptomes show little overlap in genetic regulation of gene 
expression 
 Several recent reports identified a number of master-regulatory loci in other mouse 
tissues (Chesler et al. 2005; Bystrykh et al. 2005; Peirce et al. 2006). Here, the mouse brain 
(forebrain) and liver transcriptome maps (Figure 3.3) are compared to uncover the 
similarities and differences in genetic regulation of gene expression across tissues. Both 
brain and liver contain genes that are strongly cis- or trans- regulated at single loci, or are 
regulated by multiple loci (Figures 3.3a and b, respectively). In the brain transcriptome, three 
distinct master-regulator trans-bands are located on chromosomes 1 and 2 (Figure 3.3c). In 
the liver transcriptome, the strongest trans-band is located on distal chromosome 12 (Figure 
3.3d), a locus that does not appear to be controlling expression of a large number of genes in 
the brain. While the liver and the brain both have a trans-band on chromosome 2 near 125 
Mb, the two bands are not coincident. The liver trans-band lies at 119 MB and the brain at 
135 Mb - a difference of 16 Mb.  
 Next, the QTL data for the liver and brain by selecting only those transcripts with a 
genome-wide p value ≤ 0.05 (Peirce et al. 2006) was filtered. This analysis identified 743 
transcripts that have significant QTLs in both tissues (Figure 3.3e). It is interesting to note 
that 209 transcripts are regulated by the same genomic region in both the liver and the brain 
(genes that fall of a diagonal in Figure 3.3e). Gene Ontology-based (Ashburner et al. 2000) 
analysis of the biological processes that are significantly over-represented (Fisher’s exact test 
p < 0.05 and 25% FDR) among these genes identified a number of significant categories that 
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are co-regulated in both tissues (Figure 3.3f). Furthermore, among the 743 transcripts, the 
proportion of cis-regulated transcripts in the liver was 0.59 and in the brain it was 0.55. The 
difference is due to slight differences in the transcript location between the two data sets. Of 
the 209 transcripts that have the same QTL in the liver and the brain about 95% are cis-
regulated. Collectively, this comparison indicates that important tissue-specific patterns of 
genetic control of gene expression can be elucidated by this approach and potentially form 
the basis for comparative analyses between tissues. 
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Figure 3.3. Tissue-specific transcriptome maps reveal differences and similarities in genetic 
regulation of gene expression. a-b, The brain (Peirce et al. 2006) and liver (this study) 
transcriptome maps.  The horizontal axis shows the genomic location of each genetic marker along 
the genome. The vertical axis shows the genomic location of each transcript probed by the 
microarray analysis.  Each cross represents the location of the maximum QTL for a particular gene. 
Cis-regulated genes, where the QTL is co-located with the gene, fall along a 45 degree line.  The 
vertical lines correspond to a locus with strong trans-control over many genes.  The major loci of 
control differ markedly in the murine brain and liver.  c-d, Histograms counting the proportion of 
transcripts on the array regulated at each marker.  e, A comparative transcriptome map between the 
murine liver and brain.  Significant QTLs in the liver and brain are plotted along the horizontal and 
vertical axes, respectively. Points along the diagonal represent transcripts whose maximum QTL is 
the same in both tissues, indicating a similar mechanism of expression control.  Points plotted off 
of the diagonal represent transcripts that are controlled by different loci in the two tissues. f, Gene 
Ontology analysis of the significantly enriched biological processes common between liver and 
brain in the mouse.  
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Chromosome 12 contains a strong liver-specific master-regulatory locus 
 The chromosome 12 locus regulates expression of 111 genes and is delineated by two 
SNP markers, rs13481620 at 98.47783 Mb and rs8273308 at 99.83812 Mb (Figure 3.4, 
average LRS = 42.6, genome-wide p value < 0.03 and 0.25 False Discovery Rate  
(Benjamini and Hochberg 1995)). Surprisingly, the mean LRS for the transcripts that are cis-
regulated (LRS = 31.4) at this locus is lower than that for the trans-regulated (LRS = 43.1) 
ones.  It was hypothesized that this locus contains a gene that serves as a liver-specific 
“master regulator” of this chromosome 12 trans-band. To identify the candidate gene, genes 
in a 4 Mb region (98 - 102 Mb) around the two eQTL markers identified above were 
considered (Figure 3.4, lower panel).  
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Figure 3.4. Chr12 locus is a master-regulator of gene expression in mouse liver.  A 
zoomed-in view of the region on Chr12 that controls a large number of trans-regulated 
transcripts is shown in the bottom panel. The middle panel is a detail of the QTL peak from 
98 Mb to 102 Mb showing the genes in this region.  Genes labeled in blue text have non-
synonymous coding SNPs.  Genes in italics are cis-regulated.  Genes in plain text are trans-
regulated.  The gene location marker is color coded based on relative expression in the 
mouse liver.  Green indicates low expression; red indicates high expression; grey indicates 
that the gene is not represented on the microarray.  The top panel shows the correlation 
between the expression of each gene located in this locus and the putative trans-regulated 
genes.  Red indicates negative correlation; yellow indicates positive correlation; grey 
indicates no information.  Genes in the upper part of the panel are highly expressed in 
strains with the DBA/2J allele at this Chr12 locus.  Genes on the bottom of the panel are 
highly expressed in strains with the C57BL/6J allele is at this locus.  
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 It was reasoned that the candidate gene that may be responsible for the variation in 
expression between the transcripts associated with this locus should satisfy the following 
properties: 1) be cis-regulated at the chromosome 12 locus or contain non-synonymous 
coding SNPs between parental alleles, 2) have median to high expression in liver and 3) 
exhibit strong correlation in gene expression between the candidate gene and the trans-
regulated transcripts when separated by parental allele at this locus.  Five genes that are 
located in this region are cis-regulated: Dicer1, Serpina3k, Serpina3n, Serpina9 and 
Serpina12 (Figure 3.4, middle panel, genes identified in italics). Furthermore, a number of 
genes in this region, including Serpina3k, Serpina3n, Serpina9, and Serpina12, have known 
non-synonymous coding SNPs between the C57BL/6J and DBA/2J strains. Serpina3k, 
Serpina3n, Dicer1, Serpina9 and Serpina12, among several other genes, also have median to 
high relative mRNA expression in liver. Lastly, when the strength of the correlation between 
expression of each transcript regulated by this locus and expression of all other transcripts 
located in the chromosome 12 locus is plotted (Figure 3.4, top panel), it is evident that 
Dicer1, Serpina3k, Serpina3n, Serpina9, Serpina12 and four other transcripts have a clear 
separation (positive or negative correlation) according to the parental strain allele at this 
locus. Thus, it appears that any of the 5 cis-regulated genes at this locus: Dicer1, Serpina3k, 
Serpina3n, Serpina9, Serpina12 is likely to be the candidate "master regulator" gene in liver. 
 Dicer1 is a logical candidate for the chromosome 12 locus since it is involved in post-
transcriptional regulation of genes via cleavage of double-stranded RNAs (dsRNA) into ~20-
25 base pair fragments.  These fragments are then processed by the RNA-induced silencing 
complex, which recognizes sequences complementary to the dsRNA and prevents protein 
synthesis through either mRNA degradation or inhibition of translation (Hannon 2002). To 
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date, no specific gene regulatory function has been proposed for Dicer1 in the liver. To test 
the hypothesis that Dicer1 is a master-regulator of gene expression in the liver, expression 
was compared between the chromosome 12 locus-regulated genes in livers of wild type and 
Dicer1 heterozygous [Dicer1 null mutation is embryonic lethal (Bernstein et al. 2003)] mice 
by quantitative real time PCR. As a negative control, a number of randomly selected genes 
that are not regulated by the chromsome12 locus were selected. Contrary to our hypothesis, 
no consistent correlation was found between expression of Dicer1 and chromosome 12 
locus-regulated genes (data not shown) which suggests that Dicer1 does not appear to be the 
master regulator at this locus. It should be noted, however, that Dicer1 heterozygous mice 
may not be the most appropriate system for testing this hypothesis since Dicer1 mRNA 
levels in heterozygotes are 134% of wild type levels and a small sample size (n = 3 per 
group) limits the power of the analysis  (p = 0.17). 
 Next, other means of biological interpretation of the data were considered. Gene 
Ontology (GO) and transcription factor binding site analyses of the chromosome 12 locus 
trans-regulated genes were performed. GOMiner (Zeeberg et al. 2003) examination of the 
111 transcripts with maximum QTLs at the chromosome 12 locus identified significant 
enrichment for a single biological process category – cell surface receptor linked signal 
transduction (p=8.74x10-4). The genes from this category that are trans-regulated by the 
chromosome 12 locus are mainly olfactory receptors: Bsf3, Rqcd1, Gpr50, Tcp10c, P2ry10, 
Olfr1403, Olfr1443, Olfr401, Olfr512, Olfr935, Olfr1341, Olfr341, Olfr656, Olfr1365, 
Mesp2, Met, Ltbp3, Fstl3, Centd2, and Rassf3. 
 For the transcription factor binding site analysis, the trans-regulated transcripts at the 
chromosome 12 locus (LRS values greater than or equal to 30) were divided into two groups: 
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those with high expression when either C57BL/6J or DBA/2J allele is present at the 
chromosome 12 locus.  The National Cancer Institute’s Advanced Biomedical Computing 
Center promoter analysis tool (grid.abcc.ncifcrf.gov/promoters.php) found no common 
transcription factor binding sites for the C57BL/6J list.  LVc-Mo-MuLV and SV40.11 
binding sites were identified as significant (p = 9.766e-04) in the DBA/2J list. The oPossum 
(Ho Sui et al. 2005) tool identified Freac-2 site as significant in both C57BL/6J and DBA/2J 
lists (p = 6.026e-02 and p = 1.823e-02, respectively), while ARNT (p = 8.577e-02) and 
SOX-9 (p = 9.159e-02) sites were also found to be common for DBA/2J allele-containing 
genes. The PAINT transcription factor tool (Vadigepalli et al. 2003) was also applied to the 
data and no significant transcription factor binding sites between the two lists were found 
after FDR correction of the p-values. Similarly to our observation of the lack of a consistent 
signal for a transcription factor, (Yvert et al. 2003) and (Kulp and Jagalur 2006) found that 
the genes in trans-regulated bands are not enriched for transcription factors or biological 
function. This suggests that the trans-regulated genes at the chromosome 12 locus have a 
complex mechanism of regulation that is yet to be discovered. 
 The other candidates for the master regulator at the chromosome 12 locus are 
Serpina3-family genes. These genes are the murine orthologs of human α1-anti-
chymotrypsin, a serine protease inhibitor. Serpina3n is an acute phase protein that increases 
4 to 5-fold in inflammation and infection (Kalsheker et al. 2002). In humans, α1-anti-
chymotrypsin is an inhibitor of neutrophil elastase, cathepsin G, mast cell chymase & 
pancreatic chymotrypsin (Janciauskiene 2001). In the mouse, Serpin3a targets are leukocyte 
elastase, cathepsin G and chymotrypsin (Horvath et al. 2005).  While humans have one copy 
of α1-anti-chymotrypsin at 14q32, the mouse has 14 copies at 12E1 (Forsyth et al. 2003). 
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α1-Anti-chymotrypsin has been shown to be present in the amyloid plaques of Alzheimer’s 
patients (Forsyth et al. 2003). Elzouki et al. (Elzouki et al. 1997) found an association 
between low plasma α1-anti-chymotrypsin levels and propensity to contract the hepatitis B 
& C virus. A related protease inhibitor, serpina1 (α1-antitrypsin) is involved in emphysema 
due to a failure to inhibit neutrophil elastase and cirrhosis due to an accumulation of serpina1 
polymers in the hepatocytes (Janciauskiene 2001; Perlmutter 2006).  Although the overall 
structure is well conserved in the 14 member mouse Serpina3 family, the reactive center 
loop is widely divergent, suggesting that these enzymes have function other than protease 
inhibition. Interestingly, human α1-anti-chymotrypsin was reported to be able to bind to 
DNA and has been found to inhibit DNA polymerase and DNA primase in vitro 
(Janciauskiene 2001).  Horvath et al. (Horvath et al. 2005) performed a detailed structural 
analysis of mouse SERPINA3N and found that it contains a DNA binding domain similar to 
one described in human α1-anti-chymotrypsin (Naidoo et al. 1995). However, it was also 
reported that human α1-anti-chymotrypsin binds to double stranded DNA without specificity 
to known DNA binding motifs (Naidoo et al. 1995). It has also been shown that some serpins 
may require cofactors for activation (Janciauskiene 2001) which raises the possibility that the 
behavior of the Serpina3 family changes depending on the environment. Collectively, while 
there is no firm evidence for the role of Serpina3 genes in regulation of gene expression, we 
posit that our data points to the potential novel role of this family of genes in regulating liver 
gene expression.  
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eQTL analysis facilitates the discovery of novel genotype-phenotype correlations 
 
 WebQTL contains comprehensive manually curated publicly available data for 
phenotypic and gene expression profiling of a number of recombinant inbred and F2 crosses 
in both mouse and rat along with the dense genetic marker maps for these strains. Thus, this 
data can be used to search for correlations between phenotypes, gene expression and genetic 
markers, i.e., to perform in silico genotype-phenotype association analysis. The inherent 
significance of the defined reference genetic populations, such as BXD RI strains, is in the 
ability to connect historical data generated in many laboratories to the exact genetic map of 
each strain. This provides an exceptional opportunity to add value and depth to the biological 
interpretation of the data from model organisms. Thus, even though the BXD RI panel of 
strains has not been used extensively to profile liver disease-specific responses, as compared 
to a wealth of behavioral phenotypes published over the years, it is not unreasonable to 
anticipate that more data will become available soon.  
Here, to illustrate the power of combining genome-wide, liver expression profiling in 
a reference mouse panel with phenotype profiling, we identify several phenotypes that 
strongly correlate with the expression of liver transcription factor hepatocyte nuclear factor 
4-gamma (Hnf4g, located on Chr3 at 3.620141 Mb) using standard tools available in 
WebQTL. Hnf4g is trans-regulated by the chromosome 12 locus (Figure 3.5, left panel). 
Several of the BXD phenotypes are also regulated by this locus and there is strong 
correlation (Figure 3.5, right panel) between Hnf4g expression and the induction of serum 
IL-6 after TNF injection, lethality due to TNF injection and decreased body temperature after 
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TNF injection (Libert et al. 1999). Furthermore, both the expression of Hnf4g and values of 
these phenotypes separate by parental allele at the location of the Hnf4g gene on proximal 
chromosome 3.  
 
Knowledge of the variability in basal gene expression in liver as a tool for selecting 
relevant strains to probe biology 
 Genetic engineering has been a powerful and useful tool in biomedical research. 
However, there are a number of instances when generating a knockout or knockin mouse is 
neither the best option, nor it is feasible. The process is both costly and lengthy. 
Figure 3.5. In silico discovery of gene expression to phenotype correlations using 
WebQTL.  The left panel shows QTL interval maps on Chr12 for hepatocyte nuclear factor 
4, gamma (Hnf4g) gene and three related phenotypes. The right panel shows correlation pair-
wise correlation plots for Hnf4g expression and the phenotypes. Each dot represents the 
measurements for one strain.  Blue dots indicate strains in which the C57BL/6J allele is 
present at the Chr12 (99.83Mb) locus.  Red crosses represent strains with the DBA/2J allele 
at this locus. The blue histograms along the diagonal represent the distribution of all values 
of the phenotype.  
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Furthermore, some genes are embryonic lethal while others are sufficiently redundant, thus 
limiting the ability to generate biologically meaningful data using genetic engineering 
approaches. Thus, we propose that understanding of the degree of variability in gene 
expression between strains in a reference population of mice may be used to model the 
potential biological effects of naturally occurring differences in mRNA levels between 
individuals. In fact, it is extremely rare that people are complete nulls for a particular gene, 
but the polymorphisms in certain genes are known to predispose the individuals to some 
exposures or lead to disease (Dolphin et al. 1997; Rudnick and Perlmutter 2005).  
Accordingly, the liver expression data in WebQTL may be utilized to select strains that 
differ in basal mRNA level of genes of interest and then used for phenotypic studies that are 
designed to test the role of the genes in a particular phenotype. 
The flavin-containing mono-oxygenases are a class of phase I enzymes that oxidize 
organic nitrogen and sulfur containing compounds such as cimitidine, methimazole and 
nicotine (Ziegler 1993; Cashman et al. 1995; Ripp et al. 1997).  Fmo3 is the most common 
isoform in the human liver (Ripp et al. 1999).  While no sex differences in human activity of 
Fmo3 have been shown, in mice Fmo3 expression has been shown to be much higher in 
females (Falls et al. 1995; Ripp et al. 1999).  Basal expression of Fmo3 varies widely across 
the BXD strains (Figure 3.6, top panel). We confirmed this by running quantitative real time 
PCR on strains with high, medium and low expression of Fmo3 in 9 out of 40 strains (Figure 
3.6, lower panel). The correlation between the expression measured by microarray and PCR 
is strong (R2 = 0.74). Thus, WebQTL can be used to query the expression database to find 
genes with the highest differential expression across strains to generate a potential list of 
candidate strains for hypothesis testing. Since Fmo3 expression varies widely across BXD 
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strains and mutations in this gene have been implicated in trimethylaminuria (Dolphin et al. 
1997), a disease in which trimethylamine is not metabolized but is excreted in the breath and 
sweat, leading to a persistent fishy body odor, we suggest that BXD strains with high or low 
relative expression of Fmo3 may be used to model this disease. Similar logic may be used to 
test other genes without the cost and time of generating knockout animals. 
 
Conclusions 
 
 In conclusion, this study describes a new public resource that will facilitate our 
understanding of the genetic regulation of gene expression in liver. We describe several 
genetic loci that control expression of large numbers of genes. By using eQTL mapping, we 
identified the Serpina3 family of genes as potential novel master regulators of transcription 
in the liver. By comparing the liver and brain transcriptome maps, we highlighted tissue-
specific differences in regulation of gene expression. Finally, this study demonstrates how 
this publicly available data may be used to infer genotype-phenotype correlations, generate 
testable hypothesis, and select mouse strains for further testing based on the genetically-
determined differences of expression of the key genes.   
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Figure 3.6.  WebQTL-assisted strain selection for phenotypic profiling. The main panel 
shows relative expression of Fmo3 (flavin monooxygenase 3) across BXD strains measured 
by microarray. Red circles are values in females; blue squares – in males and the strain 
means are shown as black circles. The lower panels show relative Fmo3 expression in select 
strains as measured by microarray vs. quantitative real time PCR. The expression of Fmo3 in 
BXD21 strain was set to 0. 
 
 
 
 
 
Chapter 4 
Sex-specific Gene Expression in the BXD Mouse Liver 
Introduction 
 Physiological differences between the sexes have their roots in sexually dimorphic 
levels of gene expression (Mode and Gustafsson 2006; Waxman and Holloway 2009b). 
Despite containing identical autosomes and differing by a single Y chromosome, genes 
exhibiting expression differences are broadly distributed throughout the genome. In the liver, 
many of these differences are driven primarily by the pituitary growth hormone (GH) 
(Waxman and O'Connor 2006) which acts through the signal transducer and activator of 
transcription 5b (STAT5b) (Clodfelter et al. 2007; Holloway et al. 2007) and hepatocyte-
enriched nuclear factor (HNF4α) (Holloway et al. 2008). These transcription factors, through 
direct and indirect mechanisms, are thought to regulate expression of many steroid and 
xenobiotic metabolizing enzymes, leading to observed patterns of sexually dimorphic 
expression in a number of important biological pathways (Waxman and Holloway 2009b). 
 Several investigators have examined sexually dimorphic gene expression in the 
mouse liver using microarrays. Rinn et al. (Rinn et al. 2004) surveyed the expression of 
13,977 genes in male and female Swiss-Webster mice in the hypothalamus, kidney, liver, 
and reproductive tissues.  Using a criteria of fold change (FC) between sexes >3 and 
p<0.001, they found six genes to be sexually dimorphic in the liver, Cyp2b13, Cyp3a16, 
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Cyp4a12, Hsd3b5m, Elovl3 and Keg1.  (Clodfelter et al. 2006) studied liver gene expression 
changes in Stat5b knockout and wild type mice, finding 1,603 differentially regulated genes, 
with 850 being male- and 753 female-biased (p<0.05 and FC>1.5). A large study consisting 
of 344 mice comprising an F2 cross between C57B/6J.apoE-/- and C3H/HeJ.apoE-/- strains 
(~50% from each sex) produced two reports (Wang et al. 2006; Yang et al. 2006) which 
examined sexually dimorphic gene expression in adipose tissue, brain, liver and muscle.  It 
was reported that 9,250 genes are dimorphic in the liver (p<0.01 and FC>1). In an effort to 
uncover regulatory pathways driven by genetic variation, the authors also performed gene 
expression quantitative trait locus (eQTL) mapping to find genomic loci responsible for 
transcriptional regulation of clusters of genes. The authors reported that one locus on medial 
Chr 5 regulated the expression of ~80 genes and the genes in this cluster were enriched for 
cell cycle, cell proliferation and DNA replication. While these, as well as other previous 
investigations into sexual dimorphism of specific genes in liver made crucial contributions to 
knowledge of sex-specific gene expression patterns in liver, their goals were either tissue 
comparisons (Rinn et al. 2004; Yang et al. 2006), discovery of the transcriptional response to 
loss of Stat5b (Clodfelter et al. 2006), or characterization of the obesity phenotypes (Wang et 
al. 2006; Yang et al. 2006).   
Even though sex-independent polymorphic local and distant QTLs, including several 
loci that control expression of the large numbers of genes, were identified using the eQTL 
approach in the BXD recombinant inbred mouse panel (Gatti et al. 2007) and confirmed in 
an independent cohort of inbred strains (Gatti et al. 2009a), relatively little is known about 
the extent of genetic control of sexual dimorphism in liver gene expression networks in the 
mouse, or in other species. In this study, we examined differences in constitutive liver gene 
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expression between sexes across a genetically diverse population of BXD recombinant 
inbred mice derived from the C57BL/6J and DBA/2J strains. We examined both genes and 
pathways that are differentially regulated or correlated between sexes in the mouse. eQTL 
mapping was performed separately for each sex only a few sex-specific hotspots of 
transcriptional regulation were identified. Finally, we compared sexually dimorphic genes 
between murine and human liver by drawing a comparison to the data from Schadt et al. 
(Schadt et al. 2008) who reported on liver gene expression in over 400 human subjects.  
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 Methods 
 
Gene Expression Data. The details of mouse breeding, housing, RNA isolation and gene 
expression are described elsewhere (Gatti et al. 2007). Tissue collection (synchronized with 
respect to the time of day) was conducted at the University of Tennessee at Memphis and 
approved by the Institutional Animal Care and Use Committee. Briefly, gene expression in 
the livers of 37 strains of male and female C57BL/6JxDBA/2J (BXD) recombinant inbred 
(RI) mice, the C57BL/6J and DBA/2J parentals, and the C57BL/6JxDB2/2J F1 generation 
(B6D2F1) mice was measured using the Agilent (Santa Clara, CA) G4121A microarray 
(20,868 transcripts). The data was normalized by taking the fitted values from a nested, 
mixed model consisting of batch, strain, sex and strain by sex interaction terms. Additional 
details regarding animals, microarrays, data acquisition, processing and analyses can be 
found at WebQTL.org (http://webqtl.org/dbdoc/LV_G_0106_B.html). The data has been 
deposited in the Gene Expression Omnibus (GSE17522). 
Gene Expression Data Analysis. A two-way (ANOVA) model with sex and strain as main 
effects was fit to each transcript and those with sex or strain q-values (Storey and Tibshirani 
2003) ≤0.01, 0.05, or 0.10 were selected. Significance Analysis of Function and Expression 
(SAFE) tool (Barry et al. 2005) was used to find significant differentially regulated Gene 
Ontology (GO) categories, as well as Kyoto Encyclopedia of Genes and Genomes (KEGG) 
pathways.  Rather than employing an arbitrary significance cutoff, SAFE uses the entire data 
set and array permutation to produce empirical p-values for each category or pathway.  
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Significant categories were selected based on q-values of ≤0.25, a 25% FDR for the entire 
list. 
Sex Specific Correlated Gene Clusters: The Spearman correlation of each transcript with all 
20,867 other transcripts on the array was calculated for males and females independently.  
Transcripts with correlations ≥0.7 in either males, or females were retained separately for 
each transcript as highly correlated clusters.  Gene sets with absolute mean differences in 
correlation between sexes ≥0.35 were selected as sex-specific correlated clusters. Both 
cutoffs were selected to produce reasonably short lists of interpretable results. The highly 
correlated sex-specific gene clusters from the above analysis were searched for GO and 
KEGG pathway enrichment using Fisher’s Exact Test.  Significant categories were selected 
with q-values ≤0.1. 
Transcription Factor Binding Site Enrichment: The Opossum  single site analysis algorithm 
(Ho Sui et al. 2007) was used to query the JASPAR vertebrate database for enrichment in 
transcription factor binding sites (TFBS).  The selected parameters, in the order they appear 
on the web site were 1) Level of conservation: top 10% of conserved regions, 2) Matrix 
match threshold: 80%, 3) Amount of upstream/downstream sequence: -5000/+5000, 4) 
Results: Z-score > 10 and Fisher score < 0.01. 
Gene Expression Quantitative Trait Locus Mapping. eQTL mapping was performed using 
single marker mapping in FastMap (Gatti et al. 2009b), which uses sample permutation to 
produce per-gene significance thresholds.  Mapping was performed on all 20,868 transcripts 
represented on the array and a set of 3,795 markers downloaded from WebQTL 
(http://www.genenetwork.org) for the BXD mice was used. Permutations (1,000) of the 
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expression data were employed to establish significance cut-offs for each gene.  Of the 
20,868 transcript, 1,204 had unknown genomic locations or were located on the Y or 
Mitochondrial chromosomes.  These were removed from the results, leaving 19,664 
transcripts that had known genomic locations on the autosomal chromosomes and the X 
chromosome. To assess a stringency of eQTL analysis, eQTL bands were derived from the 
above analysis repeated 100 times, permuting the markers each time, and counting the 
number of eQTL hotspots of each size. The probability of seeing an eQTL band of a given 
size was assessed from the empirical distribution of the number of eQTL bands of each size 
produced in all 100 permutations. 
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Results 
Characterization of Sexually Dimorphic Liver Genes in BXD Mouse Panel 
 Sexually dimorphic genes were selected using a two-way (sex and strain of each 
sample) Analysis of Variance (ANOVA) model.  P-values for sex and strain were filtered 
separately using q-values (Storey and Tibshirani 2003) of 0.01, 0.05 and 0.1, which represent 
the False Discovery Rate (FDR) of the resulting gene lists, corresponding to FDRs of 1%, 
5% and 10%. At the highest q-value, we find a similar number of dimorphic genes as a 
previous report (Yang et al. 2006) and replicate the finding that there are more female-biased 
genes than male-biased genes (Table 4.1).  To further explore the differences, we plotted the 
mean expression value for each gene in males versus that in females (Figure 4.1) and 
observed that, while there are more female-biased genes, there is also a large cluster of male-
biased genes (Figure 4.1, circle). The genes in this cluster (q≤0.01, 0≤male≤2.6, -
0.5≤female≤1.5) are significantly enriched for olfactory receptor activity (GO:0004984, 
p=9.6x10-22) which consists of G-protein coupled receptors involved in signaling.   
Table 4.1. The number of sexually dimorphic genes in the BXD mouse liver. 
 q-value p-value Male-biased Female-biased Total 
BXD 
recombinant 
inbred panel 
0.01 0.0048 2,250 3,066 5,316 
0.05 0.0342 3,048 4,495 7,593 
0.10 0.0821 3,709 5,393 9,102 
(Yang et al. 2006) NA 0.01 4,441 4,809 9,250 
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 As expected, some of the most sexually dimorphic genes (Table 4.2) are located on 
the X and Y chromosomes, including inactive X specific transcripts (Xist), DEAD box 
polypeptide 3, Y-linked (Ddx3y), and eukaryotic translation initiation factor 2, subunit 3, 
structural gene Y-linked (Eif2s3y). However, most genes that exhibit considerable fold 
difference in expression (>2) between sexes reside on autosomes. We have compared our 
results to two independent microarray studies that examined sex differences in liver gene 
expression in mice.  We compared our study with that of (Clodfelter et al. 2006) which was 
conducted on Stat5b-null and wild type mice. We used a rather conservative p≤0.01 cut-off 
for sex bias and found overlap of 51.5% (410 out of 796 genes from that study matched with 
an identical p-value). A similar comparison with a study which used an a much larger 
number of mice in an F2 cross (Yang et al. 2006) yields a 27.2% overlap (9,250 genes were 
reported as sexually dimorphic with p≤0.01, of which 8,087 mapped to Agilent 4121A 
microarray and 2,196 matched our results). 
Figure 4.1. Comparison of expression of 20,868 genes in livers of male and female BXD 
recombinant inbred mice. (a) Mean expression (log2) of each gene in all males is plotted 
versus that in all females, colored by the statistical significance (see color bar inset) of 
differential expression. (b) Volcano plot of differential expression versus –log10(p-value) for 
the sex effect from the ANOVA analysis.  Positive values indicate higher expression in males. 
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 We also examined the differential expression of several cytochrome P450 (CYP) 
enzymes previously reported to be sexually dimorphic. Consistent with previous reports 
(Rinn and Snyder 2005), we found that liver expression of Cyp2c55, Cyp2d9, Cyp4a12, 
Cyp7b1, and Cyp8b1 is male-biased, and Cyp2a4, Cyp2b10, Cyp2b13, Cyp2c40, Cyp3a16, 
Cyp3a41 is female-biased.  However, in contrast to some previous observations, we find that 
Cyp2j13 is male-biased and Cyp2e1 is female-biased in the BXD mouse panel. 
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Table 4.2. Genes with significant differential expression ( mean log2(diff) > 2) between sexes. 
Probe ID Gene Gene Name Sex Bias 
Mean 
log2(diff) 
Chr 
(Clodfelter 
et al. 
2006)* 
(Yang 
et al. 
2006)* 
A_51_P145453 Xist Inactive X specific transcripts F 5.9 X   
A_51_P479715 Eif2s3y 
Eukaryotic translation initiation 
factor 2, subunit 3, structural gene 
Y-linked 
M 5.4 Y 
  
A_51_P269404 Fmo3 Flavin containing monooxygenase 3 F 5.5 1 
  
A_51_P426513 Sult3a1 Sulfotransferase family 3A, member 1 F 5.3 10 
  
A_51_P114722 Hao3 Hydroxyacid oxidase 3 F 5.0 3   
A_51_P182370 Cyp2b10 Cytochrome P450, 2b10 F 2.5 7   
A_51_P184750 Cyp2b10 Cytochrome P450, 2b10 F 2.9 7   
A_51_P402994 Ddx3y DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked M 4.5 Y 
  
A_51_P480533 Sult2a2 
Sulfotransferase family 2A, 
dehydro-epiandrosterone-
preferring, mem. 2 
F 4.4 7 
  
A_51_P467076 Cyp2b9 Cytochrome P450, family 2, subfamily b, polypeptide 9 F 4.2 7 
  
A_51_P492339 Cyp2b13 Cytochrome P450, family 2, subfamily b, polypeptide 13 F 3.8 7 
  
A_51_P192886 Cml5 Camello-like 5 M 3.7 6   
A_51_P324636 Elovl3 
Elongation of very long chain 
fatty acids (FEN1/Elo2, 
SUR4/Elo3, yeast)-like 3 
M 3.3 19 
  
A_51_P496162 Hsd3b5 
Hydroxy-delta-5-steroid 
dehydrogenase, 3 beta- and 
steroid delta-isomerase 5 
M 2.8 3 
  
A_51_P461429 Cyp7b1 Cytochrome P450, family 7, subfamily b, polypeptide 1 M 2.7 3 
  
A_51_P238576 Cyp4a14 cytochrome P450, family 4, subfamily a, polypeptide 14 F 2.7 4 
  
A_51_P352005 Hsd3b4 
Hydroxy-delta-5-steroid 
dehydrogenase, 3 beta- and 
steroid delta-isomerase 4 
M 2.6 3 
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A_51_P290535 Abcd2 ATP-binding cassette, sub-family D (ALD), member 2 F 2.6 15 
  
A_51_P252002 Susd4 Sushi domain containing 4 M 2.2 1   
A_51_P299528 Ust3m Putative integral membrane transport protein; 3' UTR F 2.2 19 
  
A_51_P165111 Slco1a1 Solute carrier organic anion transporter family, member 1a1 M 2.4 6 
  
A_51_P249297 Abcd2 ATP-binding cassette, sub-family D (ALD), member 2 F 2.2 15 
  
A_51_P103137 Slco1a1 Solute carrier organic anion transporter family, member 1a1 M 2.2 6 
  
A_51_P319213 Atp6v0d2 ATPase, H+ transporting, lysosomal V0 subunit D2 F 2.1 4 
  
A_51_P374464 Gstp1 Glutathione S-transferase, pi 1 M 2.1 19   
A_51_P496045 Sorbs1 RIKEN cDNA 9530039L23 gene M 2.1 19   
A_51_P414072 Prom1 Prominin 1 F 2.1 5   
*, Comparison of the overlap in sexually dimorphic genes with other studies. Gray shading represents 
concordance with the results reported in Ref. 48 or 215. 
 In order to find transcription factors responsible for sexually dimorphic gene 
expression, we submitted lists of male- and female-biased genes to Opossum (Ho Sui et al. 
2007), a web-based tool that searches for transcription factor binding site (TFBS) enrichment 
in lists of genes.  In males, paired box protein 5 (Pax5) was significantly enrichched 
(p=4.15x10-31) in 165 of the male-biased genes.  In females, hepatocyte nuclear factor 1-
alpha (Hnf1α) was significant (p=5.77x10-65) and its TFBS motif was found in 395 of the 
female-biased genes. 
 While the examination of expression differences between individual genes increases 
our understanding of physiological differences between the sexes, it is often informative to 
search for functionally related gene sets that are differentially expressed. SAFE (Barry et al. 
2005) is a permutation-based software tool that assesses the significance of differentially 
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expressed gene sets, in this case between males and females, using the entire data set rather 
than a pre-defined “significant” gene list. We found 89 significant KEGG pathways (q≤0.25) 
of which many are reflective of xenobiotic metabolism pathways such as Drug Metabolism–
Cytochrome P450 (KEGG 00982, q=0.01, Figure 4.2a), Retinol Metabolism (KEGG 00830, 
q=0.01), Glutathione Metabolism (KEGG 00480, q=0.05), and Fatty Acid Metabolism 
(KEGG 00071, q = 0.08).  Similarly, out of 45 significant GO Molecular Function categories 
(q≤0.25) many are also highly relevant to xenobiotic metabolism in the liver, such as 
Oxidoreductase Activity (GO:0016491, q=0.03, Figure 4.2b), Cysteine-type Endopeptidase 
Activity (GO:0004197, q=0.04), Iron Ion Binding (GO:0005506, q=0.05), Heme Binding 
(GO:0020037, q=0.08), Sulfotransferase Activity (GO:0008146, q=0.13), Glutathione 
Transferase Activity (GO:004364, q=0.14). There were 30 significant GO Biological 
Process categories (q≤0.25). The most significant (q=0.11) were GO:0006766 (Vitamin 
Metabolic Process, Figure 4.2c) and GO:0051186 (Cofactor Metabolic Process). There were 
8 significant GO Cellular Component categories (q≤0.25). The most significant categories 
were Vesicular Fraction (GO:042598, q=0.09, Figure 4.2d) and Microsome (GO:0005792, 
q=0.09), both of which include a large number of sexually dimorphic CYP450s that are 
located on the endoplasmic reticulum.  Also included in the list was Peroxisome 
(GO:0005777, q=0.1), which contains the female-biased hydroxyacid oxidase (Hao)3 and 
ATP-binding cassette D2 (Abcd2), as well as the male-biased Hao1. 
80 
 
 
Figure 4.2. KEGG and Gene Ontology categories which exhibit most significant sex 
bias in mouse liver gene expression. Representative (a) KEGG pathway, (b) GO 
Molecular Function, (c) GO Biological Pathway, and (d) GO Cellular Component 
categories that are highly significant for sex bias are shown as heatmaps of expression for 
all genes (number of the genes is shown) in each category several significantly 
differentially regulated.  In the heatmaps, red indicates high expression and blue indicates 
low expression (see color bar insets).  Genes are sorted by the –log10(p-value) for the sex 
effect (from the ANOVA analysis) which is plotted next to each heatmap with genes 
expressed more highly in females colored black and those more highly expressed in males 
colored grey. 
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Comparison of Sexual Dimorphism in Liver Gene Expression between Mouse and 
Human 
 Sex differences in human liver gene expression have been largely unexplored 
(Waxman and Holloway 2009b).  We compared the sexually dimorphic genes in the BXD 
liver data set to a recently published large human liver gene expression data set (Schadt et al. 
2008) obtained from the Gene Expression Omnibus.  Expression measurements for over 
39,000 transcripts in over 400 human samples (both male and female) were taken using a 
custom microarray. We determined that 7,342 transcript were sexually dimorphic in this 
dataset (Student’s t-test between sexes for each transcript at a q≤0.10 and p≤0.03).  Murine 
orthologs could be mapped with high certainty only for 2,850 of these genes (due to rather 
insufficient annotation of the custom array used in the human study), and 1,258 (44.1%) of 
these were also sexually dimorphic in the mouse. We compared the direction of expression 
difference between sexes in this subset of 1,258 transcripts  and found that 747 (59.4%) 
genes were sex-biased in the same direction in mouse and human, and 511 (40.6%) were 
biased in the opposite direction. The genes that exhibited unidirectional sex bias between 
species were enriched in GO Biological Process categories Oxidation Reduction 
(GO:0055514, p=3.05x10-9, q=5.60x10-6), and Glutathione Metabolic Process (GO:0006749, 
p=1.22x10-4, q=0.045); and GO Molecular Function categories Monooxygenase Activity 
(GO:0016491, p=1.68x10-7, q=1.48x10-4), and Catalytic Activity (GO:0003824 p=2.47x10-5, 
q=7.24x10-3).  
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Gene Expression Quantitative Trait Locus Analysis 
 Quantitative trait locus (QTL) mapping is a statistical technique that finds 
associations between phenotype and genotype in a genetically segregating population 
(Lander and Botstein 1989). Here, we performed eQTL mapping on the male and female 
data separately.  There were 1,137 significant (q≤0.5 and p≤0.025) male and 1,232 
female eQTLs. 
First, we explored differences in patterns of eQTL locations between sexes by 
plotting the genomic locations of each eQTL versus the transcript location (Figure 4.3a, b).  
The strong diagonal band represents local eQTLs (Rockman and Kruglyak 2006), for which 
the eQTL is located within 1 Mb of the transcript. Points off the diagonal represent distant 
eQTLs (Rockman and Kruglyak 2006) for which the eQTL is located farther than 1Mb from 
the transcript, or on another chromosome.  A histogram of the number of significant eQTL 
associated with each genomic marker is also shown for each sex (Figure 4.3c, d).  Markers 
associated with a larger number of transcripts than expected by chance, termed eQTL bands, 
may lie near genes that regulate the expression of clusters of genes. There has been 
legitimate concern expressed over the validity of eQTL bands and a permutation approach to 
assess their significance has been proposed (Breitling et al. 2008).  We applied this approach 
(see Methods) and colored the eQTL bands by their empirical p-value.  In males, there are 
four significant (p≤0.05) eQTL bands on Chr 2, 7, 12 and 17, and in females – four eQTL 
bands on Chr 1, 2, 12 and 17.  The genomic regions covered by the eQTL bands on Chr 2, 12 
and 17 overlap in males and females and contain 25, 33, 20 transcripts in common, 
respectively.    
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Figure 4.3. Sex-specific transcriptome maps reveal differences and similarities in 
the genetic regulation of gene expression in mouse liver. Male (a) and female (b) 
transcriptome maps in which significant (p<0.05) eQTL location are shown. Genomic 
location of each SNP marker (horizontal axis) and each transcript (vertical axis) are 
plotted. Each cross represents the location of the maximum QTL for a particular gene. 
Locally regulated genes are located along the 45 degree lines while the vertical lines 
correspond to the loci which regulate distant genes. The color of each symbol 
corresponds to the significance of the eQTL (color bar). eQTL histograms of the male (c) 
and female (d) data, counting the number of significant eQTL associated with each 
marker, with bands colored by permutation-based p-value (see inset in c). 
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 Second, to further explore the similarities in genetic control of liver gene expression 
between sexes, we compared the number of local and distant eQTLs, along with the overlap 
between males and females (Figure 4.4a). It is evident that a larger number of local eQTLs 
are shared between the two sexes than distant eQTLs. The strongest distant eQTL band on 
distal Chr 12 is shared between sexes and it has been previously reported (Gatti et al. 2007). 
There are 87 transcripts regulated by this locus in the male data and 45 transcripts in the 
female data; however, the two sets of genes are not identical. The union consists of 101 
genes and the intersection of these two sets consists of only 33 genes. Several Gene 
Ontology categories are significantly over-represented in the union of these genes: Response 
to Cytokine Stimulus (GO:0034097, p=0.0050), Calcium-mediated Signaling (GO:0019722, 
p=0.0070), Serine-type Endopeptidase Inhibitor Activity (GO:0004867, p=0.0064) and 
Cyclin-dependent Protein Kinase Activity (GO:0004693, p=0.0098).  A clade of serine 
protease inhibitors contains a putative regulator for these genes, as discussed in (Gatti et al. 
2009a). GO and KEGG pathway enrichment analysis for other sex-specific eQTL bands on 
Chr 1, 2, 7 and 17 did not produce significant categories or pathways (q≤0.1). No TFBS 
enrichment (p≤0.05) exists for genes in theses eQTL bands. 
 In order to examine whether the transcripts that have significant eQTLs in both sexes 
are identically regulated in males and females, we plotted the male versus female eQTL 
locations for each of these 699 transcripts (Figure 4.4b).  For 592 (84.7%) of the transcripts, 
the eQTL is in the same location (diagonal band in Figure 4.4b).  For 107 (15.3%) 
transcripts, one sex had a single significant eQTL while the other had two, one at the same 
location and another elsewhere (off diagonal points in Figure 4.4b), suggesting that sex is a 
factor in the regulation of these transcripts.   Still, for all transcripts which had a single 
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significant eQTL in one sex and two in the other, we found that either sex had a less 
significant (p≥0.05) second eQTL. 
 
 Third, we compared the sex-specific eQTL locations obtained from BXD 
recombinant inbred mice with those from an F2 cross study of Wang et al. (Wang et al. 
2006). While the comparisons of eQTL results are challenging due to the varying genetic 
backgrounds between populations, differences in microarray probe sequences, experimental 
conditions, and statistical techniques, and likely environmental differences inherent in 
Figure 4.4. Distribution of liver eQTLs between sexes in BXD recombinant inbred 
mice. (a) Venn diagrams displaying the number of intersecting eQTL in males (blue) and 
females (red) for all (top), local (middle), and distant (bottom) eQTLs.  Numbers beside 
the circles indicate total number of eQTL in each sex.  (b) Location of shared eQTL in 
males plotted versus the eQTL location in females for the same transcript. 
 
86 
 
different animal facilities; it is likely that eQTLs which overlap may serve as strong 
candidate loci for further investigation (Peirce et al. 2006). Wang et al. (Wang et al. 2006) 
reported mouse liver eQTLs for 8,349 transcripts (p<0.001) and we sub-selected the 3,855 
most significant (p<10-6) eQTLs for 2,667 transcripts. An eQTL was deemed reproducible 
between two studies if the maximal eQTL locations intersected, and we found that 
approximately 25% of local and 8.5% of distant eQTLs satisfied these criteria (Table 4.3).  
This result is consistent with previous observations that local eQTLs are more reproducible 
than distant eQTLs (Peirce et al. 2006). 
Table 4.3. Comparison of BXD eQTLs with BXH eQTLs from Wang et al. (Wang et al. 
2006). 
 Male Female 
BXD eQTLs 1137 1232 
Local 551 584 
Transcripts In Common 233 233 
Match (% of Local) 144 (26.1) 146 (25.0) 
Distant 586 648 
Transcripts In Common 144 160 
Match (% of Distant) 49 (8.4) 56 (8.6) 
 
 It has been reported that genetic polymorphisms that are located within transcript 
probe sequences may alter apparent transcript intensity in an allele-specific manner and 
hence create false local eQTLs (Doss et al. 2005; Alberts et al. 2007). To investigate this in 
our  data, we intersected the microarray probe sequences with a high-density single 
nucleotide polymorphism (SNP) data set (Szatkiewicz et al. 2008). We found that 217 of the 
87 
 
835 transcripts that had local eQTLs also had SNPs within the probe sequences and that 
probes with SNPs were enriched among local eQTLs (Fisher’s Exact test p=0.02).  If a SNP 
is present in a probe’s binding sequence, then it would be expected that the C57BL/6J allele, 
the reference strain from which probe sequences are designed, should have higher 
expression.   
 
Gene Correlation Exhibits Distinct Patterns from Gene Expression between the Sexes 
 
 While it is clear that many genes differ in expression between sexes, there is also a 
more subtle type of variation that involves variability in the correlation among genes within 
each sex, often without pronounced difference in expression. The sex-specific clusters of 
such differentially correlated genes may represent complex networks of transcriptional 
regulation that are important in physiology and pathophysiology.  
 On a genome-wide level, we examined the extent of correlation in gene expression 
between sexes. We selected genes with Spearman correlation ≥0.7, an arbitrary cut-off which 
reflects a balance between lower values, which quickly produced so many genes that analysis 
proved computationally intractable, and higher values, which yield only a small set of genes.  
We searched for genes exhibiting three types of patterns. The first type contains genes with 
stronger correlations in males than in females (i.e., male-biased correlations). Member of 
RAS oncogene family Rsb30 (Figure 4.5a) is a representative gene which does not differ in 
expression between sexes, yet exhibits strong correlation in males.  The second type of 
pattern, female-biased correlations, is exemplified by neutrophil cytosolic factor (Ncf)2 gene 
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(Figure 4.5b).  Finally, there are genes that have an equal level of correlation in both sexes 
regardless of expression levels, exemplified by potassium channel K5 (Kcnk5) gene (Figure 
4.5c).  
 
 To establish whether genes that have the highest difference in expression between 
sexes (Table 4.2) also would exhibit strong correlation, we selected genes that had the largest 
number of correlations with other genes in one of the sexes (Table 4.4). It is noteworthy that 
there is only one gene (Elovl3) which is both differentially expressed between sexes, and 
exhibits strong correlation in only one sex (males).   
 
 
 
Figure 4.5. Differential correlation of gene expression occurs between males and 
females, independent of expression level differences. (a) The correlation of Rsb30 with all 
other transcripts on the array in male samples is plotted against the correlation in female 
samples.  Rsb30 is more highly correlated with other genes in males than in females, despite 
little difference in expression (p=0.005). (b) Ncf2 exhibits the opposite pattern, with more 
correlation among females than males, again with little difference in expression (p = 0.645).  
(c) Kcnk5 is highly correlated with many genes in both males and females, despite having a 
large expression difference between sexes (p=1.9 x 10-18). 
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Table 4.4. Genes with significant differential correlation between sexes, sorted by the 
number of correlated genes. 
Probe ID Gene Gene Name Sex 
Bias 
Chr # of 
Genes* 
A_51_P402909 Ncf2 neutrophil cytosolic factor 2 F 1 164 
A_51_P110576 Lgmn legumain F 12 158 
A_51_P188704 Unc13a unc-13 homolog A (C. elegans) M 8 153 
A_51_P229990 Rsb30 RAB30, member RAS oncogene family M 7 148 
A_51_P155972 Clec14a C-type lectin domain family 14, member a F 12 147 
A_51_P470432 Pdlim4 PDZ and LIM domain 4 F 11 145 
A_51_P324636 Elovl3 
elongation of very long chain 
fatty acids (FEN1/Elo2, 
SUR4/Elo3, yeast)-like 3 
M 19 140 
A_51_P183439 C77080 expressed sequence C77080 M 4 139 
A_51_P233338 Olfr46 olfactory receptor 46 M 7 136 
A_51_P115049 Mpzl2 myelin protein zero-like 2 M 9 133 
A_51_P338040 Vopp1 vesicular, overexpressed in cancer, prosurvival protein 1 F 6 127 
A_51_P388325 Clgn calmegin M 8 122 
A_51_P365964 Tor1a torsin family 1, member A (torsin A) F 2 117 
A_51_P248394 Olfr178 olfactory receptor 178 M 16 113 
A_51_P379080 Adam24 a disintegrin and metallopeptidase domain 24 (testase 1) F 8 111 
A_51_P357341 Clic1 chloride intracellular channel 1 F 17 110 
A_51_P221781 Zfp33b zinc finger protein 33B M 5 108 
A_51_P277376 Slc8a1 
solute carrier family 8 
(sodium/calcium exchanger), 
member 1 
F 17 106 
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A_51_P473086 Tbxa2r thromboxane A2 receptor M 10 103 
A_51_P513011 Rad9b RAD9 homolog B (S. cerevisiae) M 5 101 
A_51_P391754 Soat1 sterol O-acyltransferase 1 F 1 99 
A_51_P483366 9230114N12Rik 9230114N12Rik M 16 97 
A_51_P151828 Flna filamin, alpha F X 97 
A_51_P243641 XM_994259.2 Mus musculus myeloid/lymphoid or mixed-lineage leukemia 2 M 15 96 
A_51_P372992 4632428N05Rik RIKEN cDNA 4632428N05 gene F 10 94 
A_51_P485472 4933430H15Rik RIKEN cDNA 4933430H15 gene F 3 94 
A_51_P152845 Trim24 tripartite motif-containing 24 M 6 93 
*, The number of genes this transcript correlates with within a sex at Spearman correlation 
≥0.7.  
 
There are also differentially correlated gene clusters in which a set of genes is highly 
correlated (≥0.7) with each other in one sex, but not in the other (Figure 4.6). We focused on 
the genes that had strong correlation in one sex, but considerably weaker correlation in the 
other (mean absolute correlation difference ≥0.35 between the sexes).  There were 33 
differentially correlated clusters in males consisting of 254 unique genes (Figure 4.6a-c), and 
28 clusters in females containing 332 unique genes (Figure 4.6d-f). The male-specific 
clusters are related through a complex network of correlations (Figure 4.6a) that are neither 
primarily driven by expression differences between sexes (Figure 4.6b), nor correlated in 
females (Figure 4.6c).  The female clusters exhibit a similar pattern in the opposite direction 
(Figure 4.6d-f). Finally, we searched for clusters of genes that are strongly correlated (≥0.7) 
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in both sexes. There were 2,639 genes with high correlation in both sexes (Figure 4.6g, i) and 
most of these genes were also differentially expressed between sexes (Figure 4.6h).   
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Figure 4.6. Correlation analysis of gene expression reveals sex-specific clusters. The 
gene-gene correlation of clusters of genes more highly correlated in males than in females 
is plotted in (a), clustered by correlation within males.  (b) shows a gene expression 
heatmap for these same genes, separated by sex and clustered as in (a).  Note that the 
clusters are not dominated by expression differences between the sexes. (c) shows the 
correlation of these genes in females.  Note that there is strong correlation in the males 
(bright yellow clusters) and little to no correlation in the females (red).  (d,e,f) show the 
same types of data for genes more highly correlated in females than in males.  In this case, 
there is little correlation for these genes among males (red in (d)) while there is strong 
inter-gene correlation in females (yellow in (f)). (g,h,i) show clusters that are highly 
correlated in both sexes, evidenced by the yellow blocks in both (g) and (i).  In this case, 
many, but not all, of the clusters arise due to expression differences between the sexes. 
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Discussion 
 In this study, we compared liver gene expression of males and females in a panel of 
BXD recombinant inbred mice in an effort to understand how genetic background affects 
sexually dimorphic gene expression.  Most of the differentially expressed genes, as well as 
significant eQTL, were not confined to sex chromosomes, suggesting that autosomal 
polymorphisms are an important component of the transcriptional regulation of sexually 
dimorphic genes.   
 
Sex-dependent Differences in Gene Expression in Liver: Physiological and Toxicological 
Significance 
 
 It has been long known that females exhibit a higher incidence of drug-induced liver 
injury (Maddrey 2005). There are significant pharmacokinetic differences between the sexes 
which are likely due to significant differential expression in CYP450s, glutathione S-
transferases (Gst), sulfotransferases (Sult), UDP glucuronosyltransferases (Ugt) and ATP-
binding Cassette (ABC) transporters (Schwartz 2003). Consistent with previous work, we 
found a large number of differentially expressed cytochrome P450s, including the previously 
reported female-biased genes Cyp2a4 (Tullis et al. 2003), Cyp2b9, Cyp3a16 (Waxman and 
Holloway 2009b), and the male biased Cyp1a2 (Waxman and Holloway 2009b), Cyp2d9 
(Tullis et al. 2003).  Overall, 39 of the 69 CYPs on the array (56%) were differentially 
expressed, with 26 CYPs biased toward high female expression and 13 male-biased. 
However, we also found Cyp2j13 to be male biased, and Cyp2e1 female biased, suggesting 
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that sexual dimorphism of important xenobiotic enzymes may also be affected by a complex 
interaction with genetics.   
Higher expression of most Sult genes was found in females, including Sult3a1 
(Alnouti and Klaassen 2006), Sult1a1, Sult1c1, Sult1c2, Sult1d1 and Sult1e1.  In agreement 
with previous reports, we find that Gstp1 is male-biased and Gsta3 is female-biased 
(Mitchell et al. 1997). We also find that Gstm7 is male-biased, and that most differentially 
expressed Gsts are female-biased (11 vs 23).  We found that 7 of 9 (77.8%)  Ugt genes on 
the array were differentially expressed at q-values≤0.01. Ugt genes were found to be 
exclusively male-biased, which is consistent with the finding that Ugt expression is regulated 
by male GH production in the liver (Buckley and Klaassen 2009). ABC transporters affect 
the disposition of many endo- and xeno-biotics.  About 44% of these genes on the array (out 
of 50) were more highly expressed in females than in males, whereas only 3, including 
Abcg2 (Merino et al. 2005), were more highly expressed in males. Similarly, male bias was 
observed in expression of epoxide hydrolases 1 and 2 (Ephx1, Ephx2) and critical co-factor 
supply genes hexose-6-phosphate dehydrogenase (H6pd) and nicotinamide nucleotide 
adenyltransferase 1 (Nmnat1). 
The retinol binding protein (Rbp1), alcohol dehydrogenase 1 (Adh1), retinol 
dehydrogenases 6 and 9 (Rdh6, Rdh9) exhibit strong female bias in expression. These genes 
belong to the retinol metabolism pathway and it is noteworthy since the BXD strains have 
been used extensively for studies of alcohol metabolism and behavior (Crabbe et al. 1994). 
There is considerable overlap between alcohol and retinol metabolism (Gyamfi et al. 2006) 
and Rbp1 has been proposed as a candidate for genetic control of alcohol preference in the 
mouse (Mulligan et al. 2006).   
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It should be noted that not all sex-specific gene expression differences found in the 
mouse translate to humans. While the mapping of mouse microarray probes to human array 
probes limited the comparison, we found that many genes are biased in the same direction in 
each sex, suggesting that the mouse is an appropriate model for studying human liver disease 
and function. Still, even though both human and mouse sex-specific liver gene expression 
differences are prominently enriched with xenobiotic metabolism, important gene-directed 
distinctions exist.  One example is flavin-containing monooxygenase 3 (Fmo3), a key player 
in metabolism of numerous substrates, including nicotine, tertiary amines, drugs, carbamates 
and organophosphates (Cashman 2000). It is a prominent female-biased gene in the mouse 
liver, but in humans Fmo3 is known to be expressed in livers of both sexes (Koukouritaki et 
al. 2002). Thus, extrapolations between studies and species should be exercised with caution.   
 
Transcriptional Control of Sexual Dimorphism in Liver Gene Expression 
 
The sexual dimorphism in expression of many drug metabolism and other liver-
expressed genes has been reported to be largely regulated by the temporal pattern of plasma 
GH release by the pituitary gland (Clodfelter et al. 2007; Waxman and Holloway 2009a). 
These differences are most pronounced in rodents, where plasma growth hormone profiles 
are highly pulsatile in males, but are nearly continuous in females. Hnf4α and Stat5b are key 
transcription factors that respond to sexually dimorphic GH secretion pattern responsible for 
up-regulation of males-biased genes (Wiwi et al. 2004). Our study did not identify 
enrichment in binding sites for GR, Stat5b, or Hnf4α among sexually dimorphic genes in the 
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liver of BXD mouse panel.  While Stat5b and Hnf4α undoubtedly play a major role, and can 
be identified in comparisons of male and female mice of the same strain, our result suggests 
that the regulation of sex-dependent gene expression on the population level may be complex 
and both direct and indirect linkages in the network of regulators that maintain sex-
dependent liver homeostasis are yet to be determined.  
Hnf1α was significantly enriched among female-biased genes and is known to be 
regulated by Hnf4α and to cooperate with STAT5b in transcriptional regulation (Wiwi and 
Waxman 2004).  Hnf1α is a homeodomain protein that binds to DNA as a heterodimer with 
Hnf1β.  Hnf1α -/- mice die during weaning with renal tubule dysfunction and show no 
phenylalanine hydroxylase (Pah) expression, causing a phenotype similar to phenlyketonuria 
(Costa et al. 2003).  This suggests that Hnf1α is important in liver metabolism, but its role in 
sexually dimorphic gene expression is still unclear.  The Pax5 gene encodes the BSAP 
transcription factor, which has primarily been studied in B-cell development with no directly 
known function in the liver. 
 
Genetic Component of the Sex Specific Gene Regulation 
 
It is likely that mechanisms other than growth- and sex-hormones may also contribute 
to regulation of sex-specific hepatic gene expression. QTL mapping has been adapted to 
gene expression data to find expression QTLs that represent genomics loci responsible for 
differential transcriptional regulation (Schadt et al. 2003). The sex-specific eQTL hotspots 
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discovered in our study provide some evidence for the sex-specific differences in genetic 
control that may be also important. We have assessed existence of eQTLs in males and 
females by considering gene expression data from each sex separately. While 3 loci 
identified as putative regulatory hotspots are shared between males and females, including 
the strongest regulatory locus on chromosome 12 (Gatti et al. 2007; Gatti et al. 2009a), there 
were few additional significant sex-specific putative regulatory loci.  
Ghazalpour et al. (Ghazalpour et al. 2005) also performed eQTL mapping using a 
C57BL/6JxDBA/2J intercross, but did not include all eQTL results in their publication so we 
were not able to perform a detailed comparison with their study. It was reported by the 
authors that significantly enriched eQTL bands on Chr 3, 6, 16 and 19 were identified in 
females. These bands did not reproduce in our study, and there are several possible 
explanations for the discord. The microarrays used, while both based on Agilent technology, 
were different in probes, transcripts, as well as regions of overlapping transcript. Most 
importantly, whereas the BXD mice in our study were fed a normal chow diet and were 
sacrificed at a mean of 70 days, a high fat diet and a 16 months study length were employed 
by Ghazalpour et al. (Ghazalpour et al. 2005).  
In addition, Yang et al. (Yang et al. 2006) examined the interaction of sex with 
genetic background in liver gene expression.  It is of relevance that our study was based on a 
cross between C57BL/6J and DBA/2J strains, whereas Yang et al. (Yang et al. 2006) used an 
intercross between C57BL/6J and C3H/HeJ. The genomes of these three strains differ at 
37.2% of known SNPs [http://compgen.unc.edu/DisplayIntervals/DisplayIntervals.html], 
which may at least partially account for lack of overlap.  This also means that only 62.8% of 
the mouse genome has been explored in these two studies and that much work remains to be 
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done in studying the effect of genetics on sexual dimorphism.  Collectively, since the number 
of genes regulated by the QTLs in sex-specific manner is relatively small and is poorly 
reproducible between studies, we posit that it is unlikely that genetic polymorphisms play a 
major role in controlling sex-specific gene regulatory networks. 
 
Correlation Analysis Reveals Sex-Specific Gene Expression Networks 
 
  While differential expression plays a large role in sexual dimorphism, it was also 
shown that there is a more subtle, yet important, role played by varying degrees of 
differential correlation among gene expression networks between the sexes (Voy et al. 2006).  
Correlated genes represent functionally related expression networks that are often under 
common transcriptional regulation (Chesler et al. 2005). Several of the clusters, such as the 
male immune response cluster and the female ribosomal cluster, show functional coherence 
that has been annotated in GO or KEGG.  However, many of the clusters discovered here 
have not been previously reported and represent co-expression networks that may help to 
explain differences between male and female liver metabolism. 
 One of the male-specific correlated clusters with the largest differential correlation 
has a mean absolute correlation in males of 0.68 and 0.30 in females.  It is significantly 
enriched in acute–phase response genes (GO:0006953, q=4.6x10-8) and contains three serum 
amyloid A (Saa) genes (Saa1, Saa2, Saa3)  along with 16 other highly correlated genes.  
With the exception of the Saa genes, which are located together on mouse Chr 7, the rest of 
the genes in this cluster are not co-located in the mouse genome. The Saa genes produce 
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acute phase proteins in response to inflammatory stimuli (Gabay and Kushner 1999) and are 
associated with insulin resistance in mice (Scheja et al. 2008).  Several other genes in this 
cluster have also been implicated in inflammation or the immune system including lipocalin 
(Lcn)2 (Zhang et al. 2008), intercellular adhesion molecule (Icam)1 (Gutierrez-Ramos and 
Bluethmann 1997), orosomucoid (Orm)1 (Schmidt et al. 2008), orosomucoid (Orm)2 
(Baumann et al. 1984), LPS-induced TNF-alpha factor (Litaf) (Tang et al. 2006), and beta 
galactoside alpha 2,6 sialyltransferase (St6gal)1 (Zeng et al. 2009).  Even though other genes 
in this cluster have been not implicated in the inflammatory response, their strong correlation 
may suggest that they may be also involved in immune response in liver. 
 In females, one of the most differentially correlated clusters (mean absolute male 
cor.=0.33, mean absolute female cor.=0.66) is significantly enriched in ribosomal genes 
(GO:0003755, q=4.9x10-6) and contains 12 genes, including ribosomal proteins L19, L21, 
S14 and S27.  Another cluster of 11 genes (mean absolute male cor.=0.34, mean absolute 
female cor.=0.69) is enriched for antigen processing and presentation of exogenous peptide 
antigens (GO:0002478, q=2.47x10-6) and similarly to observation in the male clusters, many 
genes that highly correlate may have yet undiscovered functional relationships. 
 The genes that are strongly correlated (≥0.7) in both sexes form two large clusters 
(upper right and lower left in Figure 4.6g, i). The lower left cluster, consisting of 620 genes 
and exhibiting no sex bias in expression, shows no significant GO category or KEGG 
pathway enrichment (q<0.05).  The upper right cluster, consisting of 740 genes with male-
biased expression, shows enrichment for ion channel activity (GO:0005216, q=6.02x10-4), a 
category that includes calcium, sodium and potassium channel transporters. These genes 
show significant TFBS enrichment for several transcription factors, including myeloid zinc 
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finger 1 (Mzf1) (p=3.09x10-4) which is known to activate calcium-activated potassium 
channels (Sun et al. 2001).  The third largest cluster consists of 245 genes female-biased 
expression pattern and shows enrichment for immune response (GO:0006955, q=8.32x10-12).  
These genes show TFBS enrichment for transcription factor SpiB (p=7.14x10-5), and signal 
transducer and activator of transcription (Stat6) (p=1.6x10-3). SpiB is known to be associated 
with the transcriptional regulation of immunity (Gallant and Gilkeson 2006) and Stat6 
controls immune response in many organs, including the liver (Gao 2005). 
 In conclusion, this study assessed the hepatic gene expression networks between two 
sexes in a BXD RI mice population. Unlike studies carried out in only one strain, the genetic 
diversity in the BXD population, combined with a comparison to human data, sheds light on 
the global sexually dimorphic gene expression that is highly relevant to the human 
population. Studies in mouse populations may allow us to generate testable hypothesis with 
regard to gene regulation networks and modes of action of toxicants. Also, our findings have 
several implications for toxicological studies. It is not only the genes that show significant 
sex differences that are important in assessing toxic responses in males and females, a large 
number of functionally related genes with small differences between sexes could also 
contribute to many sex-biased phenotypes. Caution should be taken when applying the 
results from a study which was carried out only in male subjects (which is very common in 
toxicological studies) and applying the conclusions to the whole population. Finally, sexually 
dimorphic gene expression, at least partly, may due to the genetic control. Other genomic 
information, like genome structure similarities and IBD regions, when combined with eQTL 
mapping, can facilitate the process of finding candidate regulatory genes.  
 
 
 
 
Chapter 5 
 
Replication and Narrowing of Gene Expression Quantitative Trait Loci in Inbred 
Mice 
 
Introduction 
Gene expression quantitative trait locus (eQTL) mapping is a statistical technique 
that correlates quantitative measurements of mRNA expression with genetic polymorphisms 
segregating in a population to locate genomic intervals that are likely to regulate the 
expression of each transcript (Farrall 2004; Gilad et al. 2008). When transcript expression is 
measured using microarrays, the result consists of tens of thousands of genome-wide eQTL 
profiles, one for each transcript.  The goal of such an analysis is to identify clusters of co-
regulated genes, to discover candidate genes that may regulate the expression of these 
clusters, to elucidate normal tissue-specific physiology and seek candidate genes underlying 
disease-related phenotypes.  eQTL mapping has been successfully applied in yeast (Brem et 
al. 2002), arabidopsis (West et al. 2007), maize (Shi et al. 2007), mice (Schadt et al. 2003; 
Chesler et al. 2005; Bystrykh et al. 2005) and humans (Monks et al. 2004). 
Two common features of eQTL studies are the existence of cis-eQTL, genes which 
are regulated by loci co-located within 5 Mb of the transcript, and trans-eQTL, genes which 
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are regulated by distant loci (>5 Mb or on different chromosomes) (Peirce et al. 2006; 
Kliebenstein 2008).  In general, cis-eQTL tend to produce stronger statistical associations 
than trans-eQTL (Doss et al. 2005), and this is regarded as evidence of greater biological 
plausibility for the existence of true functional cis-eQTL. Trans-eQTL can occur individually 
at a single genomic locus or can occur collectively as part of eQTL trans-bands. The latter 
are thought to be genomic loci that control the expression of a larger number of genes than 
expected by chance.  Several investigators have argued or shown that most eQTL trans-
bands are likely to be spurious (de Koning and Haley 2005; Kliebenstein 2008; Breitling et 
al. 2008) and arise simply due to the correlation structure among transcript expression.  
Briefly, if one transcript is spuriously associated with a locus, then all transcripts that are 
highly correlated with the first transcript will also show this spurious association.  The 
difficulty is that clusters of transcripts truly associated with a causative locus will also show 
this same pattern, making the detection of true positives quite difficult.  Only one eQTL 
trans-band has been biologically validated using small interfering RNA (siRNA) knockdown 
of the candidate gene to demonstrate a change in the predicted function of the genes in the 
trans-band(Wu et al. 2008).   
While linkage studies in F2 or recombinant inbred (RI) lines are thought to produce 
more robust eQTL results, the limited recombination in such crosses produces large QTL 
intervals and makes the selection of candidate genes difficult.  One approach that has been 
used to narrow individual QTL intervals is in silico haplotype mapping in laboratory inbred 
strains (Dipetrillo et al. 2005; Burgess-Herbert et al. 2008).   Another approach relies upon 
the combination of data from multiple studies to both narrow the QTL interval and select 
QTL that are reproducible.  For a single phenotype, several methods have been described 
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that can be used to combine QTL data from different crosses (Walling et al. 2000; Li et al. 
2005; Malmanger et al. 2006; Peirce et al. 2007).  However, due to the high cost of 
replicating a large eQTL study and the computational challenge of combining data for 
thousands of transcripts, these methods are difficult to apply to most eQTL studies. 
The reproducibility of eQTL in two panels of closely related mice, BXD recombinant 
inbreds (RI) (Taylor et al. 1999) and an F2 cross between the same parental strains, has been 
reported to be high (Peirce et al. 2006).  However, it is not clear whether eQTL will replicate 
in more diverse populations within the same species.  Recent work has shown that genome 
wide association (GWA) mapping in panels of inbred strains suffers from a high false-
positive rate (Manenti et al. 2009) but suggests a combined approach using GWA and 
classical linkage mapping in a genetic cross.  Here, we apply this technique to investigate the 
reproducibility of mouse liver eQTL between a linkage study in BXD RI lines (Gatti et al. 
2007) and a GWA study in inbred strains of the Mouse Diversity Panel (MDP) (Paigen and 
Eppig 2000). We observed that 9.9% of cis-eQTL and 2.0% of trans-eQTL replicate between 
the two data sets and we use the finer haplotype structure of the MDP to narrow the eQTL 
intervals. We also find that an eQTL trans-band on distal chromosome 12 is reproducible, 
and conclude that this approach should be added to the array of tools used to select candidate 
eQTL for biological validation. 
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Methods 
 
BXD Strains. The details of breeding, housing, RNA isolation and gene expression 
measurements in these mice are described in (Gatti et al. 2007).  Briefly, 38 strains of male 
BXD RI mice, C57BL/6J and DBA/2J parentals, and B6D2F1 were used to perform 
genome-wide eQTL mapping for 20,868 transcripts using Agilent G4121A microarrays 
(Santa Clara, CA). 
 
BXD QTL Mapping. eQTL mapping in the BXD panel was carried out using FastMap (Gatti 
et al. 2009b) configured to perform single-marker mapping and 1,000 permutations per 
transcript to produce per-transcript significance thresholds.  A subset of 2,486 transcripts 
(out of 20,868 on the array) were selected by retaining all transcripts with known genomic 
locations (in Mouse Genome Build 36) and a maximum eQTL peak with a p-value  0.05.  
This subset was used in the analysis of eQTL replication in the MDP eQTL data.  Cis-eQTL 
were defined as those for which the maximum QTL and the transcript were co-located within 
5 Mb.  The QTL interval was taken as the peak-width at 1 log-of-the-odds score (1-LOD) 
below the eQTL peak maximum.  Subsets of eQTL were selected at per-transcript p-values 
of  0.001, 0.01 and 0.05. 
 
Inbred strains of the MDP.  Male mice (aged 7-9 weeks) were obtained from The Jackson 
Laboratory and housed in polycarbonate cages on Sani-Chips irradiated hardwood bedding 
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(P.J. Murphy Forest Products Corp., Montville, NJ). Animals were fed NTP-2000 wafer feed 
(Zeigler Brothers, Inc., Gardners, PA) and water ad libitum, and maintained on a 12 h light-
dark cycle. Mice utilized in this study comprise 31 inbred strains that are priority strains for 
the Mouse Phenome Project (Paigen and Eppig 2000): 129S1/SvImJ, A/J, AKR/J, 
BALB/cByJ, BTBR T+ tf/J, BUB/BnJ, CAST/EiJ, C3H/HeJ, C57BL/10J, C57BL/6J, 
C57BLKS/J, C57BR/CdJ, C57L/J, CBA/J, CZECHII/EiJ, DBA/2J, FVB/NJ, JF1/Ms, 
KK/HlJ, LP/J, MA/MyJ, MSM/Ms, NOD/ShiLtJ (formerly NOD/LtJ), NON/LtJ, 
NZO/H1LtJ, NZW/LacJ, P/J, PERA/EiJ, PL/J, PWD/PhJ, RIIIS/J, SEA/GnJ, SJL/J, SM/J, 
SWR/J, and WSB/EiJ. Care of mice followed institutional guidelines under a protocol 
approved by the Institutional Animal Care and Use Committee at the University of North 
Carolina at Chapel Hill. 
 
MDP RNA isolation. To minimize variability in transcript expression that might arise due to 
circadian rhythms or lobular variation, animals were sacrificed between 9 AM and 11AM 
and the left liver lobe was selected for analysis of gene expression. RNA was extracted from 
30 mg of liver tissue using the Qiagen RNeasy kit (Qiagen, Valencia, CA). RNA 
concentrations were measured using a NanoDrop ND-1000 spectrophotometer (NanoDrop 
Technologies, Wilmington, DE) and quality was verified using the Agilent Bio-Analyzer 
(Agilent Technologies, Palo Alto, CA).  
 
MDP Microarray hybridizations. In this study, all RNA samples were hybridized to arrays 
individually; no samples were pooled. RNA amplifications and labeling were performed 
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using Low RNA Input Linear Amplification kits (Agilent Technologies). For hybridization, 
750 ng of total RNA from each mouse liver was amplified and labeled with Cy5 fluorescent 
dye. In parallel, 750 ng of a common reference RNA (Icoria Inc., RTP, NC) was labeled with 
Cy3 fluorescent dye in order to standardize analysis of global gene expression between 
mouse strains(Bammler et al. 2005). Labeled cRNA was then processed and hybridized to 
Agilent Mouse Toxicology Arrays (catalog# 4121A; 20,868 transcripts) according the 
manufacturer’s protocol. Following hybridization, arrays were washed using a custom 
protocol developed by Icoria, Inc. Briefly, array gaskets are removed under immersion in 
Wash Solution 1 (6X SSPE, 0.005% N-Lauroylsarcosine). Arrays were washed with Wash 
Solution 1 and incubated for one minute with gentle agitation on a magnetic stir plate. A 
second incubation was performed in Wash Solution 2 (0.06X SSPE, 0.005% N-
Lauroylsarcosine).  
 
MDP Microarray Data Analysis. Raw microarray intensity values were obtained from 
Agilent Feature Extraction software (v8.5) and archived in the UNC Microarray Database 
(http://genome.unc.edu).  The log2 ratio of Cy5/Cy3 intensity was normalized using 
LOWESS smoothing to eliminate intensity bias of features.   Intensity ratios were 
transformed to eliminate hybridization batch effects using the Batch Normalization feature in 
Partek Genomics Suite (Partek Inc., St. Louis, MO).  The strain means were obtained be 
averaging all arrays for each stain (1 or 2 per strain) and were used in the subsequent eQTL 
analysis.  The raw microarray data is available from the Gene Expression Omnibus (GEO) 
(GSE14563) (Barrett and Edgar 2006) as well as from WebQTL (Wang et al. 2003). 
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MDP QTL Mapping. High density single nucleotide polymorphism (SNP) data was used to 
perform eQTL mapping in the MDP (McClurg et al. 2007).  Association mapping was 
carried out using FastMap (Gatti et al. 2009b), which performs haplotype association 
mapping using a 3-SNP sliding window and performs 1,000 permutations of the strain labels 
to produce per-transcript significance thresholds (Pletcher et al. 2004).  Population structure 
was identified using a PCA plot of the SNP data and two major strata were identified; 
C57BL/6J, C57BL/10J, C57BLKS/J, C57BR/cdJ & C57L/J were in one stratum and the 
remaining strains were in the other.  We subtracted the mean gene expression value of each 
stratum from the strains in each respective stratum before mapping.  Significant eQTL were 
selected at a p ≤ 0.001, 0.01 and 0.05 levels.  After mapping, transcripts with significant 
eQTL on more than 5 chromosomes were considered to have to high a rate of false positives 
and were discarded. 
 
Determination of eQTL Reproducibility.  The eQTL intervals for three sets of transcripts, 
selected at increasing degrees of stringency (p  0.001, 0.01, 0.05) in the BXD panel were 
intersected with eQTL intervals for those same transcripts in the MDP.  The BXD eQTL 
were intersected with three sets of eQTL from the MDP selected at increasing levels of 
stringency (p ≤ 0.001, 0.01, 0.05).  An eQTL was considered to be replicated when 1) the 
eQTL was significant  in both data sets at the current significance levels and 2) the minimum 
p-value on the chromosome where the eQTL occurred in the MDP intersected the BXD 
eQTL interval. 
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Determination of Null Probability of Replication. In order to assess the probability of an 
eQTL replicating between the BXD panel and the MDP, we selected one transcript at 
random from the significant BXD eQTL and one transcript at random from the significant 
MDP eQTL and looked for an eQTL within 5.0 Mb in both panels.  This process was 
repeated 1,000,000 times. 
Determination of Probability of eQTL trans-bands.  Following the procedure outlined in 
(Breitling et al. 2008), we permuted the strains in the SNP data while holding the strain order 
in the gene expression data constant and performed eQTL mapping 100 times using 
FastMap. 
 
Identical By Descent (IBD) Regions. The software available at 
http://compgen.unc.edu/DisplayIntervals/DisplayIntervals.html was used to determine which 
regions of the genome are IBD (Zhang et al. 2009). This tool uses the SNP data produced by 
(Szatkiewicz et al. 2008) and calls a region IBD if there are 100 or more consecutive, non-
polymorphic SNPs between the two strains. 
 
SNPs in Probe Sequences.  The genomic locations of the probes on the Agilent G4121A 
microarray were obtained from Agilent (Santa Clara, CA).  High density mouse SNP data 
containing 7.87 x 106 SNPs was obtained from (Szatkiewicz et al. 2008).  Probe sequences 
containing SNPs were found and intersected with the reproducible cis-eQTL.  For each cis-
eQTL, we performed a one-sided Student’s T-test at the SNP of highest association between 
the expression of strains with the C57BL/6J allele and those with the other allele to 
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determine if the eQTL was “C57BL/6J allele high” or not.  Fisher’s Exact test was used to 
test the null hypothesis that a SNP in the probe sequence was equally likely to occur in cis-
eQTL that are C57BL/6J-high versus DBA/2J-high. 
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Results and Discussion 
 
eQTL Mapping in the Mouse Diversity Panel. 
 
eQTL studies are expensive and time consuming to carry out.  In the mouse, while 
experimental cost remains considerable for data collection, no genotyping is generally 
required as many large panels of inbred mice have been genotyped and this data is publicly 
available (Roberts et al. 2007b).  Examples include RI lines such as the BXD (Peirce et al. 
2004), BXH and LXS (Shifman et al. 2006) strains. While these strains are useful, the large 
sizes of their recombination block structures are not conducive to identifying quantitative 
trait genes (QTG).  For example, the BXD strains have a mean distance of 324,493 base 
pairs (bp) between informative markers 
(http://www.genenetwork.org/mouseCross.html#BXD). In turn, higher density genotype data 
containing 156,525 SNPs in 71 inbred strains has a mean intermarker distance of 16,611 bp 
between informative markers (Roberts et al. 2007a). While this SNP resolution in panels of 
inbred strains is almost 20 times greater, population stratification, haplotype block structure 
and local linkage disequilibrium may also confound the ability to find the QTG. 
 eQTL mapping in the MDP has been proposed as a way to both increase the 
resolution of RI-based eQTL mapping and limit the need for multiple crosses and additional 
breeding (McClurg et al. 2007). Here, we performed eQTL mapping on liver gene expression 
data obtained from 36 naïve inbred mouse strains in order to test the hypothesis that these 
strains can be successfully used for genome-wide eQTL mapping. As observed in a previous 
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eQTL study in mouse hypothalamus (McClurg et al. 2007), we found that noise, lack of 
statistical power and population stratification present a formidable challenge to data 
interpretation whereby the false positive rate is likely to be unacceptably high. For example, 
at a genome-wide significance level of 0.05, there were 2,453,897 significant loci for 4,061 
transcripts and the mean number of significant loci per transcript was 604.  In fact, one 
transcript had over 26,000 significant loci.  These loci were not clustered in a few locations, 
but were distributed throughout the genome (Figure 5.1a). 
We reason that eQTL mapping in a panel of inbred strains may not be the best 
independent way to discover eQTL for the following reasons. First, the MDP do not form a 
segregating population in which each allele can be assigned to a specific progenitor, which 
means that phenotypic associations demonstrate that an allele is identical-by-state rather than 
identical-by-descent.  Second, the MDP has a complex breeding history and performing 
association mapping in any subset may be similar to selecting the same number of outbred 
mice for association mapping; the resulting power is likely to be low.  Third, population 
stratification between M. m. domesticus and non-M. m. domesticus strains is difficult to 
overcome in a computationally feasible manner when performing mapping on 20,868 
transcripts.  Fourth, while there are 156,525 SNPs in the data set, there are only 59,255 
unique strain distribution patterns (SDP), which creates a high probability that a given 
transcript will map to more than one locus.  Often the SDPs cluster in the same region of the 
genome, but there are many cases where they are distributed throughout the genome.  Thus, 
while eQTL mapping in some subset of the MDP may be appealing, new mouse resources 
such as the Collaborative Cross (Threadgill et al. 2002; Churchill et al. 2004) are likely to 
provide much greater power and resolution for genome-wide systems genetics. 
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Figure 5.1. a) Transcriptome map of all 20,868 transcripts on the microarray using 
31 M. m. domesticus derived strains at a per-transcript p ≤ 0.05 significance level. 
b) Transcriptome map of significant eQTL in the BXD strains (grey crosses) at p 
≤ 0.05 with replicated eQTL using in the laboratory inbreds overlaid (red squares) 
at p ≤ 0.05. 
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Because of the limitations of the MDP, the effect of population structure on the eQTL 
mapping results needed to be removed. Previously, it has been suggested that removing 
distantly related strains will reduce the presence of false positives introduced by population 
stratification (Wu et al. 2008). We removed the 5 non-M. m. domesticus derived strains 
(CAST/EiJ, CZECHII/EiJ, JF1/Ms, MSM/Ms, PWD/PhJ) from the data set and performed 
eQTL mapping in the remaining 31 M. m. domesticus inbred strains of the MDP for all 
20,868 transcripts on the array. At an α = 0.05 significance threshold there were 12,749 
significant loci for 1,582 transcripts (mean of 8 loci per transcript) with a median eQTL 
interval of 24,832 bp. The resulting transcriptome map (Figure 5.1a) is also difficult to 
interpret due to a large number of likely false positives.  It has been shown for individual 
phenotypes that data from a linkage mapping study can be used in conjunction with an 
association study to produce more robust results (Manenti et al. 2009). We reasoned that an 
independent mouse liver eQTL data obtained in BXD RI panel might be used to replicate 
eQTL and narrow the width of the candidate loci.   
 
Using the BXD eQTL data to inform MDP Mapping. 
 
FastMap (Gatti et al. 2009b) was used to perform eQTL mapping for each transcript 
using data from a BXD liver eQTL study (Gatti et al. 2007).  In order to reduce the number 
of statistical tests performed in the MDP, we first selected 2,486 transcripts in the BXD 
panel that met eQTL significance thresholds of p ≤ 0.05.  We performed eQTL mapping 
using FastMap in the MDP using these 2,486 transcripts and retained all peaks with p-
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values ≤ 0.05. We then selected three significance levels in the BXD panel (p ≤ 0.001, 0.01, 
0.05) and the MDP (p ≤ 0.001, 0.01, 0.05) and compared the number of replicated eQTL at 
these thresholds (Table 5.1). At all MDP p-value thresholds, the number of replicated eQTL 
decreases with increasing stringency of the BXD threshold and cis-eQTL are more 
reproducible than trans-eQTL. 
Table 5.1. Total number of eQTL that replicate between the two data sets at varying 
significance levels in the BXD and MDP. Percent values are the number of eQTL that 
replicate divided by the number of significant eQTL in the BXD panel. 
 
BXD 
p-value 
Sig. BXD 
transcripts 
Inbred p-value 
0.001 (%) 0.01 (%) 0.05 (%) 
0.001 854 29 (3.4) 69 (8.1) 104 (12.2) 
0.01 1,338 29 (2.2) 72 (5.4) 119 (8.9) 
0.05 2,486 31 (1.2) 77 (3.1) 128 (5.1) 
Sig. 
Inbred 
transcripts 
 
238 1,190 2,981 
 
Next, we selected a BXD threshold of p ≤ 0.05 and a MDP threshold of p ≤ 0.05 and 
compared eQTL peaks between the two data sets.  We removed any transcripts from the 
MDP that showed significant loci on more than 5 chromosomes.  At these thresholds, there 
were 2,981 significant loci in the MDP data for 369 transcripts with a mean number of 
significant loci per transcript of 8 (median = 3).  Consistent with previous studies, we found 
cis-eQTL to be more reproducible than trans-eQTL, with 9.9% of cis-eQTL and 2.0 of trans-
eQTL replicating between data sets (Table 5.2).  We assessed the null probability of eQTL 
replication between the two panels of mice by selecting two transcripts at random from the 
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BXD and MDP data sets and searching for a colocated eQTL in both panels within a 5 Mb 
window.  This spurious overlap occurred only 971 times in 106 trials (0.097%), suggesting 
that the observed reproducibility in eQTL is not entirely due to chance.  These results are 
lower than we expected.  However, in genome-wide eQTL studies, we are often 
overwhelmed with potential leads.  In this case, a smaller set of eQTL which reproduce 
between independent panels of mice may be prefereble. In contrast, a study comparing eQTL 
in a BXD RI panel with those in a C57BL/5J x DBA/2J F2 cross found that 67% of the cis-
eQTL and 23% of trans-eQTL replicated (Peirce et al. 2006).  This is not surprising since it 
would be expected that there would be greater reproducibility between two panels derived 
from similar parental strains than between two panels with different breeding histories and 
different distributions of polymorphisms. 
Table 5.2. The number of replicated cis and trans eQTL between the BXD data set and 
the MDP at an inbred threshold of p ≤ 0.05 and several BXD p-values thresholds. Percent 
values are the number of replicated cis or trans eQTL divided by the number of cis or 
trans eQTL respectively in the BXD panel. 
 
 
 
 
 
 
 
We next plotted the MDP eQTL location against the transcript location for each 
transcript that was significant in the BXD strains (Figure 5.1b, grey crosses), and overlaid 
eQTL that replicated between the two data sets on this plot (Figure 5.1, red squares).  
 BXD eQTL Replicated eQTL 
BXD 
p-value 
Cis Trans Total 
Cis 
(% of BXD cis) 
Trans  
(% of BXD trans) 
0.001 639 215 854 77 (12.1) 27 (12.6) 
0.01 827 511 1,338 91 (11.0) 28 (5.5) 
0.05 988 1,498 2,486 98 (9.9) 30 (2.0) 
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Previous eQTL studies have found that  the two most common features of transcriptome 
maps are 1) a band of cis-eQTL along the diagonal and 2) vertical trans-eQTL bands that 
represent eQTL hotspots (Kliebenstein 2008).  Both of these features appear in the 
transcriptome map that results from the replicated eQTL between the BXD and MDP.  
Previously, we showed that there is a strong eQTL hotspot in the BXD panel on distal Chr 12 
that involves over 100 transcripts (Gatti et al. 2007).  In the male BXD strains there are 130 
transcripts that have a maximum eQTL on Chr12 between 103 and 108 Mb at a p-value of 
0.05 (104 transcripts at p ≤ 0.01).  There is also an eQTL trans-band on Chr 7 in the BXD 
male data set.  While the trans-band on Chr 7 does not replicate, we found that the eQTL 
trans-band on Chr 12 replicates in the independent MDP with 19 of the transcripts having a 
maximum eQTL on Chr12 between 104 & 105 Mb at a p-value ≤ 0.05  In order to assess the 
probability of seeing an eQTL trans-band of size 19 by chance, we applied a permutation 
technique that involves re-running the eQTL analysis repeatedly, reordering the strain names 
in the SNP data each time, and counting the number of eQTL that occur at each SNP 
(Breitling et al. 2008).  We found that an eQTL trans-band of size 19 never occurred and that 
the largest eQTL trans-band (17 transcripts) occurred only once in 100 permutations (Sup. 
Fig. 1).  From this, we conclude that the eQTL trans-band found in the MDP is unlikely to 
have occurred by chance. 
It has previously been demonstrated that cis-eQTL may be spuriously caused by 
polymorphism that occur in transcript probe sequences (Peirce et al. 2006; Alberts et al. 
2007).  If this were the case, it would not be surprising to see these cis-eQTL replicate in the 
two panels of mice.  Using a high density SNP data set (see Methods), we searched for 
polymorphisms within the probe sequences of the 91 cis-eQTL transcripts and found 28 with 
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at least one SNP in the probe.   We categorized the cis-eQTL as “C57BL/6J allele high” if a 
Student’s T-test between the expression of strains with the C57BL/6J allele and those with 
the other allele produced a p-value < 0.5.  We then performed Fisher’s exact test to test the 
null hypothesis that a SNP in the probe sequence is equally likely to occur in a C57BL/6J-
allele-high cis-eQTL as in a cis-eQTL that is high when the non-C57BL/6J allele is present.   
The result was not significant (p = 0.65), leading us to conclude that SNPs within the probe 
sequences are not responsible for the reproducibility of cis-eQTL between the two panels.  
This is in keeping with other studies that have searched for cis-eQTL bias on the Agilent 
platform (Doss et al. 2005). 
Narrowing eQTL using the MDP. 
As mentioned above, while the BXD strains are an excellent resource for QTL 
mapping, the recombination block structure among the strains remains large.  For example, 
the eQTL hotspot interval on distal Chr 12 is approximately 5 Mb wide in the BXD panel 
(Figure 5.2a,b), while being only ~1 Mb in the MDP (Figure 5.2c).  Similarly, among all 
significant eQTL in the BXD panel, the mean width of the QTL interval was 16.6 Mb 
(median = 12 Mb), while that of the replicated eQTL in the MDP was 0.33 Mb (median = 
0.32 Mb).  This reduction in size is likely due to the finer haplotype block structure resulting 
from the random mating during the development of these strains (Roberts et al. 2007b).  The 
improved resolution provided by the MDP reduced the number of candidate QTGs that may 
be responsible for the Chr 12 eQTL hotspot from 60 to 11 genes, all of which are part of the 
serine protease inhibitor (serpin) family of genes. 
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Figure 5.2.  Reduction in eQTL hotspot width using laboratory inbred strains.  Panel (a) 
shows the eQTL profile on Chr 12 for the BXD strains (red) and the laboratory inbred 
strains (black) using Fisher’s combined method to aggregate the p-values of all transcripts 
that have a significant QTL at this locus in each panel.  SNP density in the 156K data is 
shown in orange.  Panels (b) & (c) show successively zoomed in regions of the hotspot and 
demonstrate the narrower eQTL interval produced by the inbred strains. 
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The serpin genes at this locus consist of a cluster of Serpina1 genes, which are the 
mouse orthologs of human α1-antitrypsin, and Serpina6, 9, 10, 11 and 12. A detailed 
analysis of the Serpina1 locus showed that there are seven paralogs of these genes, denoted 
as Serpina1a-e and Serpina-DOM6 & DOM7.  DOM6 and DOM7 are two new isoforms of 
Serpina1 that were first identified by (Barbour et al. 2002). The quantity and membership of 
Serpina1 genes varies across the MDP. Some strains, including the C57BL/6J reference 
strain, contain Serpina1a through e.  Other strains, including DBA/2J, contain Seripina1a,b 
and DOM6 or DOM7 (Barbour et al. 2002).  To further elucidate possible candidate QTGs 
we performed a haplotype analysis of the SNPs between 103 & 108 Mb on Chr 12, which is 
the region of significance in the BXD strains, and found that strains in the MDP cluster 
(Figure 5.3a) in a manner similar to that detailed in (Barbour et al. 2002). We also plotted the 
aggregate significance score, represented by Fisher’s combined statistic, of the 19 transcripts 
that replicate between mouse panels at the Chr 12 locus. The peak falls clearly between 104 
and 104.5 Mb.  C57BL/6J clusters with the minor allele whereas DBA/2J clusters with the 
major allele.  Fisher’s combined method was used to aggregate the p-values of the 19 
transcripts in the MDP that have a significant eQTL at this locus and this was plotted on the 
same scale (Figure 5.3b).  While it is possible that any gene that is in strong linkage 
disequilibrium with the Serpina1 genes are candidate eQTL regulators, we believe that this 
division and clustering of the inbred strains is consistent with the hypothesis that Serpina1 
ortholog variation regulates the expression of the Chr12 hotspot. Validation of this 
hypothesis and mechanistic investigation will be the subject of future research. 
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 One advantage of using the commonly available MDP for eQTL replication is that 
the data need be collected only once for each organ.  We have produced and made public 
gene expression data in the livers of 36 MDP in GEO (see Methods). As other investigators 
produce data for additional tissues in these strains, eQTL mapping can be performed to 
search for replicated eQTL across different tissues.  Another advantage is that the QTL 
intervals in the MDP are narrower than in RI and F2 crosses, which reduces the number of 
candidate genes that the investigator must pursue.   
Figure 5.3.  Haplotype analysis of Chr 12 eQTL hotspot.  a) Grey shading represents the 8 
possible haplotypes in a 3 SNP window for the 31 strains used in this study, clustered by 
haplotype pattern.  b) –log(p-value) of Fisher’s combined statistic for the 19 transcripts that 
replicate the Chr 12 eQTL hotspot between the BXD and inbred strains. 
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There are many potential pitfalls in eQTL mapping using the MDP (Chesler et al. 
2001; Breitling et al. 2008).  One drawback to the approach of selection of eQTL using 
independent strain panels is that a failure to replicate an eQTL is uninformative.  For 
example, it has been estimated that 57% of the C57BL/6J and DBA/2J genomes are IBD 
(Doss et al. 2005). This means that many genes which are transcriptional regulators will not 
contain polymorphisms in crosses of these two strains and thus will not produce a differential 
effect in transcriptional regulation.  Among the 128 reproducible eQTL, 4 (3.1%) occur in a 
region that was called IBD between C57BL/6J and DBA/2J. In contrast, among the 241 
eQTL that are significant in the MDP but not in the BXD panel, 127 (52.7%) were in IBD 
regions between C57BL/6J and DBA/2J.  
This reasoning can be illustrated with the following example. Cytochrome P450, 
family 3, subfamily a, polypeptide 13 (Cyp3a13) has one reproducible cis-eQTL on distal 
Chr 5 (Figure 5.4a, c) that falls in a region that is not IBD.  In addition to the Chr 5 eQTL, 
the MDP also has a trans-eQTL on distal Chr 1 (Figure 5.4b) that is located in a region that 
is IBD in the BXD panel and therefore could not be detected due to the lack of 
polymorphisms.  This locus contains one gene, prospero-related homeobox 1 (Prox1), which 
is a transcription factor involved in liver morphogenesis (Papoutsi et al. 2007) and tumor 
suppression (Shimoda et al. 2006).  However, we were unable to find any connection 
between Prox1 and Cyp3a13 in the literature and therefore cannot indicate whether this is a 
true or false positive. 
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Figure 5.4.  eQTL replication cannot occur in IBD regions. a) Cyp3a13 QTL plot with 
the BXD p-values in black and the laboratory inbred p-values in red. Cyp3a13 location 
is shown by the blue triangle. b) Cyp3a13 QTL plot on Chr 1 with IBD intervals 
between C57BL/6J and DBA/2J shaded in grey, BXD markers along the top in black, 
laboratory inbred markers in red. c) Cyp3a13 QTL plot on Chr5. 
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Failure to replicate may also be due to variations in allele frequency across the 
genome in the MDP (Payseur and Place 2007).  The average minor allele frequency (MAF) 
in the BXD panel is 0.48 whereas it is 0.26 in the MDP.  A MAF closer to 0.5 will allow for 
greater power to detect expression differences between alleles and is one of the reasons that 
the BXD panel is a better mapping population.  To see if this effect was partially responsible 
for eQTL that did not replicate, we calculated the MAF in the MDP at the locus that was 
most significant in the BXD panel for eQTL that replicated and for those that did not.  Of the 
eQTL that replicated, 43% had a MAF between 0.4 and 0.6 in the MDP whereas only 24% 
had a MAF in this range among eQTL that did not replicate.  This suggests that the variation 
in power due to MAF was partially responsible for eQTL that did not replicate between the 
panels. 
Furthermore, an eQTL may not be replicable between the two data sets because there 
are complex interactions between genes that regulate gene expression.  Due to the limited 
power provided by sampling between 30 and 40 strains and the fitting of a single locus 
model, it is unlikely that we can detect more than two loci with strong effect sizes for any 
transcript.  It is also possible that an eQTL will fail to replicate because the expression of a 
transcript is spuriously associated with a genotype (Peng et al. 2007; Perez-Enciso et al. 
2007).  Such a false association may even occur for an eQTL hotspot since the expression of 
all transcripts that map to that locus is highly correlated.  This means that if one of the 
transcripts is spuriously associated with a locus, then all other highly correlated transcripts 
are also associated that locus.  The BXD male strains have another eQTL hotspot on 
proximal Chr 7 that fails to reproduce in the MDP and this hotspot may represent a false 
positive eQTL hotspot.  However, the reproduction of the Chr 12 hotspot in two separate 
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panels of mice increased the likelihood that it is an important regulatory locus in the mouse 
liver. 
 
Conclusion 
The selection of gene expression QTLs that warrant further biological investigation is 
an arduous task.  We have presented data showing that a panel of commonly available MDP 
mice can be used to replicate some eQTL from a previous, well-designed linkage study and 
guide the selection of eQTL for further biological investigation.  Consistent with existing 
studies, we found that cis-eQTL replicate with greater frequency than trans-eQTL, and that a 
major eQTL hotspot on distal Chr 12 is replicated in both data sets.  When eQTL are 
reproducible, they offer investigators a set of candidates with which to pursue further 
analyses such as RNA interference knockdowns. 
 
 
 
 
Chapter 6 
 
MicroRNA Expression Profiling of the Mouse Liver 
 
Introduction 
 Microribonucleic acids (miRNA) are short, non-coding RNAs that regulate protein 
levels by binding with complementary sequences on target mRNA transcripts.  Translation is 
then inhibited either directly or by nucleolytic degradation of the mRNA transcript 
(Hammond 2005).  While the mechanistic details underlying miRNA mediated gene 
silencing are not fully understood, several details are understood.  In plants, miRNAs bind to 
complimentary target sites and cause transcriptional degradation (Bartel 2004).  In mammals, 
miRNAs bind to target sites with imperfect complimentarity and inhibit elongation of the 
polypeptide chain during translation (Petersen et al. 2006), although transcript degradation in 
response to miRNA delivery has also been reported(Lim et al. 2005).  Both translational 
repression and transcript degradation have been observed in Drosophila, with some genes 
showing concordant decreases in both protein and mRNA levels, some genes showing 
decreases in protein levels without a corresponding decrease in mRNA levels (Behm-
Ansmant et al. 2006).  These different modes of action by miRNAs upon their targets have 
made computational prediction of miRNA target genes difficult, with accuracy rates 
(correctly predicted / total predicted) of only 50% (Alexiou et al. 2009). 
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 There are over 10,000 catalogued miRNAs in various species, with 579 reported in 
the mouse (miRBase, v14 (Griffiths-Jones et al. 2008)), with conserved miRNA target sites 
predicted in 20 to 60% of human genes (Xie et al. 2005; Friedman et al. 2008).  Several 
studies have surveyed the tissue-specific expression of miRNAs using microarrays.  Human 
studies reported tissue-specific miRNA expression, including the liver specific miR-
122a(Thomson et al. 2004; Shingara et al. 2005).  Murine studies also reported miR-122a as 
being highly expressed in the liver, along with miR-148a and miR-194(Babak et al. 2004; 
Beuvink et al. 2007).  MiRNA microarrays have also been combined with transcript 
expression arrays to search for correlations between miRNA and transcript expression, often 
in an effort to identify miRNA target genes.  These studies have shown that miRNA 
expression and the expression of their target transcripts are often negatively correlated 
(Arora and Simpson 2008; Ritchie et al. 2009), that miRNAs physically located within or 
near mRNA transcripts are positively correlated(Baskerville and Bartel 2005; Gennarino et 
al. 2009) and that miRNA function may be inferred by performing Gene Ontology analysis 
on transcripts with expression that is correlated with miRNA expression reveals functional 
coherence among the correlated transcripts. 
 Only a few studies have studied the effect of genetic variation on miRNA and 
transcript expression, 2 in human cell lines (Ruike et al. 2008; Wang et al. 2009) and one in a 
panel of inbred mice (Zhao et al. 2009).  In the present study, we profiled the expression of 
577 miRNAs using microarrays in two panels of mice, a BXD recombinant inbred cross and 
a panel of commonly used laboratory inbred mice.  We combine this with gene expression 
data, also measured using microarrays, from the same animals.  We found that miRNA 
expression is highly conserved across genotype, but that it was poorly correlated with target 
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transcript expression.  This suggests that liver transcript abundance is not regulated by 
miRNA expression levels.  
 
Methods 
 
miRNA Isolation. Total RNA was isolated using the Ambion (Austin, TX) miRVANA kit 
according to the manufacturer’s instructions.  RNA quality was assessed using the Agilent 
(Stanta Clara, CA) Bioanalyzer RNA Nano chip.  Small RNAs (< 40 nucleotides) were 
concentrated using the Ambion FlashPAGE system, applying 500 ug to each gel. 
miRNA Microarrays. The Agilent G4472A mouse miRNA microarray was used to measure 
miRNA expression.  Labeling and hybridization were carried out according to manufacturer 
instructions using 10 ng of concentrated small RNA on each array.  The Agilent miRNA 
microarray is a one color array and we performed quantile normalization on all arrays 
because a comparison of miRNA normalization techniques demonstrated the quantile 
normalization performed best by minimizing the mean square error in their experiment (Rao 
et al. 2008). 
 
Gene Expression Data. The BXD liver data set (GEO…) and the MDP liver data set 
(GEO…) were both run on the Agilent G4121A microarray platform.  The data was 
downloaded from the University of North Carolina microarray database (UNCMD, 
http://genome.unc.edu) using the log2 Lowess normalized red/green ratio (mean background 
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subtracted spot intensity).  A spot was excluded if it had a Lowess normalized net signal < 10 
in either channel. Transcripts detected on > 90% of the arrays were retained and arrays with 
non-null values for > 70% of transcripts were kept.  16,738 transcripts were retained in the 
BXD data and 14,214 transcripts were retained in the MDP data. The arrays were run in 
separate batches and batch effects were removed by subtracting the batch mean of each gene 
from the gene expression values.  Final values were normalized by fitting a linear model with 
strain, sex and the strain by sex interaction term to the gene expression data. 
 
miRNA to Transcript Expression.  Transcripts with putative miRNA target binding sites were 
downloaded from the Targetscan(Friedman et al. 2008), Miranda(Betel et al. 2008) and 
Pictar (Krek et al. 2005) websites.  For each miRNA target prediction algorithm and for each 
of the 144 detected miRNAs, we found the correlation of the predicted target transcripts with 
the current miRNA as well as the correlation of the non-target transcripts with the current 
miRNA.  We then performed a one-sided Student’s T-test against the alternative hypothesis 
that the target-to-miRNA correlations are lower than the non-target-to-miRNA correlations.  
To determine an empirical p-value for this test, we found the mean number of target 
transcripts per miRNA for each prediction algorithm, randomly selected 10,000 transcripts 
sets of the same size, and performed the T-test.  We then used the p-value distribution from 
the random sampling to obtain an empirical p-value that indicated whether the target 
transcripts were more negatively correlated with the miRNA than the non-target transcripts.  
Bonferroni corrected p-values (α ≤ 0.05) were used to select transcripts with significant 
negative correlation with their target miRNA.  This procedure was carried out separately in 
BXD and MDP data. 
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SNPs in miRNA Binding Sites. For each of the 20,868 transcripts on the array, we 
downloaded the Miranda (Betel et al. 2008) predicted miRNA binding sites.  We then 
intersected these sites with predicted SNPs, insertions and deletions between C57BL/6J and 
DBA/2J from the mouse resequencing track in Emsembl (Hubbard et al. 2009) to select 
1,160 transcripts which may be influenced by differential miRNA binding.  Of these, 943 
were detected on the array in the BXD data set.  For each transcript, we performed a two-
sided Student’s T-test of the transcript expression versus the BXD genotype in the 3’ UTR 
(from WebQTL: http://www.genenetwork.org/genotypes/BXD.geno).  Gene expression 
quantitative trait locus (eQTL) mapping data for the BXD strains (Gatti et al. 2007) was 
downloaded from WebQTL.  A set of 2,379 significant local eQTL was selected using 
Storey’s q-value (Storey and Tibshirani 2003) of 10% or less (p ≤ 0.05).  Fisher’s Exact test 
was conducted on a 2x2 contingency table with local/distant eQTL on one axis and SNP/ no 
SNP in a miRNA binding site on the other axis. 
 
MiRNA Quantitative Trait Locus Mapping.  BXD genotype data for 3,795 informative 
markers was downloaded from WebQTL (from WebQTL: 
http://www.genenetwork.org/genotypes/BXD.geno) and single marker mapping using 
FastMap (Gatti et al. 2009b) was performed on each of the 144 detected miRNAs.  MDP 
genotype data, consisting of 156,000 SNPs, from (McClurg et al. 2007) was used to perform 
haplotype association mapping in a 3–SNP sliding window (Pletcher et al. 2004).  Multiple 
testing across SNPs was addressed by performing 1,000 permutations of the SNP data for 
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each miRNA and calculating a p-value from the empirical distribution of maximum test 
statistics under permutation.  Multiple testing across miRNAs was addresses by applying the 
q-value algorithm to the maximum p-values from each miRNA and retaining those with 
qFDR < 0.1.  A local QTL was defined as a maximum QTL located within 5 Mb of the 
miRNA genomic location. 
 
Results 
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 Most tissue-specific studies of miRNA expression have used a few samples of each 
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tissue and did not vary the genotype.  However, three studies have examined the effect of 
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genetic variation on transcript and miRNA expression.  Genome-wide transcriptional and 
miRNA profiling in human lymphoblastoid cell lines showed that more transcripts are 
positively correlated with miRNA expression than are negatively correlated (Wang et al. 
2009).  The transcripts that were correlated with miRNA expression also exhibited some 
functional enrichment.  A similar analysis in 16 human cells lines found that some miRNAs 
were negatively correlated with their known target transcripts and that correlated transcripts 
showed functional coherence(Ruike et al. 2008).  Both studies also showed that miRNAs that 
are closely located in the genome (< 0.5 Mb) tend to be positively correlated with each other.  
Only one other mouse study has examined liver miRNA expression in wild type and ob/ob 
mutants derived from C57BL/6J and BTBT T+ tf/J strains and found approximately 150 
consistently expressed miRNAs (Zhao et al. 2009). 
Figure 6.1. Liver miRNA expression is consistent across genotype.  (a) Histogram of 
log2(miRNA intensity) across all strains with the 75th to 95th percentiles of the distribution 
colored from green to red.  (b) Mean log2(miRNA intensity) in the BXD and MDP strains 
with grey lines representing standard deviations in each panel.  Points are colored by the 
percentiles of the intensity distribution as in (a). 
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We profiled the expression of 577 miRNAs using the Agilent G4472 miRNA 
microarray in two panels of mice; a BXD recombinant inbred panel consisting of 36 strains 
and an inbred  laboratory mouse panel (Mouse Diversity Panel, MDP) consisting of 34 
strains.  The range of miRNA expression covered a 10-fold range (Figure 6.1a).  We selected 
the number of detected miRNAs by taking the top 75th percentile of the intensity distribution 
of all miRNAs.  The number of miRNA above various percentiles is shown in Table 6.1.  We 
also found that miRNA expression was remarkably consistent between strains (Figure 6.1b), 
with the liver-specific miR-122 showing the highest expression in all strains. 
 
Table 6.1. Number of detected miRNA at different thresholds. 
Percentile 75% 80% 85% 90% 95% 
Number of miRNA 144 117 85 56 29 
      
 We compared the 29 miRNAs with the top 95th-percentile of liver miRNA expression 
in this study with that of other mouse and human studies  (Figure 6. 2).  The most highly 
expressed miRNA in both the human and mouse liver is miR-122 (Girard et al. 2008).   miR-
21,  miR-22 and miR-192 are also consistently reported as highly expressed in many studies.  
miR-720, the fourth most highly expressed miRNA in our study was not reported by the 
other studies, possibly because is was first reported in 2006 (Mineno et al. 2006).  The miR-
30 family, of which miR-30a and miR-30a are the 9th and 15th most highly expressed in this 
study, has been reported as essential for hepatic development (Hand et al. 2009a). 
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 Next, we examined the correlation between miRNAs in the BXD and MDP data by 
hierarchically clustering the miRNA correlations in each panel (Figure 6.3a & b).  Several 
clusters appear in both panels and are marked with colored bars in between the two panels.  
The number of miRNAs in each cluster and the mean correlation within each cluster are 
shown in Table 6.2.  Surprisingly, transcript expression was not significantly correlated with 
the miRNAs in any cluster (p ≤ 5x10-6, q ≤ 0.1). 
Table 6.2. miRNA clusters in the BXD and MDP. 
Color # miRNA Mean BXD miRNA cor. 
Mean MDP 
miRNA cor. 
Red 12 0.898 0.943 
Orange 8 0.993 0.994 
Green 3 0.998 0.999 
Blue 5 0.990 0.992 
Purple 34 0.981 0.982 
Figure 6.2. Expression of the top 95% of miRNAs detected in the mouse liver in this study 
compared with 2 other mouse (Zhao(Zhao et al. 2009), Beuvink(Beuvink et al. 2007) and 4 
human (Thomson(Thomson et al. 2004), Girard(Girard et al. 2008), Shingara(Shingara et 
al. 2005), Barad(Barad et al. 2004)) liver miRNA surveys.  The data from each study is 
normalized to 1 and high values are shown in red, proceeding to lower values in grey and 
black.  White indicates no reported data. 
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It has been reported that the expression of miRNAs that are closely located in the 
genome  (approx. <0.5 Mb) tend to be positively correlated in human cell lines (Ruike et al. 
2008).  We examined the correlation between miRNAs on the same chromosome and plotted 
this versus the genomic distance between the miRNAs (Figure 6.4).  Consistent with these 
results, we found that miRNAs that are located within ~ 10,000 bp of each other tend to be 
positively correlated.  This finding is consistent with the idea that miRNAs that are closely 
located are co-transcribed together. 
 
 
 
Figure 6.3. MiRNA expression correlation is consistent between the MDP and BXD strains.  
The correlation of the expressed miRNAs in the MDP (a) and the BXD (b) is hierarchically 
clustered to reveal consistent patterns of co-expression.  Five clusters are marked with 
colored rectangles between the plots.  Colors are Pearson correlations ranging from 1.0 
(yellow) to -1.0 (blue). 
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Gene Expression 
 
 In order to understand how miRNA may regulate gene expression and vice versa, we 
correlated the miRNA expression with gene expression in both panels of mice.  Calculating 
the Pearson correlation of all 144 expressed miRNAs with all expressed transcripts in both 
panels yielded 234 significant miRNA-transcript correlations in the BXD panel and 1,176 in 
the MDP.  at a q-value ≤ 0.1 (p ≤ 2.83x10-7).  We noted that the correlation p-value 
distribution for some miRNAs was skewed toward 1.0 (Figure 6.5a).  This diluted the 
significance of miRNAs which appeared to have significant correlation with transcripts 
(Figure 6.5b).  We hypothesized that the large number of statistical tests along with the 
possibility that transcript degradation is not widespread in mammals diminished our ability 
to detect miRNA to target transcript correlations. 
Figure 6.4. MiRNAs that are closely located in the genome are more likely to be 
positively correlated.  The log10 of the genomic distance (in bases) is plotted versus the 
correlation of expressed miRNAs in the MDP (a) and the BXD (b) strains. 
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We then examined the correlations in a miRNA-specific manner to see if there were 
certain miRNAs that were significantly positively or negatively correlated with transcripts.  
For each detected miRNA in each data set, we calculated the Pearson correlation of the 
miRNA with all transcripts and selected significantly correlated transcripts (q ≤ 0.1).  There 
were 30 miRNAs with at least one significantly correlated transcript in both the BXD data 
set and 53 in the MDP, with an overlap of 12 miRNAs.  However, there was no overlap in 
the transcripts that were correlated with these 12 miRNAs between the two panels of mice.  
In the BXD panel, only miR-202-3p showed any GO or KEGG pathway enrichment for 
sensory perception of chemical stimulus (GO:0007606, p = 3.275 x 10-10), a category with 
many G-coupled receptors.  In the MDP, the transcripts correlated with miR-23a showed 
enrichment for ATP-dependent DNA helicase activity (GO:0004003, p = 6.673 x 10-5) and 
the transcripts correlated with miR-27a showed enrichment for endonuclease activity 
(GO:0004519, p = 1.107 X 10-4). 
Figure 6.5. P-value distributions from the correlation of a miRNA with all transcripts on 
the array.  (a) The Pearson correlation of miR-494 with transcripts on the array is 
skewed to the right. (b) The Pearson correlation of let-7c with transcripts on the array 
shows some significantly correlated transcript on the left. 
139 
 
   
Overall, the above approaches did not generate miRNA-transcript correlations that 
were reproducible in the two data sets or that provided a clear indication of the biological 
function of the transcripts that were correlated with each miRNA.  We tried a more targeted 
approach by downloading predicted miRNA gene targets from Targetscan(Friedman et al. 
2008), Miranda(Betel et al. 2008) and Pictar(Krek et al. 2005).  For each target prediction 
algorithm and each miRNA, we calculated the correlation of all predicted targets and non-
targets with the miRNA and performed a Student’s T-test to see if the predicted target 
transcripts were more likely to be negatively correlated with miRNA expression than non-
target transcripts.  This procedure was performed in the BXD and MDP separately.  MiR-
101a had a significant negative correlation with its target transcripts in both mouse panels 
using all three prediction algorithms.  MiR-101a has been associated with cyclooxygenase-2 
(Cox2) expression and cell proliferation in mammary gland development(Tanaka et al. 
2009), but we were unable to replicate this finding because Cox2 is not queried on the array 
platform that was used.  The target transcripts showed an enrichment for the “positive 
regulation of gene expression” GO Biological Process (BP) (p = 4.108 x 10-10).  We then 
looked for miRNAs that had consistent positive correlations with transcripts in both mouse 
panels.  Among the Targetscan predictions, miR-142-3p was positively correlated with a set 
of 61 transcripts in both panels and miR-30e with 38 transcripts, but neither set exhibited any 
GO or KEGG enrichment. 
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miRNAs in host genes 
 It has been reported that miRNAs that are located within or near transcripts are co-
expressed (Baskerville and Bartel 2005; Gennarino et al. 2009).  We downloaded the 
genomic locations of all miRNAs from the Sanger miRNA data base and intersected these 
locations with the transcript locations of all transcripts on the array.  Of the 144 detected 
miRNAs, 76 (52.8%) were located with transcripts.  For each data set, we calculated the 
Pearson correlation of each miRNA with the transcript nearest to it and found no significant 
positive correlations (p < 0.05) (Figure 6.6).   
 
 
 
Figure 6.6. MiRNA expression is not correlated with the expression of host transcripts.  
MiRNAs that are located within transcripts do not show significant positive correlation with 
the host transcript, as shown by the lack of p-value enrichment < 0.05.  (a) BXD strains, (b) 
MDP strains. 
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SNPs in miRNAs 
 
 It is possible for SNPs in miRNAs to increase target transcript levels by failing to 
properly bind to the target site on the transcript 3’ UTR.  We downloaded the sequence and 
location of all 600 mouse miRNA from the Sanger miRNA database and searched for SNPs 
in those regions using the mouse resequencing data on Ensembl.  There were 21 miRNAs 
with SNPs that differed between C57BL/6J and DBA/2J.  Of these, miR-24-2 and miR-680 
were detected in the BXD liver data set.  MiR-24-2 had a mean log2 expression of 9.4 in the 
BXD strains and contains a single SNP (rs49245174) in the pre-miRNA that does not affect 
the mature miRNA sequence.  We investigated whether this SNP might nevertheless affect 
miRNA expression or processing by performing a Student’s T-test of the miR-24 expression 
in strains containing the C57BL/6J allele versus the DBA/2J allele of miR24 and found no 
significant difference (p = 0.648).  Mir-680 has much lower expression (mean log2 5.95) in 
the BXD liver, but has 6 SNPs in two of its three genomic locations.  MiR-680-1 (Chr 6: 
129.6415 Mb) contains 4 SNPs (rs51107210, rs45902352, rs1356740, rs50887828) in the 
pre-miRNA, none of which affects the mature sequence and miR-680-3 (Chr 12: 35.8795 
Mb) contains 2 SNPs (rs49621977, rs48662351)in the pre-miRNA, one of which is within 
the mature sequence.  There was no difference in miR-680 expression based on the allelic 
content at the miR-680 locus on Chr 12 (p = 0.549) and none of the target transcripts of miR-
680 had an association to this locus (p ≤ 0.05). 
 
 
SNPs in miRNA Target sites 
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 MiRNAs are thought to regulate translation by binding to partially complementary 
sites in the 3’ untranslated region (UTR) of transcripts.   For each of the 20,868 transcripts 
on the array, we downloaded the Miranda (Betel et al. 2008) predicted miRNA binding sites.  
We then intersected these sites with predicted SNPs, insertions and deletions between 
C57BL/6J and DBA/2J from the mouse resequencing track in Emsembl (Hubbard et al. 
2009), leaving 1,160 transcripts, of which 943 were detected in the BXD data set.  Using the 
BXD genotype nearest the 3’UTR and the expression of these transcripts, we performed a 
two-sided Student’s T-test against the null hypothesis that there was no difference in 
expression between the two alleles.  We found 196 transcripts with p-values ≤ 0.01, 
suggesting that SNPs in miRNA binding sites may have an effect on transcript expression.  If 
this is the case, we hypothesized that some gene expression quantitative trait loci (eQTL) 
that are co-located within 5Mb of the transcript location (termed local eQTL) might be 
caused by SNPs in miRNA binding sites.  We downloaded eQTL for the expressed 
transcripts in the BXD data set and selected 2,379 significant eQTL with q-values ≤ 0.1 (p ≤ 
0.05).  We then tested the hypothesis that the proportion of local eQTL with SNPs in miRNA 
binding sites is greater than the proportion of distant eQTL (with eQTL farther than 5 MB 
from the transcript) with SNPs in miRNA binding sites using Fisher’s Exact test.  This test 
was highly significant (p = 2.357x 10-12). 
 
MiRNA Quantitative Trait Locus Mapping 
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 In order to discover genomic loci which may regulate the expression of miRNAs in 
the liver, we performed miRNA QTL mapping in both the BXD and MDP data sets (Figure 
6.7).   At a threshold of q ≤ 0.1 (p ≤ 0.05), there were 33 and 18 significant QTL in the BXD 
and MDP data sets respectively.  Mir-345, located on Chr 12: 109.2 Mb, has a local QTL at 
108 Mb and is the only QTL that replicated between the two data sets.  MiR-31 and miR-34a 
have local QTLs in the BXD data set and this is consistent with a previous report of local 
QTLs for these two miRNAs (Zhao et al. 2009).  Mir-31, miR-34a and miR-345 have local 
QTLs in the BXD data set and the remaining QTLs are distant. 
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Figure 6.7. MiRNA QTLs in the BXD and MDP. The maximum QTL location is plotted 
on the horizontal axis and the miRNA location on the vertical axis. 
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Discussion 
 In this report, we surveyed the expression of 577 miRNAs in the livers of two panels 
of inbred mice and detected 144 miRNAs consistently in all samples.  The first and most 
striking result is the great degree of similarity in miRNA levels across all samples, reflected 
by the low variance of miRNAs in both mouse panels in Figure 6.1.  This is consistent with 
the hypothesis that miRNA expression is important for liver homeostasis and the observation 
Dicer1 is required for overall mouse development (Bernstein et al. 2003).  Paradoxically, 
liver development and function is preserved when miRNA processing is abolished through 
the selective knockout of Dicer1 in the liver (Hand et al. 2009b).  However, as these 
selective Dicer1 knockouts aged, the authors observed progressive liver damage including 
increased apoptosis, cell proliferation and inflammation, suggesting that miRNAs are 
important, but that their effect on translation is subtle.   
 Several sets of miRNAs are co-expressed in both panels and, consistent with previous 
observations (Baskerville and Bartel 2005), many of these are physically located near each 
other in the genome.  Surprisingly, we were unable to detect significant positive correlation 
between miRNAs that lie near or within transcripts (Ritchie et al. 2009; Gennarino et al. 
2009).  Further, while several other approaches have successfully elucidated miRNA target 
genes in HepG2 cells (Wang and Wang 2006) and brain, liver, heart, kidney, lung, ovary, 
skeletal muscle and testes (Arora and Simpson 2008), we were unable to detect a significant  
number of miRNA targets using our approach.  We attribute this to the low variance of 
miRNA expression which limited our ability to detect both positive correlations with host 
transcripts and negative correlations with putative target genes.  These results suggest that 
miRNA target discovery is better conducted using tissue surveys (Huang et al. 2007), 
146 
 
case/control studies (Nunez-Iglesias et al. 2010) or targeted knock-down of specific miRNAs 
(Hand et al. 2009a).  The lack of GO category or KEGG pathway significance among 
transcripts that were correlated with miRNA expression may be due to the still poor 
understanding and annotation of genes in these databases (Bumgarner and Yeung 2009). 
 MiR-345 was the only miRNA with a QTL that replicated in the two panels of mice.  
While there is currently no known function for miR-345 in the liver, over-expression has 
been associated with progression toward oral squamous cell carcinoma (Cervigne et al. 
2009) and miR-345 has been shown to target multidrug resistance-associated protein 1 
(MRP1) in human MCF-7 cell lines (Pogribny et al. 2010).  In the mouse, Abcc1, the 
ortholog of human MRP1, plays an important role in regulating cellular concentrations of 
endogenous and exogenous compounds.  While there was no significant correlation between 
miR-345 and the Abcc1 transcript in our dataset and Abcc1 has no significant QTL in either 
panel (Gatti et al. 2007; Gatti et al. 2009a), there may be an undetected association with 
protein levels.  Mir-34a and miR-31 have both been shown to have local QTLs in the liver 
(Zhao et al. 2009) and the replication of this finding in a separate inbred mouse cross 
between C57BL/6J and BTBR <T+> tf/J leads to increased confidence in these results.  Mir-
34a was previously shown to be up-regulated by p53 and to be involved in the promotion of 
apoptosis  (Chang et al. 2007; Pogribny et al. 2009).  We searched for a SNP in the p53 
binding site identified by (Chang et al. 2007) and found no polymorphisms between 
C57BL/6J and DBA/2J to indicate that the QTL is caused by genetic variation at this site.  
Thus, the replication of the QTL for miR-34a in two separate crosses indicates that more 
complex regulatory mechanisms may exist.  MiR-31 is part of a group of miRNAs that, while 
transcribed, are not always processed to the mature form and exported from the nucleus (Lee 
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et al. 2008).  There are no polymorphisms between C57BL/6J and DBA/2J within 100 bases 
of miR-31.  However, it is possible that differential processing of miR-31 leads to different 
levels of the mature miRNA in different strains. 
 In conclusion, we have surveyed the expression of 577 miRNAs in the livers of 76 
inbred mice.  We detected a set of 144 miRNAs that are consistently present in all strains and 
find that the variance of miRNA levels between strains is low.  MiRNAs that are co-located 
in the genome tend to have expression profiles that are positively correlated.  Surprisingly, 
the expression of miRNAs located within the introns of genes were not found to be 
positively correlated with the expression of their host transcript.  MiRNA expression was 
also not highly correlated with the expression of predicted miRNA targets.  We attribute 
these two null findings to the low variance of miRNA profiles across genotype.  However, 
this strong conservation of expression levels across diverse genetic backgrounds suggests 
that miRNAs play an important, but poorly understood role in liver homeostatis. 
 
 
 
 
Chapter 7 
Conclusions and Future Directions 
 The number of parameters that can be measured in biological samples has increased 
dramatically in the past decade.  The sequencing of several mammalian genomes have allows 
high density genotype data to be generated containing millions of SNPs.  Gene expression 
microarrays generate tens of thousands of measurements per sample.  This explosion in data 
volume has been both a boon for biologists and a challenge for data analysts. 
 Here, we have analyzed several large expression data sets in the mouse liver.  We 
performed eQTL mapping in a panel of BXD mice and studied both strain and sex 
differences in expression.  eQTL mapping is primarily a hypothesis generating technique that 
produces potential regulatory relationships between genes and genomic loci.  The expression 
levels of genes with cis-eQTL are regulated by polymorphisms close to the gene and have 
proven more reproducible than trans-eQTL due to the more direct mechanism of regulation, 
i.e. a polymorphism in the promoter region.  We found the same to be true in our 
comparisons of the BXD and MDP data sets.  In many mouse crosses, the marker resolution 
is too coarse to allow direct discovery of genes that regulate other genes.  However, as 
demonstrated here with the Chr 12 locus, several techniques can be applied to narrow the list 
of likely regulatory genes.   
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 Many papers have focused on differences in gene expression between the sexes, 
although only a few have examined the complex interaction of sex and genotype by 
performing this type of analysis in a genetically diverse population.  Most studies have also 
focused on differences in gene expression.  We show here that there are also important 
differences in the connectivity of genes between the sexes, as evidenced by the differential 
degree of correlation between some clusters of genes between males and females.  While 
most clusters of genes are similarly correlated between males and females, the clusters with 
distinct correlations in each sex imply a different “wiring” of genes that may help to explain 
differences in liver metabolism between the sexes. 
 With the development of FastMap, we have moved closer to performing eQTL 
mapping in larger panels of mice with high density SNP data.  Human and mouse data sets 
are now being produced for consisting of millions of SNPs.  If the Collaborative Cross is 
able to produce 1,000 strains genotyped at 600,000 markers, this will provide a rich 
opportunity for genome wide systems genetics, provided that computational tools are able to 
keep up with the demands of larger data sets. 
 Several groups have examined the reproducibility of eQTLs in different panels of 
organisms.  They have consistently found that cis-eQTL are more reproducible than trans-
eQTL, a finding that is consistent with our study in the BXD and MDP mice.  
Encouragingly, we found that a number of genes in the Chr 12 eQTL hotspot replicated 
between the two studies.  This is an exciting result because it represents the only eQTL 
hotspot or which we are aware that has been replicated in the mouse.  The potential genes, 
transcription factors and miRNAs that are involved in the differential regulation of these 
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genes provide the best opportunity for further work in constructing networks of  co-regulated 
gene in the mouse liver. 
 Finally, we were surprised at the small degree to which miRNA expression 
influences gene expression.  While miRNAs have been shown to have roles in development 
and disease, in the mouse liver their influence on constitutive transcript abundance is mild.  
While we found that the expression of miRNAs closely located together in the genome tend 
to be positively correlated, we did not find significant correlation with transcript abundance.  
However, the relative expression levels of miRNAs were very consistent across strains, 
suggesting that miRNAs play some important role.  We speculate that miRNAs are 
expressed and retained in the cell, but may not be active under normal conditions.  When 
some external stimulus stresses the cell, they may be activated, in some as yet undiscovered 
manner, and regulate transcript abundance or protein levels to respond to the stessor event. 
 
Significance 
 
Several authors have studied gene expression and transcriptional regulation in the 
BXD strains (Chesler et al. 2005; Bystrykh et al. 2005).  Here, we present the first study of 
gene expression and transcriptional regulation in the BXD liver, examining both sex and 
strains differences.  We report a large number of cis- and trans-eQTL and several eQTL 
hotspots, one of which replicated in a separate panel of inbred mice.  The replicated eQTL 
between these two studies offer a robust set of genes for further analysis that are most likely 
to influence gene expression in many of the commonly used laboratory inbred mice. 
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EQTL mapping is a computationally intensive undertaking and will only grow in size 
as the number of transcripts and markers increases.  Exon arrays and next generation 
sequencing technologies will produce more than the current twenty to thirty thousand 
transcripts and the most recently developed mouse genotyping array queries over 600,000 
SNPs.  FastMap and the associated algorithm offer an improvement in computational speed 
that allows eQTL mapping to proceed on standard desktop computers as opposed to larege 
computing clusters.  The graphical interface allows biologists without a computational 
background to easily perform the mapping. 
Sex differences in liver metabolism have been studied in a number of model systems 
and several important discoveries have been made in studies with a single genotype.  A few 
reports have examined the interaction between sex and genotype by studying liver gene 
expression in a panel of male and female genetically segregating mice.  Here, we report the 
first study of sex differences in liver gene expression in the BXD recombinant inbred strains 
and find a large number of differentially expressed genes, some of which are consistent with 
previous work and some of which are new discoveries.  We also highlight the importance of 
examining differential correlation between sexes by finding clusters of genes that have 
different degrees of correlation between sexes, without a large difference in expression.  The 
existence of these clusters demonstrates that the male and female liver differ not only in 
expression differences, but in the internal wiring of coregulated genes.  This observation may 
also be important in studies of disease and toxicant exposure and differential correlation 
should be examined along with differential expression in such studies. 
MiRNAs have been implicated in the many areas such as organ development and cancer 
progression.  Here, we studied liver miRNA expression in two panels of inbred mice with the 
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expectation that miRNAs would have a measurable effect on transcript abundance.  Instead, 
we found that while miRNA expression is remarkably stable across genotype, its effect on 
transcript abundance is low.  This observation is consistent with a report that liver 
development and function are not impaired by the removal of the siRNA processing gene 
Dicer1 from the liver during development (Hand et al. 2009b).  We should be careful about 
the breadth of conclusions that we draw from this study.  It is possible that translational 
repression predominates over transcript degradation and as such, we were unable to detect 
the true influence of miRNAs on liver homeostasis with by measuring transcript expression 
with microarrays.  It is also possible that miRNAs are activated to respond to environmental 
stimuli and will show a much greater role in liver gene expression in response to treatment 
with toxicants.  Also, while miRNAs have a mild effect on transcript abundance in the 
mouse liver, it is possible that their effect is more pronounced in humans or other species. 
 This work has greatly expanded our working knowledge of the complex networks of 
transcriptional regulation in the mouse liver and has broadened our understanding of how 
genetic variation affects these networks.  We have leveraged the power of new, high-density, 
post-genome analytical tools to revolutionize the speed and magnitude of data that can be 
generated from a single experiment.  By applying sophisticated statistical techniques and 
rigorous biological investigation, we have replicated the first eQTL hotspot in two separate 
panels of commonly used laboratory mice.  The genes that are regulated by this locus have a 
major influence on liver metabolism and are certainly involved in a vide variety of biological 
processes.  While the discovery that miRNAs are not critical for liver transcriptional 
homeostasis was surprising, it is an important and valuable contribution to the hepatological 
literature because it suggests that miRNA expression does not vary greatly across genotype 
153 
 
in the murine liver.  Hence, toxicologists can focus their attention on other important causes 
of differential toxicity such as promoter and non-synonymous coding SNPs, variations in 
transcription factor activity and disruptions in cellular signaling. 
 
Limitations 
 
 The study of transcriptional regulation in panels of mice derived from two somewhat 
related parental strains has advantages and disadvantages.  The BXD strains are derived from 
the C57BL/6J and DBA/2J inbred strains, both of which are primarily descended from Mus 
musculus domesticus.  As such, they contain non-polymorphic regions that are identical by 
descent over ~45% of their genomes.  For an investigator that is studying differential alcohol 
metabolism, this is a benefit because it eliminates 45% of the genome from investigation.  
For the investigator interested in genome wide systems genetics, this produces “blind” 
regions that limit the amount of genetic variation that can produce expression changes.  
These regions are also the likely cause of the observed eQTL hotspots in inbred mouse cross 
experiments.  Gene expression is a complex trait in which many genes influence the 
expression of a single gene.  If the regions in which 4 out of 5 regulator genes lie is identical 
by descent between the two parental strains, then only the gene in the polymorphic region 
will have an allele specific influence on expression in a cross derived from the parental 
strains.  This influence will thus be more easily detected as a QTL, but fails to produce the 
full picture which includes all of the genes that regulate the expression of a given gene. 
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 While FastMap and its associated algorithm provide a 10 fold increase in speed for 
eQTL mapping, this comes at the expense of flexibility.  The current method does not permit 
the addition of additive covariate or interaction terms in the model.  This is a necessary 
compromise given the large size of eQTL data sets but would be a valuable addition to future 
versions of the software. 
 It is likely that the expression levels of most genes are regulated by a complex set of 
factors, some of which are activated at different times by different stimuli.  Here, we have 
examined regulatory relationships in untreated mice using constitutive gene expression.  
These regulatory relationships may change when external stimuli, such as toxicant dosing, 
are applied to the mice.  Hence, a gene with a cis-eQTL which arises due to a polymorphism 
in a certain transcription factor binding site may not show the same cis-eQTL when that 
transcription factor is no longer activated and other factors are regulating the gene’s 
expression.  Also, as mentioned above, miRNAs may play a greater role in the dynamic 
response to changing environmental conditions rather than in the maintenance of steady state 
liver conditions.  The approaches developed in this report should be applied to studies in 
which there is a disease or clinical phenotype which can be correlated with gene and miRNA 
expression levels. The addition of liver toxicity phenotypes to this would improve its utility 
since genes with eQTL that are collocated with clinical phenotype QTLs would be primary 
candidates for further investigation. 
 
Future Directions 
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 There are several directions in which this research could proceed.  The replicated 
eQTL hotspot on distal Chr12 represents the best candidate region for further study.  SiRNA 
knockdown of candidate regulator genes, such as the Serpina1 family, could be performed in 
cultures of primary hepatocytes from C57BL/6J and DBA/2J.  Quantitative PCR could then 
be performed on the putative regulated genes to discover which gene(s) are regulating the 
eQTL hotspot.  The high degree of sequence homology between the Serpina1s will produce 
some technical challenges in finding gene specific siRNAs, but even if a set of Serpina1 
genes can be knocked down together, this will narrow the list of candidate regulatory genes.  
This in vitro work could be followed up with in vivo work in which siRNAs are delivered to 
the liver via hydrodynamic tail vein injection. 
 The influence of transcription factors on gene expression would further our 
understanding of how transcriptional networks are wired in the liver.  A survey of 
transcription factor activity in the mouse liver for a large number of transcription factors 
would provide data that could be correlated with the gene expression microarray data to infer 
transcription factor targets as well as to construct causal networks that connect 
polymorphisms, transcription factors and regulated genes.  By measuring transcription factor 
activity in response to siRNA knockdown of gene suspected of regulating an eQTL hotspot, 
we would be able to develop a causal model that includes regulator gene expression, 
transcription factor activity and the regulated genes. 
How will all of these discoveries influence our ability to improve human health?  
While much of the work in this dissertation is at the level of basic science, it lays a 
foundation for understanding transcriptional regulation in the mammalian liver.  One of the 
long term goals of toxicology research is the creation of a computational model of the human 
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liver.  This task, which will likely involve supercomputing resources and require a decade or 
more to implement, will require detailed mechanistic information on the complex networks 
of transcription, translation and signaling that occur in the mammalian liver in order to make 
accurate predictions regarding chemical toxicity.  The data to construct these realationships 
will come from a wide variety of sources.  Many investigators will need to provide data on 
gene expression, metabolite production, protein abundance, transcription factor activity and 
intra- and inter-cellular signaling.  eQTL mapping provides a piece of the puzzle by 
generating hypotheses about the relationship between genotype and transcript abundance. 
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Appendices 
Appendix 1 
BXD Sample Information 
Strain Name Sex WebQTL Strain ID 
C57BL/6J M and F C57BL/6J 
DBA/2J M and F DBA/2J 
B6D2F1 M and F F1 
BXD1 M and F BXD1 
BXD2 M and F BXD2 
BXD5 M and F BXD5 
BXD6 M and F BXD6 
BXD8 M and F BXD8 
BXD9 M and F BXD9 
BXD11 M and F BXD11 
BXD12 M and F BXD12 
178 
 
BXD13 M and F BXD13 
BXD14 M and F BXD14 
BXD15 M and F BXD15 
BXD21 M and F BXD21 
BXD23 F BXD23 
BXD24 M BXD24 
BXD28 M and F BXD28 
BXD29 M and F BXD29 
BXD31 M and F BXD31 
BXD32 M and F BXD32 
BXD33 F BXD33 
BXD34 M and F BXD34 
BXD38 M and F BXD38 
BXD39 M and F BXD39 
BXD40 M and F BXD40 
BXD42 M and F BXD42 
BXD43 M and F BXD43 
BXD44 M and F BXD44 
179 
 
BXD45 M and F BXD45 
BXD48 M and F BXD48 
BXD51 M and F BXD51 
BXD60 M and F BXD60 
BXD62 M and F BXD62 
BXD69 M and F BXD69 
BXD73 M and F BXD73 
BXD77 M and F BXD77 
BXD85 M and F BXD85 
BXD86 M and F BXD86 
BXD92 M and F BXD92 
 
 
